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1 Summary   1 
1 Summary 
 
The blood-brain barrier (BBB) controls the passage of toxic and xenobiotic substances from 
the blood to the interstitial fluid of the brain. The transcellular pathway to the brain is strictly 
controlled by the morphological base of the BBB, the microvascular endothelial cells. These 
cells are linked with well developed tight junctions building up close connections between 
adjacent cells and prevent paracellular diffusion for various hydrophilic substances. 
Furthermore, these cells are equipped with a variety of transporters which actively extrude 
possibly harmful compounds from the cells back to the blood. Many in vitro models for the 
BBB are available but it is controversly discussed which model best approaches the in vivo 
situation. An in vitro-model of microvascular endothelial cells approves an investigation of 
mobility for pharmaceutics across the BBB and thus, allows prognoses for effective drug-
treatment of the brain. Furthermore, it allows investigations on the regulatory pathways 
controlling the tightness of cell-cell contacts. Many existing models are based on endothelial 
cell lines, like the endothelioma cell line bEnd5 from mouse brain capillaries. These cells are 
immortalised and not comparable to the in vivo situation. Other models are not even based on 
brain-derived cells like human umbilical vain endothelial cells (HUVEC) or peripheral 
microvessel endothelial cells1.  
To complete the investigations of a well established porcine primary capillary endothelial cell 
culture model of the blood-brain barrier, a new model was established based in mouse-derived 
brain microvascular endothelial cells. After the characterisation of this model the effect of the 
glucocorticoid hormone hydrocortisone on the blood-brain barrier properties of the cultured 
cells was investigated. By determination of the transendothelial electrical resistance it could 
be shown that hydrocortisone leads to altered barrier properties of the cells cultured in serum-
free medium. This finding is accompanied by a change in the cell shape and redistribution of 
actin filaments. The advantages of a murine based model of the bbb are the availability of 
murine-specific antibodes, the known genomic data and the possibility to use knock out 
animals for further relevant studies. Together with the primary culture of porcine 
microvascular endothelial cells, two reliable in vitro models are now available to mimic the 
blood-brain barrier phenotype in vitro. The murine system facilitates application of modern 
                                                 
1 Nakagawa, S., Dohgu, S., Yamauchi, A., Shirabe, S., Kataoka, Y., Niwa, M.;  An in vitro model of the blood 
brain barrier with human peripheral microvessel endothelial cells; poster on the “Sixth Symposium on Signal 
Transduction on the Blood-Brain Barrier” Szeged, Hungary, 2003 
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molecular biological methods using the advantages of this model while the porcine system 
with its high electrical resistance and low sucrose permeability corresponding to the in vivo 
situation allows determination of permeability for pharmaceutics. Both systems give a good 
basis for further physiological studies and the investigation of the pharmacokinetical 
background. 
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2 Introduction 
 
The blood-brain barrier (BBB) provides both, anatomical and physiological protection for the 
central nervous system (CNS). The barrier strictly regulates the entry of substances, proteins 
and blood borne cells into the nervous tissue. Pharmacological treatment remains difficult for 
disorders of the central nervous system like Kreuzfeld-Jakob-Syndrom, Alzheimer and 
Multiple Scleroses due to poor drug passage across the blood-brain and the blood-
cerebrospinal fluid barriers (Frick, 1965; Gardner, 1968; Spector and Johanson; 1989). The 
blood-brain barrier builds up a boundary between the blood and the brain interstitium and is 
morphologically based on endothelial cells lining the microvascular capillaries in the brain. 
The blood-cerebrospinal fluid barrier is mainly located in the choroid plexus separating the 
blood in the choroid plexus capillaries from the cerebrospinal fluid that fills the ventricles and 
cushions external surfaces of the brain. Both barriers provide a defined ionic environment for 
the brain and control strictly the passage of substances by restricted passive diffusion and by 
various transport phenomena like facilitated diffusion, active transport mechanisms, receptor 
mediated endocytosis and metabolism. On one hand these features provide the brain with 
nutrients and keep the homeostasis of the brain interstitium and on the other hand they 
prohibit the treatment of brain disorders with drugs. Thus, it is important to understand the 
regulation of the blood-brain barrier permeability as well as the transport mechanisms. 
 
 
2.1 Barriers of the central nervous system 
 
The brain, especially the neuronal signal transduction, is sensitive against infinitesimal 
changes in composition of the interstitial fluid. The signal transduction of neurons is mediated 
in two ways: the rapid propagation of electrical activity along the neuronal axons by 
modulation of the membrane potential mediated by voltage-gated Na+-channels and the 
transmission across the synaptic cleft with neurotransmitters regulated by voltage-gated Ca++-
channels (Alberts et al., 1998). Both processes require a stable chemical milieu of the 
interstitial fluid because changing its chemical composition would disturb the well regulated 
signal transduction (Bradbury, 1993). Furthermore, an unhindered entry of neurotoxic 
substances into the interstitial fluid would influence the chemical signal transduction within 
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the synaptic cleft (Abbott, 1992). Thus, the chemical environment of the brain parenchyma 
needs to be separated from the blood-stream. Furthermore, neurotoxins must be hindered from 
entering the brain, as neurons have to last a lifetime without replacement because they are 
terminally differentiated and are unable to divide (Alberts et al., 1994). The chemical 
composition of the blood, respectively, hormones, amino acids and ions fluctuates in the body 
especially after meals or bouts of exercises. If the brain is exposed to such fluctuations, the 
result might be uncontrolled nervous activity, since some hormones and amino acids serve as 
neurotransmitters. Especially potassium ions influence the threshold for the firing of nerve 
cells. 
 
 
2.1.1 Historical background 
 
The concept of a barrier system in the brain arose in the late 19th century. The bacteriologist 
Paul Ehrlich observed that certain dyes, administered intravenously to small animals, stained 
all of the organs except the brain tissue (Ehrlich, 1885). Ehrlich´s interpretation of this 
observation was that the brain has a lower affinity for the applied dyes. Somewhat later, in 
1898, Roux and Borrel observed that tetanus toxin injected into cerebrospinal fluid caused 
marked cerebral symptoms but when administered intraveniously, produced no discernible 
cerebral effect in these animals (Roux, 1889). In 1913, Goldman injected the dye trypan blue 
directly into the cerebrospinal fluid of rabbits and dogs and found that the dye readily stained 
the whole brain but did not enter the bloodstream to stain the other organs. Thus, Goldman 
showed that the central nervous system is separated somehow from the blood by a barrier of 
some kind (Goldmann, 1913). His findings correlated with the other researchers (Roux, 1889, 
Lewandowsky, 1900) and these three investigators attributed their results to special 
permeability properties of small blood vessels in the brain. But the hypotheses that capillaries 
provide the anatomical base of the barrier properties was not confirmable in the early 20th 
century as no method was available to investigate the small ultrastructure of the blood vessels 
in the brain. With the development of electron microscopy, in the 1950´s insights into the 
anatomical structures of the brain were provided. Today, detailed information about the 
cellular organization of the different permeability barriers of the central nervous system are 
available (Saunders et al., 1999). 
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2.1.2 Barrier systems in the mammalian brain 
 
There are different structures in the brain which maintain the homeostasis of the brain 
interstitium: A large network of cerebral capillaries, which separates the bloodstream from the 
brain interstitial fluid and which is defined as the blood-brain barrier (BBB), an arachnoid 
membrane that covers the brain’s outer surface and a highly vascularized choroid plexus 
(figure 2-1). The latter structures act as barriers between the blood and the cerebrospinal 
fluid (CSF) and are named blood-cerebrospinal-fluid barrier (BCFB). While these two 
systems protect the central nervous system at its macroscopic border areas, the BBB controls 
the entry and exit of compounds within the brain and is mainly responsible for providing the 
brain with necessary nutrients. The choroid plexus produces the cerebrospinal fluid, which 
contains nutrients, ions and other essential molecules and which flows through the ventricular 
system, around the spinal chord, into the subarachnoid space surrounding the brain and drains 
back into the blood. Finally, the cerebrospinal fluid forms a protecting fluid layer around the 
brain that cushions bumps against the skull during abrupt movements and it provides the brain 
with nutrients and ions. As the cerebrospinal fluid freely exchanges substances with the 
interstitial fluid which surrounds the brain’s neurons, the BCSFB must also keep toxic 
compounds out of the brain. 
Figure 2-1: Schematic view of the mammalian brain. Overview about the ventricles of the choroid 
plexus. (Spector and Johanson, 1989) 
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While the subarachnoidal membrane is generally impermeable for water-soluble substances 
and its role in forming the BCSFB is largely passive, the choroid plexus, however, actively 
regulates concentrations of molecules in the CSF. According to that, the BCSFB-barrier is an 
active barrier. Different from the BBB the capillary epithelial cells in the choroid plexus are 
fenestrated (Keep and Jones, 1990). Here the surrounding epithelial cells are sealed together 
by intercellular junctions that impede the passage of even small water-soluble molecules 
between the blood and the CSF. Active transport systems provide an ion gradient across the 
epithelial cell layer which results in a net transport of NaCl and thereby induces an 
osmotically driven water flow into ventricles forming the CSF. Additionally, the CSF is 
enriched by active transport systems with substances derived from the blood which are 
essential for the brain, but only in a small amount, like vitamin C, folates, vitamin B6 and 
desoxiribonucleosides (Spector and Johanson, 1989).  
 
 
2.2 Organization of the blood-brain barrier 
 
Brightman and Reese (1969) were the first, who showed by electron microscopy, that the 
capillary endothelial cells are the anatomic structures of the blood-brain barrier. After 
injecting horseradish peroxidase into the blood stream, in most organs the enzyme penetrated 
the capillary wall through channels and gaps between adjacent endothelial cells or it was 
engulfed in pinocytotic vesicles. In the brain, the infiltration of peroxidase was stopped by the 
tight connection between adjacent endothelial cells. Later, Brightman and Reese injected 
horseradish peroxidase into one of the cerebral ventricles and observed that the enzyme was 
distributed in the extracellular space of the brain, but it was prevented from leaving the brain 
by the tightly joined endothelial cells (Brightman and Reese, 1969). 
Figure 2-2 shows a micrograph of a cross-section of a brain capillary and adjacent glia cells. 
The capillary lumen (1) is completely surrounded by endothelial cells, which are inter- and 
intracellular connected with tight junctions. These junctions seal off the intercellular cleft 
against smallest molecules and actually convert the endothelial cell layer into a closed 
interface between the blood and the brain interstitium. At the abluminal (basolateral) side the 
cells are surrounded by a 100 – 150 nm thick basement membrane built up by extracellular 
matrix molecules (2). The main molecules are laminin A and B, fibronectins, collagen IV and 
proteoglycans (Krause et al., 1991). Embedded within this basement membrane the pericytes 
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are localized (3). Different from smooth muscle cells of the larger vessels, the pericytes are 
not assembled in capillaries but their cell bodies are orientated parallel to the capillary while 
its long processes extend around the capillary (Shepro and Morel, 1993). Their exact function 
is unclear, but experimental evidence indicates that they influence cell proliferation 
(Balabanov and Dore-Duffy, 1998; Orlidge and D´amee, 1987) and play a role in 
phagocytotic procedures of neuronal immune defence (Balabanov and Dore-Duffy, 1998) or 
other transport processes (Krause et al., 1991; Sims, 1986). And finally they participate in 
endothelial differentiation (Balabanov and Dore-Duffy, 1998). The brain capillary is 
separated from the surrounding tissue by the so-called Membrana limitans gliae 
perivascularis, which consists of the astrocytic end feet (4). The astrocytic end feet cover 
99% of the surface of the capillaries and form cell-cell contacts to the surrounding neurons 
(Pardridge, 1993). They ensure a rapid recovery of the resting membrane potential of the 
neurons by uptake of potassium ions directly after an action potential was triggered (Hertz, 
1989). Furthermore, it is controversly discussed, if astrocytes play an important role in the 
induction of the blood-brain barrier phenotype (Holash et al., 1993; Minakawa et al., 1991; 
Stewart and Wiley, 1981; Svendgaard et al., 1975). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2: Micrograph of a cross-section of a brain capillary (Krstic, 1988). 
(1) lumen with erythrocyte; (2) basal lamina; (3) pericyte; (4) astrocytic end foot; (5) tight junctions. 
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2.2.1 Cell-cell contacts between brain capillary endothelial cells 
 
The brain capillary endothelial cells form a single layer and a continuous interface between 
the blood and the interstitial fluid. So they form a “belt-like” structure that inhibits passive 
diffusion and unspecific passage of compounds to the brain. The structural features of the 
cells are responsible for these properties of the whole capillary. The single cells form neither 
pores nor fenestrations. Additionally, the number of vesicles is much lower than in other 
capillaries like for instance in muscles (Betz, 1886). Three major functions are implicated in 
the term blood-brain barrier: First, the protection of the brain from the blood milieu as 
achieved by complex tight junctions. Second, the selective transport by specialised transport 
systems either to provide the brain with necessary nutrients or to remove metabolites and 
finally, the metabolism or modification of blood- or brain-borne substances. 
The apparently most interesting structural attribute of the blood-brain barrier are the so called 
tight junctional complexes (figure 2-3). They are the molecular basis of the blood-brain 
barrier and form a continuous belt around the cells and seal the paracellular cleft between the 
cells (Reese and Karovksy, 1967). In electron micrographs of freeze fracture replicas, the 
tight junctions appear as a network of small ridges on one side, and complementary grooves 
on the opposite side (Dermietzel, 1975; Nico et al., 1992). The molecular structure of the tight 
junctions is still not completely clarified, but there is unequivocal evidence for a lipidic and 
proteinaneous nature of these structures.  
 
Figure 2-3: Molecular structure of the tight junctions. The cellular cleft is sealed with the 
transmembrane proteins occludin and different claudins. Directly associated is ZO-1 which belongs to 
the family of membrane-associated guanylate kinases (MAGUK). The tight junctional zone is linked to 
the cytoskeletal elements (actin stress fibres). Figure taken from (Fanning et al., 1999). 
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Following the lipidic model of Kachar and Reese, the exoplasmatic membrane-domains of the 
lipid bilayer of two adjacent cells fuse. As a consequence of this, a continuous lipid-layer at 
the apical part of the junctions is formed. The tight junction strands are formed by lipidic 
cylinders in which lipids are arranged in inverted micelles (Grebenkamper and Galla, 1994; 
Hein et al., 1992; Karchar and Reese, 1982). The protein model is based on transmembrane 
proteins located at the cell-cell contacts. The proteins span the intercellular cleft and are 
connected extracellulary by non-covalent protein-protein interactions (van Meer et al., 1986; 
van Meer and Simons, 1986). The participation of the transmembrane proteins occludin 
(Furuse et al., 1993), different transmembrane proteins from the family of claudins (Furuse et 
al., 1998) as well as the cytosolic peripheral membrane proteins Zonula Occludens-protein-1 
(ZO-1) (Stevenson et al., 1986), ZO-2 (Jesaitis and Goodenough, 1994) and ZO-3 (p130) 
(Anderson et al., 1993; Haskins et al., 1998) is generally excepted. The proteins cingulin (Citi 
et al., 1989) and 7H6 antigen (Zhong et al., 1993) seem to be associated to the tight junctions 
as well. One model which proposes a combined lipid and protein model was published by 
Wegener and Galla (Wegener and Galla, 1996). In this model the proteins are responsible for 
the formation of inverse micellar structures within the tight junction strands. Wolburg (2000) 
has suggested that the P-face association of tight junction particles in electron micrographs 
from freeze fracture micrographs is an indicaton of a functional barrier (Kniesel and Wolburg 
2000; Wolburg et al., 1994). Besides these morphological investigations, substantial data 
implies that the phosphorylation state of the junctional proteins is involved in the restricted 
permeability characteristics in brain capillary endothelial cells rather than the quantity of the 
proteins (Kniesel and Wolburg, 2000; Rubin and Staddon, 1999). 
 
 
2.2.2 Selective transport functions of capillary endothelial cells 
 
As the tight junctions seal the paracellular cleft of adjacent brain capillary endothelial cells, 
each transfer of compounds across the brain endothelium has to be transcellular. There are 
several essential transfer mechanisms which stabilise the interstitial brain environment as well 
as supply the brain with adequate important nutrients. The most decisive factor for passive 
diffusion across the blood-brain barrier is the lipophilic solubility, which enables the 
molecules to dissolve into and pass through the lipidic core of the cell membranes. What 
happens inside of the predominantly aqueous interior of the cell is unclear but presumably 
such lipid-soluble molecules are able to leave the cytoplasm at the other side of the cell along 
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the concentration gradient to reach the interior of the brain. Several studies have shown a 
clear correlation between the octanol/water partition coefficient and penetration into the brain, 
as long as the regarded compound is not a substrate for any specific transport system (Levin, 
1980; Lohmann et al., 2002; Pardridge, 1993). Apart from the lipid solubility, the molecular 
size is another key factor that determines the penetration of a molecule into the CNS 
(Abraham et al., 1994; Habgood et al., 2000; Habgood et al., 1999). 
 
D-glucose, the main source of energy for the brain, enters the brain via facilitated diffusion. In 
the brain the glucose transport via the GLUT-1 protein (Crone, 1965) is highly stereospecific 
for D-glucose (Johansson, 1990) and directed from a region of high concentration (blood) to a 
lower concentration (brain). In such movement, the gradient provides the energy source for 
transport and the carriers merely facilitate the diffusion. Without the carriers, transport would 
occur more slowly. The stereospecific transport of large amino acids, required for the 
synthesis of neurotransmitters and proteins, occurs the same way with specific transporters 
(Oldendorf and Szabo, 1976).  
 
Other systems transport substances actively against their concentration gradient across the 
blood-brain barrier endothelium. These transport processes require external energy. For 
instance the small neutral amino acid transporter is distributed in the abluminal membrane to 
ensure that those acids can be transported out of the brain into the endothelial cell (Goldstein 
and Betz, 1986). These transporters protect the CNS from glycine or GABA, for instance, 
which act as neurotransmitters (Dermietzel and Krause, 1991). In the case of glycin, the 
inward movement is coupled to the sodium gradient to provide the needed energy.  
Some substances are transported from the blood to the brain interstitium by receptor-mediated 
endocytoses. Brightman (1989) found receptors for insulin present in the luminal membrane 
of brain capillaries, but it is still unclear whether insulin is degraded within the endothelial 
cells or transported into the brain (Brightman, 1989). Another active carrier system is the 
receptor mediated transport protein transferrin which ensures the supply with ferrum. The 
luminal membrane localised transferrin receptor presumably releases ferrum after 
internalising transferrin as Fe2+ or a low molecular complex across the abluminal membrane 
to the brain interstitum (Bradbury, 1993). 
Another system of protection is a transport system which carries lipophilic substances out of 
the endothelial cells and is incorporated into the plasma membrane. This system, called the 
Multi-Drug Resistance-System, consists of different transport proteins like P-glycoprotein 
2 Introduction  11 
(Pgp) (Cordon-Cardo et al., 1989; Schinkel et al., 1994) and the brain multidrug resistance 
protein (BMDP) (Eisenblatter and Galla, 2002). These proteins belong to a group of ABC-
transporters protecting the brain by active transport of toxic substances provided with energy 
by ATP. 
 
 
2.2.3 Metabolic elements of the blood-brain barrier 
 
The combination of permeable barriers and selective transport mechanisms is not the only 
means of the blood-brain barrier to prevent the brain from uncontrolled chemical fluctuations 
within the interstitial fluid. Compounds that enter the endothelial cells either due to their 
lipophilic nature or to their affinity to one of the transport proteins can be converted by 
metabolic processes into a chemical compound incapable of traversing the abluminal 
membrane. For example, 4-hydroxy-tryptophane and L-dopa are carried by the L-system of 
amino acid transporters to the cytosol of the endothelial cells. An uncontrolled passage across 
the abluminal membrane would be dangerous because these compounds are precursors of the 
neurotransmitter serotonin and dopamine. Once in the endothelium, these substances are 
converted to dopamine and dihydroxyphenylacetic acid  (DOPAC) and cannot cross the 
luminal membrane into the brain. This phenomenon, which is found for a lot of compounds 
(Goldstein and Betz, 1986; Greig 1992; Johansson, 1990; Vorbrodt, 1988) is called the 
metabolic blood-brain barrier. 
 
 
2.3  In vitro models of the blood-brain barrier 
 
There has been considerable interest in establishing blood-brain barrier cell culture models. 
The original reason was to set up an assay system for pharmacological studies to predict drug 
penetration across the blood-brain barrier. Examinations on cell cultures are better represented 
and more reproducible. Larger quantities of cell populations are accessible in in vitro studies 
as well as working with cell culture models avoids animal experimentation. Another major 
reason has been to understand the modulation of barrier properties and the phenotypical 
characteristics of isolated capillary endothelial cells. In culture, numerous structural and 
functional properties of capillary endothelial cells, including junctional tightness, rate of 
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endocytosis and presence of specific transporters, can be assayed reproducibly. Cell culture is 
also an excellent tool to investigate pathological disorders affiliated to the blood-brain barrier, 
such as brain tumours, Alzheimer´s disease, Multiple Scleroses and AIDS-associated 
syndromes. Using the cell culture also gives an advantage in analysing transmigration 
processes in inflammatory states of the endothelial cells or blood-brain barrier dysfunction 
caused by the Malaria pathogen Plasmodium falciparum (Brown et al., 1999). Information 
from pharmacological, physiological and pathological investigations could accelerate the 
development of new pharmaceuticals and novel drug delivery strategies. The major goal is the 
derivation of microvascular endothelial cell-cultures which express the blood-brain barrier 
phenotype. Therefore, it is necessary to identify common features of endothelial cells from 
large vessels and of cerebral microvascular endothelium to clarify, to what extent cultured 
cells are differentiated. Common endothelial features are listed in table 2-1. 
 
Table 2-1: Common Features of Endothelial Cells (Deli and Joo, 1996) 
Characteristics Authors 
Presence of General Endothelial Markers  
Factor VII-related antigene (Phillips et al., 1979a) 
Alkaline phosphatase (Bowman et al., 1981a; Karnushina et al., 1980b) 
Specific binding of lectins (Diglio et al., 1982) 
Uptake of acetylated LDL (Krause et al., 1982; Tontsch and Bauer, 1989) 
Active Arachidonic Acid Metabolism  
Presence of cyclooxigenase (Gecse et al., 1982; Gerritsen et al., 1980; Gesce 
et al., 1981; Goehlert et al., 1981; Maurer et al., 
1980) 
Presence of lipooxigenase (Moore et al.; 1988a; Moore et al., 1988b) 
Prostacycline synthesis (Chamoux et al.; 1991; Marceau et al., 1989; 
Rosenthal and Jones, 1988) 
Reactive Second Messenger Systems  
Adenylate cyclase (Baranczyk-Kuzma et al., 1992; Joo et al., 1975; 
Joo and Toth, 1975; Palmer et al., 1980a; Palmer 
et al., 1980b) 
Guanylate cyclase (Homayoun et al., 1989; Joo et al., 1983; 
Karnushina et al., 1980a; Nakane et al., 1983) 
Protein kinase C (Catalan et al., 1989; Hanson-Painton et al., 
1993; Krizbai et al., 1995; Markovac and 
Goldstein, 1988) 
Calcium/calmodulin-dependent protein kinase II  
Synthesis and Secretion of Vasoactive 
Substances 
 
(Deli et al., 1993) 
Nitric oxide (Durieu-Trautmann et al. 1993; Morin and 
Stanboli 1993) 
Endothelin (Bacic et al., 1992)  
Angiotensin II (Gimbrone et al., 1979) 
 
The distinguishable features of cerebral microvascular endothelial cells from other 
endothelium are the presence of tight interendothelial junctions, the paucity of pinocytotic 
activity (Brightman and Reese 1969, Joo 1971), high number of mitochondria (Oldendorf et 
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al., 1977), the absence of fenestrations (Stewart et al., 1994) and expression of specific marker 
enzymes like transferrin receptors (Jefferies et al., 1984) and γ-glutamyltranspeptidase 
(Orlowski et al., 1974). However, among the variety of specialised properties, the most 
important one is an efficient endothelial barrier function with a low paracellular permeability, 
which can easily be probed by monitoring the passage of small solutes (e.g. sucrose or inulin) 
across the cellular monolayer. Often used tracer methods, however, have a rather limited time 
resolution and tight junction complexity and barrier function is most sensitively and readily 
quantified by the measurement of the transendothelial electrical resistance (Schneeberger and 
Lynch, 1992). 
 
 
2.3.1 Primary cultures of brain capillary endothelial cells 
 
In 1978, Panula and coworker demonstrated that isolated rat brain microvessel endothelial 
cells could be kept in culture (Panula et al., 1978). Today, most research groups use a primary 
culture of brain capillary endothelial cells (Audus et al., 1996) derived from rat (Abbott et al., 
1992a, Barrand et al., 1995), dog (Speth and Harik 1985) cow (Audus and Borchardt 1987, 
Cecchelli et al., 1999, Dehouck et al., 1990; Meresse et al., 1989, Rubin et al., 1991), pig 
(Mischek et al., 1989; Hoheisel, 1998), primate (Shi and Audus, 1994) or human brain 
(Stanimirovic et al., 1996) (see also table 2-2). In general, the brain tissue is either 
enzymatically or mechanically dispersed followed by filtration and centrifugation steps. The 
cultured cells evince the typical properties of microvascular endothelial cells which include 
the typical protein pattern, attenuated pinocytosis, lack of fenestrations and tight junctions 
(Audus and Borchardt, 1986; Audus and Borchardt, 1987; Bowman et al., 1983). However, 
the isolation of pure endothelial cells, as a blood-brain barrier model, is fraught with a number 
of problems. Even though there have been improvements in techniques for isolation and 
growth of the cells, the process is still time consuming, labour intense and expensive. 
Isolating primary endothelial cells is prone to preparation variations, the cells are fastidious in 
their growth requirements and they have a limited life and utility span. Furthermore, very 
often cells de-differentiate in vitro. These facts lead to the difficulties in comparing results 
from experiments with different cell preparations or passages. 
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2.3.2 Cell lines as in vitro models of the blood-brain barrier 
 
An alternative approach is the cultivation and investigation of immortalised brain capillary 
endothelial cells which would represent a significant progress in this area as long as they can 
be shown to maintain their barrier properties and characteristics. Higher reproducibility, more 
homogeneity, the ease of propagation, a short population doubling time and the lack of 
exogenous growth requirements motivate researchers to develop cell lines derived from rat 
(Durieu-Trautmann et al., 1991; Greenwood et al., 1996, Lechardeur et al., 1995, Roux et al., 
1994, Tan et al., 2001; Trautmann et al., 1993) bovine (t-BBEC-117; (Sobue et al., 1999); 
(Stins et al., 1997), porcine (PBMEC/C1-2; (Teifel and Friedl, 1996) and human brain 
microvessels (SV-HCEC) (Muruganandam et al., 1997). There are several alternatives to 
immortalise the isolated endothelial cells. Exposing to radiation causes random modification 
in the genome which can lead to an immortalisation of cells. Culturing these clones followed 
by a characterisation of the cell´s properties can lead to a blood-brain barrier related cell line. 
Other prevalent methods are transfection with SV40 thermosensitive large T gene 
(Lechardeur et al., 1995), viral oncogenic immortilization with polyoma virus early genes 
(Robinson et al., 1986), Rous sarcoma virus E1A gene (Roux et al., 1994) or SV40 early 
genes (Durieu-Trautmann et al., 1991; Tatsuta et al., 1992). However, to date, none of these 
immortalised cell lines express all of the features necessary for an entirely useful blood-brain 
barrier model in a consistent fashion. There have been attempts to induce the blood-brain 
barrier differentiation in endothelial cell lines (Lechardeur et al., 1995) but no cell line 
expresses all features of a reliable blood-brain barrier in vitro model. This is particularly 
evident for measuring the barrier function and integrity by transendothelial resistance. Some 
cerebral endothelial cell lines have been shown to restrict the passage of macromolecules and 
have been used in studies of paracellular permeability. None of them have been shown to 
consistently express a transendothelial resistance that is comparable to blood brain barrier in 
vivo situation. 
To overcome this problem several attempts have been made to reinduce blood-brain barrier 
properties in endothelial cells (cell lines and primary cultures of endothelial cells) by co-
culturing them with astrocytes or glioma cells (Gaillard et al., 2000; Gaillard et al., 2001; 
Hurst and Fritz, 1996; Rubin et al., 1991) or brain-derived factors (table 2-2). There is 
substantial evidence that the establishment and maintenance of the unique cerebral endothelial 
cell phenotype results from the neuronal milieu especially specific interactions provided by 
astrocytic foot processes which surround the brain microvessels (Dermietzel and Krause, 
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1991; Janzer and Raff, 1987; Stewart and Wiley, 1981). Furthermore, numerous studies have 
utilised conditioned medium generated from cultures of rat brain astrocytes or C6-glioma 
cells and found that induction does not require direct cell-cell interactions (Cancilla et al., 
1993; Dehouck et al., 1994; Hurst and Fritz, 1996; Igarashi et al., 1999; Ramsohoye and Fritz, 
1998; Raub, 1996; Rist et al., 1997; Rubin et al., 1991). However, neither cocultures with 
astrocytes, nor addition of astrocytic conditioned medium provide endothelial cell monolayers 
with such low sucrose permeability properties found in vivo. 
 
Table 2-2: Effects of compounds on different blood-brain barrier models in vitro 
(modified from Beuckmann and Galla, 1998) 
Species and cell type Influencing factor Effects on 
Bovine bcec subcultured A Tight junctions 
Bovine bcec ACM, cAMP TEER, Psucrose 
Bovine bcec  Forscolin, phorbol esters, 
A, ACM 
Tight junctions, TEER, Pinulin 
Bovine bcec 3. passage A-CCM TEER, GGT, Psucrose, Pinulin 
Human umbilical vein EC A-CCM, ACM ALP, tight junctions 
Bovine bcec C6, astrocytoma-CM TEER, Psucrose, Pdextran Ppeg, GGT 
Bovine bcec cloned C6-PM GGT, NaK-ATPase 
Bovine bcec cloned C6,C6-PM, neuron PM GGT, NaK-ATPase 
Bovine bcec primary A, C6 ALP, GGT 
Bovine bcec primary ACM, C6-CM GLUT-1 
Human bcec A Butury-choline esterase 
Porcine bcec primary HC TEER, Psucrose, protein patterns, P-
glycoportein, capillary-like 
structures 
Porcine bcec primary A, C6 ALP, GGT 
Porcine and murine bcec cloned Heparin, ECGF Protein patterns 
Canine bcec - GLUT-I 
Bovine bcec cell line Bovine brain 
homogenate, TNF-α 
GLUT-I, actin 
Bovine bcec cloned A-CCM LDL-binding 
Porcine bcec primary A, C6, NB, PE ALP 
Calf artery EC ACM, interleukin-6 ALP 
RAT bcec immortal All-trans-retinoic acid GGT, P-glycoprotein 
Porcine bcec primary cAMP ALP 
Rat bcec immortal APM, C6-PM, C6-CM, 
A-CCM 
Capillary-like structures 
Mouse bcec immortal C6  
Mouse bcec ACM Glucose uptake 
Bovine retinal capillary EC A, C6 Capillary-like structures 
Bovine retinal capillary EC Steroids, C6 Capillary-like structures 
 
Abbreviations: A, astrocyte; ALP, alkaline phosphatase; bcec, brain capillary endothelial cells; C6, 
C6-glioma; CCM, continuously conditioned medium; CM, conditioned medium; EC, endothelial cells, 
GF, growth factor; GGT, γ-glutamyltranspeptidase; HC, hydrocortisone; NB, neuroblastome; PE, 
plexus epithelium; peg, polyethyleneglycol; PM, plasma membranes; TEER, transendothelial electrical 
resistance; TNF, tumor necrosis factor. 
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Therefore, other approaches have been made to achieve high transendothelial electrical 
resistance within the cell culture. Cyclic Adensosin-3´,5´-monophosphate (cAMP) is a 
compound commonly discussed in correlation with modulation of tight junctional complexes. 
It influences cell-proliferation (Davison and Karasek, 1981) and morphology (Antonov et al., 
1986) of endothelial cells. cAMP is a second messenger and is produced by adenylatcyclase 
from adenosintriphosphate (ATP). Proteinkinase A is induced by cAMP and is able to induce 
a signal transduction cascade by phosphorylation of serin- or threonin residues of catalytic 
subunits of different proteins. For instance, (Rubin et al., 1991) found that elevation levels in 
the brain endothelial cells produce a striking increase in tight junction resistance and 
structural changes consistent with inducing high-resistance junctional complexes. 
Supplementation of the medium with physiological amounts of the glucocorticoid steroid 
hydrocortisone (550nM) and the withdrawal of serum, Franke et al., have established a cell 
culture model of porcine capillary endothelial cells (Franke et al., 2000; Franke et al., 1999; 
Hoheisel et al., 1998c) that closely mimics the in vivo blood-brain barrier phenotype. For the 
first time, a cell culture model was available with transendothelial resistance of more than 
1000 Ωcm2 and up to 2000 Ωcm2 measured in brain capillaries in vivo (Crone and Olesen, 
1982). 
The paracellular permeability of 14C-sucrose, 5·10-7 cm/s, has also been shown to be similar to 
the measured in vivo value (Levin, 1980). The expression of tight junction proteins was 
confirmed by both, northern blot analysis and immunocytochemistry (Eisenblätter et al., 
2001; Nitz et al., 2001). Even P-glycoprotein has been proven to be expressed (Ferfer, 2000). 
Thus, a cell culture model has been developed with fully differentiated brain capillary 
endothelial cells well suited to study physiology, pharmacology and pathology of the blood 
brain barrier (Franke et al., 2000; Hoheisel et al., 1998a). 
 
 
2.4 Regulation of blood brain barrier properties: Hormones 
 
Regulation of the tight junctions is a dynamic process determined by several cellular and 
metabolic factors (Anderson et al., 1993; Citi, 1993; Madara, 1988) including calcium, 
phorbolic esters, members of the insulin-like growth factor-I family (Buse et al., 1995a) and 
glucocorticoids. As mentioned in section 2.3.2 glucocorticoids influence the barrier properties 
of cultured brain microvessel endothelial cells derived from pig. Buse et al (Buse et al., 
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1995b) determined that the synthetic glucocorticoid dexamethasone effects the formation of 
tight junctions. Singer et al. (1994) have shown that dexamethasone increases the ZO-1 
expression but the effects that cause a drastic increase of transendothelial resistance are still 
unknown (Singer et al., 1994). Hydrocortisone does not influence tight junction proteins on 
RNA-, nor on protein-level. While it is known that extracellular matrix compounds play an 
important role during formation of the blood-brain barrier properties, newer results imply that 
MMPs are involved in barrier-forming processes (Alexander and Elrod, 2002; Lohmann, 
2003). 
During evolution, three major systems were established to control and adjust the function of 
the organs, tissues and cells of organisms: the nervous system, the immune system and the 
hormonal system. While the neuronal information is very fast and able to transfer information 
within parts of a second, the hormonal communication last between a few seconds and several 
minutes. The latter is mainly responsible for adjustment of the whole organism. Hormones are 
chemically very diverse compounds which are produced usually from specific anatomically 
defined cells and tissues assembled in so called glands. They are secreted to the blood and 
cause specific metabolic processes in their effector organs.  
 
 
 
 
Figure 2-4: Regulation of glucocorticoid secretion. The Hypothalamus is not only addicted from the 
information of the CNS but underlies a feedback-control by HC. After processing all incoming data, the 
neuronal cells in the hypothalamus release neurosecretoric hormones, either corticoliberin (activating) 
or corticostatin (inactivating). These hormones are affecting an appropriate signal in the hypophysis 
and either inhibit or elevate the secretion of glandiotrope hormones within the hypophysis. The 
glandiotrope hormones attain the adrenal cortex via blood-stream and stimulate the biosyntheses and 
secretion of glucocorticoits respectively mineralcorticoids. The glucocorticoid hydrocortisone regulates 
the hierarchical upstream lying glands by feedback-inhibition. This leads to a sensitive regulation of 
hydrocortisone concentration and is influenced at the same time by several factors. CRH: 
corticotrophin-releasing hormone; ACTH: adrenocorticotropic hormone 
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Classifying hormone action is very difficult due to their varying chemical structures and 
functions. Most of them cause a signal transduction cascade within the cell mediated by 
specific receptors beginning with a second messenger signal or act like a transcription factor 
by binding to an intracellular receptor. Although the concentration of hormones is frequently 
low, it fluctuates depending on physical state, intrinsic rhythm and physiological conditions. It 
is strictly controlled within the organism and can be effected by the rate of secretion and 
activation. The activity of several glands is regulated by hormonal control mechanisms, which 
are shown for the hypophyses-hypothalamus system in figure 2-4. 
Hydrocortisone is the main glucocorticoid hormone and belongs to a group of lipophilic C21-
steroidhormones. It is synthesised in the adrenal cortex from the hormone progesterone 
(Stryer, 1996). The concentration in the blood is strictly controlled by the hypophysis-
hypothalamus system and varies between 70 and 550 nM. Hydrocortisone enters the cells by 
passing from the blood across the cell membrane to the cytoplasm. There it binds to 
glucocorticoid receptors (GR) and constitutes a receptor-hormone complex. The receptor is 
expressed in two isoforms called GRα and GRβ. The correlated 95 and 90 kDa proteins are 
encoded by one gene (Encio and Detera-Wadleigh, 1991) and are generated by alternative 
splicing from exon 9 (figure 2-5). The 5´terminal part of the gene encodes the specific sequence 
 
 
 
 
Figure 2-5: A: Schematic representation of the human GR gene and the alternatively spliced cDNAs 
encoding the α and ß isoforms of this receptor. B: Functional domains of the GR. Functional domains 
and subdomains are indicated. DBD: DNA-binding domain (Encio and Detera-Wadleigh, 1991). 
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for the α-isoform while the 3´-terminal part contains the information for the β-isoform 
(Oakley et al., 1999). The glucocorticoid receptors are associated with heat-shock proteins 
(HSP 90 and HSP 59) (Gehring 1993; Rexin et al., 1988). After binding, the heat shock 
proteins are released by the glucocorticoid receptors and the cytoplasmic glucocorticoid-
receptor complex dimerises (figure 2-6). The proteins then translocate to the nucleus where it 
regulates transcription by binding to glucocorticoid response elements. The zinc-finger-
motive mediated interaction with the glucocorticoid-response elements of an enhancer-region 
of a gene either enhances or reduces the gene-expression (Eggert et al., 1995). The response 
to the signal can vary and depends on the affected organ. The primary cause is an induction of 
tissue-specific enzyme expression. The second effect is determined by the induced enzymes. 
A common effect of hydrocortisone is an influence on the glucose metabolism, which is 
directed to gluconeogenesis. Furthermore, it inhibits the peripheral utilisation of glucose and 
has a catabolic effect on the protein metabolism, which entails an immunosuppressive effect 
caused by the reduced production of antibodies. 
 
Figure 2-6: Signal transduction pathway of glucocorticoids. The lipophilic molecules penetrate the 
membrane and bind to cytoplasmic localised GR associated with heat-shock proteins (HSP). After 
release of the HSP two receptor-ligand complexes dimerise and translocates to the nucleus. 
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2.5 Objectives of the project 
 
Many attempts have been made to establish in vitro blood-brain barrier model systems that 
closely mimic the in vivo situation (section 2.3.1). Primary cultures of brain capillary 
endothelial cells are reliable models to investigate blood-brain barrier phenomena. In our 
group a culture system of porcine derived endothelial cells was established which is defined 
by high TEER and low sucrose permeability (Hoheisel et al., 1998b). This model is well 
characterised and based on serum-free medium supplemented with hydrocortisone in a 
physiological concentration. In order to investigate if hydrocortisone is able to induce similar 
effects in other mammalian cell systems, the main goal of this work was to establish a murine 
brain capillary endothelial cell (MBCEC) culture system comparable to the porcine system. 
After characterisation of this MBCEC primary culture, effects of hydrocortisone should be 
investigated. Furthermore, a blood-brain barrier model system based on murine derived cells 
gives better access to molecular biological works due to access to the mouse genome data. 
This allows using sequence data to apply modern methods like small interfering RNA-
methods or the investigation of knock-out mice for further experiments. Furthermore, 
antibodies against mouse-proteins are easily available and finally, a lot of groups work with 
murine model systems. For this reason, received data can be compared to results within the 
same species. A murine in vitro model of the blood-brain barrier is thus highly demanded. 
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3 Experimental 
 
3.1 Cell biology 
 
All working procedures concerning the cell culture experiments including the handling and 
sterilisation of pipettes and buffers were applied as described by Freshney to minimize the 
risk of contaminations (Freshney, 2000). 
Cell culture work was exclusively performed in a laminar-flow hood with sterile equipment, 
solutions and media. For cell plating, culture flasks (75 cm2), petri dishes (10 cm2 and 
28 cm2), 8-well electrodes and 8-well plates were used. The cells were cultured at 37°C in a 
water saturated atmosphere with 5% (v/v) CO2. 
 
 
3.1.1 Primary culture of murine brain capillary endothelial cells (MBCEC) 
  
Preparation: The isolation of murine brain capillary endothelial cells from 6-10 weeks old 
mice (C57BL6/J) was performed as described by (Deli et al., 2003) and modified in our lab. 
The mice were sacrificed with cervical dislocation. The head was rinsed in 70% (v/v) ethanol 
and the mice were decapitated with a pair of scissors. After fixing the head, the skin was cut 
from the neck to the forehead. The cranium was opened with a sagittal incision and the 
forebrain removed with forceps. The forebrain was transferred into ice-cold PBS containing 
the antibiotics penicillin (200 U/ml) and streptomycin (200 U/ml). Fresh storage buffer was 
applied under the laminar-flow hood. Secretoric and non-cortical parts of the brain were 
removed and the brains were cut into halfs. The meninges were removed by spreading and 
gently rolling the hemispheres on Whatman paper. Visible vessels were removed and the 
brain was stored until usage in ice-cold DMEM. The grey and white matter consisting of the 
cerebral tissue was then cut with scalpels, the pieces were homogenised with forceps and 
transferred into a tube and supplemented with 13.5 ml DMEM. After mechanical 
homogenization by pipetting up and down at least 25 times until complete homogenization 
1.0 ml Collagenase (CLS2 10 mg/ml) and 200 µl DNase I (1 mg/ml) were added. The 
homogenate was mixed thoroughly and incubated in a shaker for 1 h at 37°C. To isolate the 
released capillaries the suspension was mixed with 10 ml DMEM and centrifuged (20°C, 
22   
 
1000 x g, 10 min). The supernatant was discarded and the pellet was thoroughly resuspended 
in 25 ml 25% (w/v) BSA/DMEM. This suspension was centrifuged (4°C, 1000 x g, 20 min, 
swing-out bucket rotor). Both supernatant phases were discarded and the pellet containing the 
capillaries was resuspended in 9 ml DMEM. The second digest with 1 ml collagenase/dispase 
(10 mg/ml) and 100 µl DNaseI (1 mg/ml) was performed like the first digestion step. After 
complete digest the cell suspension was mixed with10 ml DMEM and the mixture was 
centrifuged (20°C, 700 x g, 8 min). The supernatant was discarded and the pellet thoroughly 
resuspended in 2 ml DMEM. The suspension was carefully applied on the top of a percoll-
gradient and centrifuged (4°C, 1000 x g, 10 min, swing-out bucket rotor). The white-colored 
interphase containing the digested capillaries was aspirated with a syringe-attached long 
needle and diluted in 10 ml DMEM avoiding contact with the red-colored interphase 
containing red blood cells, pericytes and astrocytes. After  the following centrifugation (20°C, 
1000 x g, 10 min) the pellet was resuspended in DMEM, again centrifuged (20°C, 700 x g, 
8 min) and resuspended in mouse plating medium. The isolated capillaries were plated on a 
total of 3 to 4 cm2/brain in plating medium on collagenIV/fibronectin-coated petri dishes. 
 
Culturing. One day after the isolation of capillaries the medium was substituted with fresh 
plating medium. Two days after the preparation the plating medium was removed and the 
cells were cultivated in mouse culture medium. 
 
Passage of cells. After reaching 80% of confluence the cells were subcultured. First, cells 
were washed twice with PBS and detached from their substrate with trypsin solution (0.25% 
w/v) at room temperature. For complete detachment of cells the trypsin solution was carefully 
pipetted over the cell layer. The displacement of the cells was followed by inverse 
microscopy and trypsin digestion was stopped by addition of serum-containing medium as 
soon as cell-detachment was completed. The cell suspension was centrifuged (20°C, 140 x g, 
10 min). Cells were resuspended in plating medium and plated on either collagen-G coated 8-
well ECIS-electrodes (AP-Biophysics), 8-well chamber slides (LabTeq, NUNC) or 
alternatively on rat tail collagen coated microporous polycarbonate filter membranes (0.4 µm 
pore size, 1.13 cm2 or 0.33 cm2 growth area; TranswellTM No. 3401 and 4312, Costar®) with a 
density of 220,000 cells/cm2.  
 
Exchange of media. Two days after the passage the medium was replaced by serum-free 
medium supplemented either with or without hydrocortisone. Alternatively, cells were 
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cultured in serum-containing medium. The cells were cultured for one or two more days to 
assure that they had reached confluence until they were used for histological investigations, 
TEER determination or permeability studies. 
 
PBS    140 mM  NaCl 
    2.7 mM KCl 
    8.1 mM Na2HPO4 
    1.5 mM KH2PO4 
 
PBS++      PBS 
0.5 mM MgCl2 
0.9 mM CaCl2 
 
mouse culutre medium 20 ml  plasma derived serum (PDS) 
1 ng/ml bFGF 
80 ml  DMEM 
1 µg/ml heparin 
1% (v/v) gentamycin 
0.7 mM L-glutamine 
 
mouse plating medium mouse culture medium  
4 (µg/ml) puromycin 
 
 
percoll-gradient   19 ml   PBS 
1 ml   PBS (10 fold concentration) 
1 ml   PDS  
10 ml   percoll 
centrifugation (4°C, 30,000 x g, 1h) 
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3.1.1.1 Primary culture of porcine brain capillary endothelial cells (PBCEC) 
 
Preparation. The isolation of porcine brain capillary endothelial cells (PBCEC) from 
6 month old pigs was performed as described by (Tewes et al., 1996). 
The hemispheres of porcine brains were taken from freshly slaughtered pigs and collected in 
ice-cold 70% (v/v) ethanol. For transport, ethanol was replaced by ice-cold PBS containing 
the antibiotics penicillin (200 U/ml) and streptomycin (200 U/ml). The storage buffer was 
refreshed once again in the laminar-flow hood. After shortly flaming the hemispheres, the 
meninges and adhering larger vessels were carefully removed. Secretory brain areas were 
dissected, and the grey and white matter consisting of cerebral tissue was then mechanically 
homogenized using scalpels and a sterile cutter with rolling blades. The homogenate was 
supplemented with preparation medium (37°C) to a final volume of 100 ml per brain. After 
addition of 1.6% (w/v) dry powdered unspecific protease/dispase II the suspension was stirred 
at 37°C for 2 h. To isolate the released capillaries, 100 ml of the digested homogenate were 
mixed with 150 ml of a 18% (w/v) dextran solution (4°C, MW ~ 160 kDa) and centrifuged 
(4°C, 6800 x g, 10 min). Both supernatant phases were discarded and the pellet containing the 
capillaries was resuspended in 9 ml plating medium per brain. This suspension was filtered 
through a nylon mesh (180 µm pore size) to remove larger blood vessels. In order to improve 
the separation of the capillaries, the filtered suspension was triturated up and down 5 times in 
a 10 ml sized pipette with the pipette tip placed directly onto the bottom of a petri dish, This 
mechanical disruption of capillary fragments to small pieces allows a shorter incubation time 
of the second digestion: A mix of collagenase/dispase II (0.1% (w/v)) was added to remove 
the mainly collagen containing basement membrane and to release the endothelial cells. This 
digestion was performed at 37°C for 30 min in a flask with a hanging magnetic stirrer to 
avoid any cell damage. State of digestion was controlled by inverse microscopy. The isolated 
endothelial cells were collected by centrifugation (20°C, 140 x g, 10 min) and resuspended in 
10 ml plating medium per percoll gradient. This discontinuous percoll gradient was prepared 
from 15 ml percoll solution of a density of ρ = 1.07 g/ml and 20 ml percoll solution of ρ = 
1.03 g/ml. 10 ml of the cell suspension were carefully placed onto the top of the gradient and 
centrifuged in a swing-out bucket rotor (4°C, 1300 x g, 10 min). The cell load of each 
gradient was adjusted to correspond to 1-2 brains. The red-stained, sharp interface containing 
the endothelial cells was aspirated from the lower middle of the gradient and diluted in plating 
medium. After a final centrifugation (20°C, 140 x g, 10 min), the pellet was gently 
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resuspended in plating medium and the cell yield of one brain was plated on a total of 6 x 75 
cm2 collagen-G coated culture substrates. 
 
Culturing. One day after preparation the cells were washed twice with PBS++ buffer to 
remove cell debris and non-adherent cell bodies and afterwards supplied with fresh culture 
medium afterwards.  
 
Passage of cells. To reduce contamination with other cells from the brain parenchyma, the 
cells were subcultured two days after preparation. First, cells were washed twice with PBS 
and detached with trypsin solution (0.25% w/v). The displacement of endothelial cells was 
followed by inverse microscopy and trypsin digestion was stopped by addition of serum as 
soon as the majority of endothelial cells had lifted off the culture surface. The cell suspension 
was centrifuged (20°C, 140 x g, 10 min), the cell pellet was resuspended in plating medium 
and plated on either collagen-G coated flasks, glass cover slips or alternatively on rat tail 
collagen coated microporous polycarbonate filter membranes (0.4 µm pore size, 1 cm2 growth 
area, TranswellTM No.3401, Costar®) with a density of  220,000 cells/cm2. 
 
Exchange of media. Two days after passage the plating medium was replaced by 
hydrocortisone containing serum-free medium without further washing. The cells were 
cultured for two more days until they were used for immunocytochemistry, permeability- and 
TEER studies or RNA- and protein-isolation. 
 
preparation medium    Earle´s Medium 199 
0.7 mM L-glutamine 
1% (v/v) penicillin/streptomycin (10 mg/ml) 
1%   gentamicin (10 mg/ml) 
 
pig plating medium    preparation medium 
    10%  newborn calf serum (NCS) 
      
pig culture medium    plating medium without gentamicin 
 
serum-free medium (SFM)   DMEM/Ham´s F12-Medium 
0.7 mM  L-glutamine 
1% (v/v) penicillin/streptomycin (10 mg/ml) 
1% (v/v) gentamicin (10 mg/ml 
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SFM + hydrocortisone   SFM 
    550 nM hydrocortisone 
 
dextran solution  200 ml  Earle´s buffer (10 x) containing phenol red 
    4.4 g  NaHCO3 
    360 g   dextran (~ 162 kDa/mol) 
    ad 2 l  ddH2O 
 
percoll solutions 
 ρ = 1.03 g/cm3 400 ml  PBS 
    90 ml  percoll 
    10 l  Earle´s Medium M199 (10 x) 
 
 ρ = 1.07 g/cm3 200 ml  PBS 
    270 ml  percoll 
    30 l  Earle´s Medium M199 (10 x) 
 
 
3.1.2 Transfection of cells with small interfering RNA 
 
Inhibiting the expression of specific target proteins is a powerful tool to investigate the 
function of these proteins in vitro. Many techniques were developed to induce knock-down or 
knock-out of targets including knock-out animals or in vitro techniques like the transfection 
with antisense DNA oligonucleotides and plasmids, respectively expressing antisense DNA 
inside the cells. Elbashir (Elbashir et al., 2001) described an application of RNA interference 
in mammalian cells, which was used until then for non-mammalian systems like plants and 
C.elegans (Bosher et al., 1999; Fagard et al., 2000). The basis of this method is the 
introduction of small interfering double-stranded RNA with sequence homology to a target 
mRNA. During transfection with small interfering RNA, specific double-stranded RNA is 
introduced into the cells and interrupts the translation of target genes by complementary 
binding and degradation of mRNA targets within the cytoplasm.  
This method was sought to apply to primary cultures of brain capillary endothelial cell 
cultures. 
The transfection with small interfering RNA (siRNA) was performed either before passage in 
75 cm2 flasks and 10 cm2 petri dishes or after passage in 24-well plates. To transfect the 
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double-stranded RNA into either MBCEC or PBCEC the cationic lipid reagent 
Oligofectamin
TM (Invitrogene) was used. The positively charged lipids interact with the 
negatively charged RNA and the lipid-RNA-complex is able to penetrate the cell membrane 
and reach the cytoplasm of the cell. Transfection was performed according the manufacturer’s 
instructions. First, OligofectaminTM was mixed with Opti-MEM® I reduced serum medium 
and incubated for 10 min at room temperature (solution I). In parallel, siRNA (20 µM) was 
diluted in Opti-MEM I (solution II), mixed, combined with solution I and incubated for 15-
20 min at room temperature. In between, the cells were washed with Opti-MEM and medium 
was applied (table 3-1) The transfection mixture was added to the cells and incubated for 4 h 
(37°C, water-saturated atmosphere, 5% (v/v) CO2). Finally, growth medium with 3-fold 
concentration of antibiotics and serum were applied and cells were cultured until used for 
experiments in the incubator. For concentrations and amount of solutions used, see table 3-1. 
 
Table 3-1: Overview of amounts and concentrations of used solutions during transfection with siRNA 
Solution I Solution II   
Reagent 
siRNA (20µM) Opti-MEM I Opti-MEM I Oligofectamine Opti-MEM Growth- 
medium 
Flask (75 cm2) 39 µl 1484 µl 30 µl 10 µl 6.25 ml 3.9 ml 
Petri dish (10 cm2) 24 µl 420 µl 18 µl 4.5 µl 1.39 ml 1.2 ml 
 
Growth medium   plating medium 
30 % (v/v) FCS 
 3 % (v/v) penicillin/streptomycin (10 mg/ml) 
     2.1 mM L-glutamine 
 
3.1.3 Immunocytochemistry 
 
For immunofluorescence studies, murine and porcine brain capillary endothelial cells were 
plated on either collagen-G coated coverslips placed into 24 well-plates or alternatively on rat 
tail collagen coated microporous polycarbonate filter membranes. In the latter case, all 
experimental steps until the embedding were performed on the filter-inserts placed in 12-well 
plates. The cells were washed twice with PBS before fixation was performed by adding 
250 µl 4% (v/v) paraformaldehyde (PFA) followed by an incubation period of 10 min at 
20°C. Before incubation with the primary antibody, fixed cells were washed 5 times with PBS 
and non-specific binding-sites were blocked for 20 min at room temperature supplemented 
with 3% (v/v) NGS and 0.1% (v/v) TRITON-X-100 in PBS. Afterwards the primary antibody, 
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diluted in PBS supplemented with 0.3% (v/v) NGS and 0.1% (v/v) TRITON-X-100, was 
added and the specimen were incubated for 1 h at room temperature (RT). For the dilution of 
the primary antibodies see table 3-2. Both antibodies were centrifuged at 15,000 rpm for 
5 min to avoid antibody precipitations. After incubation, probes were washed with PBS and 
blocked with 10% (v/v) NGS (in PBS) again, before the secondary antibody (table 3-3) was 
applied in a 1:1000 dilution in PBS containing 3% NGS followed by a 30 min incubation at 
20°C. After further washing (2x with PBS) cells were postfixed with 4% (v/v) PFA for 
10 min at room temperature. The fixative was removed by washing 5 times with PBS and 
cover slips or filters were then shortly treated with ddH2O and dried on Kimwipes
®. For 
embedding, one drop of Paramount (Polysciences) was placed onto an optical slide and the 
coverslip was then put face down onto the slide. Filters membranes were excised from the 
inserts, transferred to the optical slide and allowed to settle. The samples were stored at 4°C in 
darkness to prevent bleaching of the fluorophores. Normally, the detection was performed 
48 h after embedding of the cells, either by epifluorescence or laser scanning microscopy. 
Otherwise samples were stored at 4°C. 
Table 3-2: Primary antibodies used in immunofluorescence staining 
Antibody dilution (in PBS, 0.3% (v/v) NGS, 0.1% (v/v) TRITON-X-100) 
Rabbit anti-Occludin (Zymed) 1:200 (1.25 µg/ml) 
Mouse anti-Occludin (Zymed) 1:200 (2.50 µg/ml) 
Rabbit anti-Claudin 5 1:100 (2.5 µg/ml) 
Rabbit anti-ZO1 (Zymed) 1:100 (2.5 µg/ml) 
Rat anti-ZO1 (Chemicon) 1:100 (2.3 µg/ml) 
Rabbit anti-GFAP (Sigma) 1:80 (1.25 µg/ml) 
BMDP (AB 3912) 1:100 (not available) 
Mouse anti-α-sm-Actin (Zymed) 1:100 (81 µg/ml) 
Lamin A/C (Santa Cruz) 1:100 (1.13 µg/ml) 
 
Table 3-3: Secondary antibodies used in immunofluorescence staining 
Antibody Antibody dilution  
Anti-mouse FITC (Mobitec) 1:1000 (20 ng/ml) 
Anti-mouse TRITC (Mobitec) 1:1000 (20 ng/ml) 
Anti-rat TRITC (Mobitec) 1:1000 (20 ng/ml) 
Anti-rabbit FITC (Sigma) 1:1000 (20 ng/ml) 
Anti-rabbit TRITC (Sigma) 1:1000 (20 ng/ml) 
 
 
                                                 
2 From Susan E. Bates, Rockville Pike, Bethesda (MD), USA 
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Fixing    4% (w/v) paraformaldehyde (in ddH2O) 
 
blocking solution  10% (w/v) new-born goat serum 
    0.5% (v/v) Triton X-100 
    1% (w/v) bovine serum albumine 
 
antibody incubation solution 3% (w/v) new-born goat serum 
    0.5% (v/v) Triton X-100 
    0.1 % (w/v) NaAzid 
    1% (w/v) bovine serum albumine 
 
 
3.1.4 Atomic force microscopy 
 
In contrast to electron microscopy techniques, atomic force microscopy (AFM) allows 
imaging the surface of living cells under physiological conditions with high resolution (Drake 
et al., 1989, Schar-Zammaretti et al., 2002; Yamane et al., 2000). The fixing and contrasting 
procedures during the preparation of biological samples for electron microscopy often causes 
artefacts. The surface imaging of living cells is less error-prone concerning artefacts than 
electron microscopy techniques. The use of phase imaging techniques enables the 
discrimination between different cell membrane components and offers detailed high 
resolution information about cell-cell contacts or cytoskeletal elements (stress fibres) (Chasan 
et al., 2002; Zhang et al., 2003). In addition to these topographic measurements, the AFM can 
be used to measure the long range attractive or repulsive forces between the probe tip and the 
sample surface, elucidating local chemical and mechanical properties like adhesion and 
elasticity. These two features of AFM, force mapping and imaging, were applied for studying 
MBCEC in vitro.  
Experimental setup. For atomic force microscopy the cells were cultured as described in 
3.1.1 and 3.1.1.1 and after passage seeded on collagen-G coated 8-well Lab-Tek® chamber-
slidesTM (Nalgene) (45,000 – 90,000 cells/cm2) and cultured until confluence. After reaching 
confluence, the medium was replaced by incubation medium (either SFM with and without 
hydrocortisone or in serum-containung medium). After 24 or 48 hours in culture, the medium 
was removed and cells were washed (PBS++, 37°C) to remove proteins from the cell surface. 
The chambers were shifted. The slide with the cells was transferred into a petri dish, fixed and 
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covered with PBS++. The experiments were performed with a Bioscope equipped with a 
NanoscopeIIIa controller (Digital Instruments) employing gold-coated V-shaped cantilevers 
(Veeco Instruments) with a spring constant of 0.01 N/m. The spring constant was determined 
exactly by thermal noise measurements (National Instruments, NI5411). The cells layer 
surface was scanned in contact mode processed by the manufacturer´s software (version 
4.43.R6). Subsequently, the force mappings were accomplished with a trigger of 50 nm at 
750 nm long force curves (lateral solution: 64 x 64 per image). 
The determination of the Young´s modulus was based on the Hertz model. For the analysis of 
the force curve, the cantilever tip is presumed to be conical and the contact area to be 
spherical. Following Sneddon´s modification of the Hertz model the incision of elastically 
bodies can be solved geometrically (Domke, 1998, Hertz ,1881; Sneddon, 1965). 
 
 
3.1.5 Transmission electron microscopy 
 
While the resolution of light microscopy is restricted by the wavelength of visible light (400-
700 nm), transmission electron microscopy (TEM) permits to observe cellular structures 
within the range of the wavelength of electrons. Electrons can reach wavelengths as low as 
1 pm. Practically the resolution in ultrathin sections of biological samples is around 1 nm.  
 
Preparation of cell samples. For transmission electron microscopy the cells were 
subcultured after reaching 70% confluence (3.1.1) onto rat tail collagen coated microporous 
polycarbonate filter membranes. Fixation and embedding were performed as follows: The 
cells were washed twice with PBS++ and fixed for a minimum of 1 h in sodium cacodylate 
buffer (0.1 M sodium cacodylat, 2.5% glutaraldehyde, 2 mM CaCl2) at room-temperature. 
Afterwards, the specimen were washed with ddH2O (30 min, shaker) and incubated for 45 
min at room-temperature in 0.5 % (w/v) OsO4 solution in sodium cacodylate buffer) followed 
by a second washing step for 30 min in ddH2O. Subsequently, the samples were dehydrated 
by incubation in 75% (v/v) ethanol, 2 x 100% ethanol and finally propylene oxide for 5 min 
each. After incubation in a mixture of propylene/epon (1:1) for 30 min the specimen were 
incubated in pure epon for 15 min. Finally, the samples were embedded in a pure epon 
containing mold and dried for 24-48 h at 60°C. Ultrathin sections were examined and 
photographed using a Philips EM 201. 
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3.1.6 Measurement of electrical properties of primary cultured murine 
brain capillary endothelial cells 
 
The determination of electrical properties of cells allows determining the barrier properties for 
small inorganic ions like Na+ and Cl- (Schneeberger and Lynch 1992). To determine the 
TEER of MBCEC, impedance spectroscopy has been applied. This method allows to extract 
the transendothelial resistance of the cell monolayer. The cells are not affected by this 
method. This enables the performance of long term measurements. 
 
 
3.1.6.1 Determination of transendothelial electrical resistances of cells grown on filter 
membranes 
 
The filters for TEER determination were coated with rat-tail collagen one day before cell 
inoculation and incubated over night at 37°C in a water saturated atmosphere. Afterwards the 
filters were dried in the laminar flow hood and stored at 4°C. The cells were cultivated on 
fibronectin/collagen IV coated petri dishes (3.1.1) and passaged after reaching 70-90% 
confluence. For measuring the TEER the cells were seeded on the coated filters in a density of 
220,000 cells/cm2. The medium was replaced by incubation medium (either serum-containing 
medium or SFM with or without hydrocortisone) after the cells had reached confluence on 
filters and the measurement was performed after one and two days in incubation medium. The 
filters containing the cultured cells were transferred into a chamber with a gold coated 
bottom. A platinum ring electrode was placed into the medium of the apical chamber (figure 
3-1). A frequency generator (Solartron) applied alternating voltages (10-100 mV) in a 
frequency range from 1 to 105 Hz, measured the resulting current in a phase-sensitive fashion 
and calculated the impedance according to Ohm´s law. The recorded impedance spectra were 
analysed by equivalent circuit modelling as described by (Wegener et al., 2000a). 
Alternatively, time dissolved measurements were performed using an automated apparatus 
reading 12 electrodes in parallel developed in our laboratory3. 
                                                 
3 Developed by Abrams, D., Janshoff, A., Willenbrinck, W., Wegener, J. 
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Figure 3-1: In vitro model of BBB and experimental setup for TEER measurement. The apical 
chamber represents the lumen of the vessel while the basolateral chamber simulates the brain side. 
The platinum ring electrode was placed into the apical chamber using the gold coated surface of the 
basolateral chamber as counter electrode.  
 
3.1.6.2 Electric cell-substrate impedance sensing 
 
Electric cell substrate sensing (ECIS) is an experimental method for investigating the 
electrical impedance as a function of the frequency of cell covered film electrodes. In contrast 
to the TEER measurement as described in section 3.1.6.1 cells are directly cultured on gold 
electrodes (figure 3-2 A). The analysis of the data allows conclusions about the resistance Rb 
between adjacent cells, which is a measure of the integrity and barrier function of the layer, 
the parameter α that describes the impedance contribution from the cell substrate adhesion 
zone and the capacitance of the cell membrane (CM). Together, these parameters permit 
characterisation of the barrier and adhesion properties of cells in one experimental setup. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2: Setup for electric cell substrate sensing (ECIS). A: The cells are cultured directly onto gold 
electrodes. The working electrode is 300-fold smaller than the counter electrode. Thus, the working 
electrode becomes a bottle neck for the current and the electrical impedance of the system is 
dominated by the cells grown on the this electrode. B: Equivalent circuit (approximation). This model 
allows the determination of the parameters α, Rb and CM.  
Filter compartment 
Cell layer Gold electrode 
Platinum 
 
A B 
α Rb 
CPE 
CM 
Rbulk 
Platinu  electrode 
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Preparation of the electrodes. The ECIS device is based on AC impedance measurements 
using weak AC signals (Giaever and Keese, 1993; Lo et al., 1995, Mitra et al., 1991; Wegener 
et al., 2000b). An oscillator applies an AC signal of 70 mV amplitude to the two-electrode 
system using culture medium as the electrolyte. The data analysis had been described 
elsewhere (Wegener et al., 2000a). 
For electrical cell-substrate impedance sensing (ECIS) 8-well arrays with 10 electrodes each 
(Applied Biophysics, figure 3-3) were used. Each well consists of 10 active electrodes at the 
bottom of the dish (each 250 µm diameter), electrically in parallel. Before cell culturing the 
arrays were cleaned for 5 min in an argon plasma cleaner (Harrick, New York) and the 
electrodes were immersed with an aqueous solution of L-cysteine (10 mM) to stabilise the 
interface impedance. Afterwards the electrodes were washed and coated with collagen-G. 
MBCEC were trypsinised as described in section 3.1.1. Cell density was monitored after 
centrifugation by using a standard hemacytometer and 300,000 cells were seeded into each 
chamber. Directly after seeding the arrays were placed into the array holder, electrical contact 
was established and the measurement was started.  
 
 
Figure 3-3: ECIS electrode in 8-well format (8W10E, Applied BioPhysics, Troy, NY). Each array 
consists of 8 wells with 10 electrodes per well in parallel.  
 
 
3.1.7 Quartz Crystal Microbalance 
 
The quartz crystal microbalance (QCM) is a sensitive technique to follow adsorption 
processes and adhesive properties of cells in vitro (Wegener et al., 1999, Wegener et al., 
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2000c). The shifts in resonance frequency correlate with the number of cells attached to the 
resonator surface. This allows to investigate the adhesion kinetics of cells grown under 
different conditions and adhesion properties of cells after reaching confluence. 
 
3.1.7.1 Preparation of quartz resonators for cell culture 
 
Before cell culturing all quartz crystals were cleaned for 5 min in an argon plasma cleaner 
(Harrick, New York). For gelatine coating of quartzes gelatine was dissolved in ultrapure 
water (0.5% (w/v) and the resonators were flooded with this solution for 90 min at room 
temperature. Subsequently, the gelatine solution was removed and glutaraldehyde 
(2.5% (w/v)) was applied for 15 min at room temperature to cross-link the gelatine. After 
incubation, the aldehyde was removed and chambers were incubated for 5 min in 70% ethanol 
for further sterilisation. Finally, the chambers were washed 5 times with sterile water and 
incubated overnight in ultrapure H2O. The next day, the chambers were washed again 5 times 
with ultrapure H2O to remove all traces of glutaraldehyde and ethanol which would inhibit 
cell growth. To perform quartz crystal microbalance (QCM) measurements the cells were 
cultured until 70-90% confluence as described in section 3.1.1 and then harvested and plated 
for QCM experiments onto gelatine-coated 5 MHz-AT-cut quartz resonators (figure 3-5 A). 
 
3.1.7.2 Experimental setup for QCM measurement 
 
For all QCM experiments plano-plano AT-cut quartz plates (14 mm in diameter) with a 
5-MHz fundamental resonance frequency (KVG, Neckarbischofsheim) coated with gold 
electrodes on both sides, each exhibiting an area of 0.33 cm2 were used (figure 3-5 A). For 
culturing cells on the quartz resonators small glass tubes were fixed onto their surface to 
allow direct culture of cells in chambers on the crystal’s surface. 
QCM measurements were performed in two different modes: The cell mode allows the 
determination of resistance values for the monolayer analogous to the ECIS measurement (cf. 
3.1.6.2). It allows the electrical characterisation of the cell monolayer in a frequency range 
from 1-105 Hz with determination of the parameters α, Rb and CM by use of the low 
impedance platinum dipping electrode in combination with the gold electrode beneath the 
cells (figure 3-5 B). 
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Figure 3-4: A: Experimental setup for QCM. Depicted is the chamber with the plano-plano AT-cut 
quartz at the bottom and the platinum ring electrode dipping in the culture medium from above. B+C: 
Equivalent circuits used for curve fitting of QCM experiments. B: Fitting of cell mode (ECIS). This 
model is an approximation. The dotted box represents the influence of the cell layer on the impedance 
spectrum. Rc.l. represents the transendothelial resistance arising from the formation of tight junctions 
between the cells. Ce.l. is the capacitance of the cell monolayer (cf. ECIS). C: Equivalent circuit non-
linear curve fitting of the phase spectra recorded in quartz-mode measurements. R, L, C and Cp are 
the parameters of the unperturbed quartz crystal while the additional elements Rload and Lload 
representing the liquid loading and the cell monolayer, respectively, attached to the quartz surface 
(Wegener et al., 2001). 
 
 
The quartz mode reads modifications of cell-substrate interactions via an electrical 
characterisation of changes in the quartz resonance (figure 3-4 C). Therefore, the electrical 
impedance of the oscillation is determined in a range of 4.96 to 5.04 MHz by using the 
electrodes on both sides of the quartz. A change in the adhesion of cells is detectable by a 
change of mechanical properties of the quartz which is mirrored in its electrical characteristics 
due to the piezoelectric coupling. After measurements in quartz and cell mode have been 
performed the cell layer was removed by cleaning the surface mechanically and the empty 
quartz resonator was measured again. The difference of the load resistance allows conclusions 
of cell-substrate interactions of cultured cells in quartz mode (Wegener et al., 2001). 
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3.1.8 Permeability studies 
The permeability of murine brain microcapillary endothelial cells is, corresponding to the 
TEER, a measure for the integrity of the cell monolayer. To quantify endothelial permeability, 
hydrophilic marker substances with low molecular weight are used. Whereas lipophilic 
substances are able to penetrate the cell membrane and to pass the monolayer on transcellular 
pathways across the cells, small hydrophilic molecules only pass the layer through gaps 
between adjacent cells or (active) transport. These molecules are unable to penetrate and 
diffuse across the plasma membrane. To determine the paracellular permeability of the 
monolayer sucrose as a small hydrophilic molecule was used in all experiments as no 
transport systems for sucrose are known in brain capillary endothelial cells. 
The experiments were performed as follows: cells were trypsinised, harvested and 90,000 
cells were seeded on 0.33 cm2 filters (Costar 3401). The cells were incubated for 2 days until 
reaching confluence. The medium was then replaced by incubation medium and cells were 
incubated for two more days. Which particular media were used for individual experiments is 
described in the results. 14C-sucrose (1 µCi/filter) was applied into the apical chamber and 
samples were taken after certain incubation times (5, 10, 15, 20, 40, 60 and 80 min) from the 
basolateral compartment. 
 
3.1.8.1 Analysis of permeability data 
The permeation rate of compounds across a cellular barrier is described by a permeability 
coefficient P (cm/s). This coefficient can be calculated following (Pardridge et al., 1990) or 
(Walter et al., 1995). In these models, the permeability coefficient (Pe) of cells on a filter 
membrane is corrected by the Pe of the filter membrane itself to obtain the Pc of the cells only 
(equation 2). The following steps were used to calculate the absolute permeability of the cell 
layer (equation 1). 
0
e
basonP
C t A
=
⋅ ⋅
      Equation 1 
with nbaso equals the amount of permeated sucrose (Schinkel et al.,); c0 = concentration of 
sucrose in the apical chamber [mol/l]; t = permeation time [s] and A = permeation area [cm2]. 
1 1 1
( ) ( ( )e e eP cells P cells filters P filters
= −
+
  Equation 2  
All values were normalised to the filter area and time. Thus Pe is given in units of cm/s.  
[cm/s] 
) ) 
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3.2 Molecular biology 
 
All devices, solutions, pipette tips and reaction tubes were sterilised by routine sterilisation 
techniques. Only chemicals of molecular biology grade were used. When working with RNA 
material, solutions were treated additionally with 0.1 % (v/v) dimethylpyrocarbonate (DMPC) 
to inactivate RNases. Glassware was treated at 200°C for at least 4 h and gloves worn during 
all RNA preparations and handlings. 
 
 
3.2.1 Quantification of nucleic acids 
 
3.2.1.1 Photometric determination of nucleic acid concentrations 
 
Concentrations of nucleic acids were measured with an UV-VIS recording spectrophotometer 
(UV-2401PC, Shimadzu) at a wavelength of 260 nm which is most suited for RNA/DNA 
quantification due to the absorbance of purine and pyrimidine bases. Using a 1 cm cuvette an 
optical density at 260 nm (OD260) corresponds to 40 µg/ml of single stranded RNA and to 
50 µg/ml of double stranded DNA.  
The purity of isolated nucleic acids was determined by measuring the optical density at 
280 nm where the aromatic amino acids of proteins show highest absorbance. The ratio 
OD260/OD280 is supposed to be between 1.8 and 2.1 for RNA dissolved in buffer with pH > 7 
and about 1.8 for DNA. 
 
 
3.2.1.2 Determination of concentrations by ethidiumbromide staining 
 
The quantity of DNA, especially when used for cloning, was estimated on ethidiumbromide 
stained agarose gels with the help of commercially available DNA ladders from Eurogentech. 
The so called SMART-ladders contain definite amounts of DNA in each visible band to 
which the intensity of analysed DNA sample was visually compared and thus, the amount of 
DNA of the sample could be estimated.  
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3.2.2 Agarose gel electrophoresis 
 
Nucleic acids can be separated according to their size in an agarose gel electrophoresis. The 
concentration of agarose was varied according to the expected size of the DNA fragments in 
order to obtain optimal separation results (table 3-4). To guarantee that nucleic acids move in 
the electrical field to the anode the electrophoresis must be performed at a pH close to neutral 
pH. Therefore, 1 x TAE-buffer for non-denaturing gels (DNA) and 1 x MEA-buffer for 
denaturing gels (RNA) were used. In case of DNA gels variable amounts of agarose were 
directly dissolved in 1 x TAE-buffer by heating in a microwave, whilst for RNA gels 
1% (w/v) agarose was first dissolved in DMPC treated water. Afterwards 10 x MEA and 
formaldehyde (37%) were added to a final concentration of 1 x MEA and 6% (v/v) 
formaldehyde. Prior to electrophoresis the samples were diluted in DNA- or RNA-loading 
buffer. Furthermore, RNA samples were denatured for 10 min at 65°C and both formaldehyde 
and formamide present in the loading buffer inhibited further formation of RNA secondary 
structures. To determine the size of DNA fragments DNA ladders (Life Technologies and 
Eurogentech) were used. Gel electrophoresis was performed at 100 V. Nucleic acid fragments 
were visualised under UV-light (254 nm) using ethidiumbromid as dye. In case of DNA 
separation, gels were stained after electrophoresis in ethidiumbromid containing solution 
(0.5 mg/ml in 1 x TAE-buffer) while for RNA-visualisation 1 µl of an ethidiumbromid 
solution (1 mg/ml) was directly added to the samples prior loading.  
 
Table 3-4: Concentrations of agarose gels 
Agarose concentration (% w/v) 0.3 0.6 0.8 1.0 1.2 1.5 2.0 
nucleic acid range (kb) 5-60 1-20 0.8-10 0.5-5 0.4-7 0.2-3 0.1-2 
 
50 x TAE   2 M  Tris 
    2 M   sodium acetate 
    0.5  EDTA 
      pH 7.4-7.8 
10 x MEA   0.01 M, pH 8 EDTA 
    0.2 M  MOPS 
    0.05 M sodium acetate 
      pH 7.0 
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10 x DNA-loading buffer 0.25 % (w/v) bromophenol blue 
    0.25 % (w/v) xylene cyanole 
    15 % (v/v) Ficoll 
 
1 x RNA- loading buffer  50 % (v/v) formamide de-ionised 
    10 % (v/v) 10 x MEA 
    16 % (v/v) 37 % formaldehyde 
    5 % (v/v) glycerol 
    0.25 % (w/v) bromophenol blue 
 
 
3.2.3 Isolation of DNA from agarose gels 
 
Gel extraction of DNA fragments was performed by using the QIAquick Gel Extraction Kit 
(Qiagen) according to the manufacturer´s instructions. The DNA fragment was excised from 
agarose gel, weighed and dissolved in 3 gel volumes of Buffer QG at 50°C for 10 min 
(1 mg ~ 1 µl). Afterwards, one gel volume of isopropanol was added and DNA was purified 
by a QIAquick spin column. DNA adsorbs to the silica membrane in the presence of a high 
concentration of chaotropic salts at pH<7.5, while contaminants pass through the column and 
are efficiently washed away. The pure DNA was then eluted by 30-50 µl of 10 mM Tris/HCl 
and pH 8.5. Concentrations of purified DNA fragments were determined as described in 3.2.1. 
 
 
3.2.4 Isolation of plasmid DNA 
 
For different applications as PCR, restriction digest and sequencing, plasmid DNA was 
isolated from E. coli. The QIAprep Spin Miniprep (Qiagen) was used to isolate plasmid DNA 
from E. coli cultures grown overnight in LB-medium containing ampicillin. The isolation 
procedure is based on the principle of alkaline lyses of the cells, precipitation of genomic 
DNA, cell debris and proteins and adsorbance of plasmid-DNA onto silica in the presence of 
high salt concentrations. After removal of molecular contaminants plasmid-DNA was eluted 
by a low salt buffer at a pH between 7 and 8.5. The procedure was performed according the 
manufacturer’s instructions given in the manual.  
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3.2.5 Isolation of RNA 
 
Total RNA from cultured cells was isolated using commercial available kits. For the isolation 
of porcine and murine brain capillary endothelial cells, the High Pure RNA Isolation Kit® 
(Roche) was applied according to the instructions given in the manual.  
 
 
3.2.5.1 Isolation of RNA from capillary endothelial cells 
 
The cells were washed with PBS before lysis is carried out by incubating the sample with 
400 µl Triton® X-100 and guanidine hydrochloride containing lysis/binding buffer to 
inactivate RNases. Cells were detached with a rubber policeman and collected in a clean 
RNase-free tube. The cell suspension was applied to the filter tube where RNA binds to the 
surface of glass fibres in the presence of chaotropic salt. The binding process is specific for 
nucleic acids, and here optimized for RNA. The rest of the contaminating DNA were digested 
by DNase I, applied directly on the glass fibre fleece and incubated for 15 min at room-
temperature. The bound RNA was then purified from salts, proteins and other cellular 
impurities by three washing steps and was finally eluted in 100 µl RNase-free water. The 
purity of the RNA was checked by OD260/OD280-ratio (see section 1.2.1.1). RNA was 
quantified by measuring the OD260 (section 3.2.1) and stored at -70°C. 
 
 
3.2.6 cDNA synthesis  
 
cDNA was transcribed from 5 µg of total RNA using Superscript™ II RNase H- Reverse 
Transcriptase (Life Technologies™). The reaction mix was supplemented with accompanied 
5 x First Strand Buffer and 0.1 M DTT as well as a primer mix. To synthezise cDNA for 
amplification of gene fragments for cloning oligo (dT)12-18 (500 µg/ml) and for TaqMan 
Realtime PCR random primer mix was applied. 1 µl primer solution was added to the RNA 
sample to a final volume of 12 µl, incubated in case of random primer first for 10 min at 25°C 
and afterwards for 20 min at 50°C. The first incubation was skipped when using oligo (dT) 
primer. Then the sample was denatured at 65°C to dissolve secondary structures and 
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immediately chilled on ice. 4 µl First Strand Buffer, 2 µl 0.1 M DTT and 1 µl dNTP mix (10 
mM each dATP, dCTP, dGTP, dTTP) were added and incubated at 42°C for 2 min before 
1 µl (100 units) of SuperScript II™ was added. cDNA synthesis was performed at 42 °C for 
50 min and finished by inactivation of the enzyme  at 70°C for 15 min. The cDNA pool was 
either used directly for Real-Time PCR or stored at -20°C. 
 
 
3.2.7 Polymerase chain reaction methods 
 
3.2.7.1 PCR 
 
The polymerase chain reaction (PCR) was applied to amplify DNA fragments using two 
specific primers complementary to the ends of the desired DNA fragment. As templates either 
plasmid DNA or cDNA pools were used. All primers and their annealing temperatures are 
listed in appendix D. PCR with plasmid-DNA was performed to generate enough material for 
probing northern blots. In these cases the thermostable Taq DNA polymerase™ (Life 
technologies) and a reaction volume of 50 µl was used as follows: 5 µl 10 x PCR buffer and 
1.5 µl 50 mM MgCl2 (both provided by the manufacturer), 2 µl dNTP mix (10 mM each 
nucleotide), 0.5 µl of 5´- and 3´-primer (10 µM), 0.5 µl plasmid DNA (approx. 0.2 µg/µl), 
40.5 µl ddH2O and finally 0.5 µl of Taq DNA polymerase were gently mixed and incubated in 
the mastercycler gradient (Eppendorf). The PCR was performed according to the following 
program: 3 min initial denaturation at 95°C, 30 cycles of 30 sec denaturation at 95°C, 1 min 
annealing of the primers at specific temperatures (listed in appendix D) and 1.5 min 
elongation at 72°C. Afterwards the mixture was incubated for 5 min at 72°C for complete 
elongation of PCR fragments and finally stored at 4°C. PCR products were then analysed by 
agarose gel electrophoresis (section 3.2.2), purified from agarose gels (section 3.2.3) 
quantified (section 3.2.1) and used for probing either in northern blotting or cloning. 
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3.2.7.2 Quantitative real-time polymerase chain reaction (QRT-PCR) 
 
TaqMan Real-time PCR was performed to determine the quantity of specific mRNA targets 
within isolated RNA (section 3.2.5.1). Comparable to northern blot analysis this method is 
used to quantify the mRNA expression of different RNA species of interest. This method is 
sensitive and the required amount of RNA is lower than in northern blot analysis. Real time 
PCR is a two step RT-PCR system. In the first step the RNA is transcribed by reverse 
transcriptase to complementary DNA (cDNA) by applying random primer mix as described in 
paragraph (3.2.6). The following second step is based on the polymerase chain reaction 
technology combined with a fluorescence detection system. Special dyes intercalate during 
the amplification of the targets and allow a determination of differences in the quantity during 
the exponential phase of amplification. Due to the fact that the applied dye intercalates 
unspecific into double stranded DNA it is mandatory to use primers with special standards. A 
reliable quantitative comparison of two independent sequences (target and house keeping 
gene) demands a similar efficiency of amplification in the exponential phase of amplification. 
Primers were chosen regarding the following criteria: The GC-content was between 40-60% 
and the length of oligonucleotides corresponded to 15 to 25 base pairs. For all primers the 
melting temperature constituted 60°C. Primers were chosen using the software Primer 
Express (version 2.0; Applied Biosystems). 
 
3.2.7.2.1 TaqMan SYBR-Green PCR protocol 
20 µl of the RT-product obtained as described in section 3.2.6 were diluted to a volume of 
40 µl with DMPC-ddH2O. 2.5 µl of this dilution were applied to the reaction mix containing 
7.88 µl SYBR-Green universal PCR Master Mix™ (PE Biosystems), 3 µl of 5´- and 3´-primer 
(5 µM each) and 9.77 µl DMPC-ddH2O (all primers are listed in appendix D). The SYBR-
Green universal PCR Master Mix™ contains reaction buffer, dNTPs, MgCl2, AmpliTaq Gold 
DNA-polymerase and two fluorescence dyes, the reporter dye SYBR-green which intercalates 
into DNA and a reference dye whose fluorescence properties are not influenced by 
amplification of DNA. The fluorescence of the reporter dye is normalized to the reference dye 
to avoid falsification of fluorescence fluctuation. The TaqMan-PCR was performed using a 
GeneAmp 5700 (PE Biosystems; software version 1.3) according to the following program: 
initial denaturation at 95°C for 10 min, 40 cycles of denaturation at 95°C for 15 sec followed 
by hybridisation and finally elongation at 60°C for 60 sec completed by a final elongation at 
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60°C for 15 min. To check the specifity of the obtained DNA fragment the amplification 
protocol was followed by dissociation at 95°C for 15 sec and hybridization at 60°C for 20 sec. 
The final slow heating from 60 to 90°C was detected by fluorescence and when a distinct 
signal is present the obtained amplification signals can be assumed to be specific estimated 
targets. 
 
 
3.2.7.2.2 Analysis of quantitative Real-Time PCR data 
To analyse real-time PCR data a relative quantification of target genes was performed by 
determing the amount of specific targets in one cDNA-population compared to another cDNA 
population. cDNA populations were transcribed from RNA from cells cultivated in SFM 
containing hydrocortisone in comparison to cells cultured in serum-containing medium 
without hydrocortisone. Fluorescence values are recorded during every cycle with a CCD 
camera and represent the amount of product amplified to that point in the amplification 
reaction by determination of the intensity of SYBR-green fluorescence. The fluorescence 
intensity of this dye increases by intercalation into the small groove of double-stranded DNA. 
The more templates present at the beginning of the reaction, the fewer number of cycles it 
takes to reach a point in which the signal is first recorded as statistically significant above 
background (Gibson et al., 1996). This point is defined as the threshold cycle (Ct) and will 
always appear during the exponential phase of amplification (figure 3-5). Therefore, 
quantification is not affected by any reaction components becoming limited in the plateau 
phase. 
To correct for varying quality of applied nucleotides, the results of the target genes were 
compared with those of an internal reference gene. Moreover, the PCR buffer contains a 
fluorescence dye (ROX) which allows to normalise fluctuations of the fluorescence intensity 
of SYBR-green. 
For preliminary analysis of the expression of target genes, the ∆Ct values of specific targets 
were compared. The latter are proportional to the normalised starting quantity of target genes. 
Higher values for ∆Ct correspond to lower expression level of target genes (XN). The values 
were displayed inversely and normalise to the internal control (Y0-∆CT) with Y0 as the 
threshold cycle of the internal control (Y0 = 15). Higher values now represent higher 
expression levels. The value 0 is corresponding to signals detected later than cycle 30. Those 
signals are not significantly higher than the background of the reaction.  
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Figure 3-5: Semilog diagram of the fluorescence signal intensity versus cycle. Ct is the number of 
cycle where the fluorescence intensity is first recorded as significant above background in the 
exponential phase of amplification. ∆Ct gives the difference of fluorescence intensity corresponding to 
an internal reference gene (β-actin or GAPDH). 
 
 
3.2.8 Nucleic acid blotting and hybridisation 
 
3.2.8.1 Northern blotting 
 
After separating RNA molecules in a denaturing gel (section 3.2.2), RNA was transferred 
from the gel onto a positively charged nylon membrane (Hybond, Amersham Biotech) by 
capillary transfer. The RNA of interest was then identified by hybridisation with radioactive, 
32P-labelled probes and visualisation by autoradiography as described in the following section 
(3.2.8.3). For the experimental setup a nylon membrane and Whatman™ filter papers were 
equilibrated in transfer buffer (20 x SSC) and the gel was soaked in RNase-free water 
immediately after gel electrophoresis. Capillary transfer proceeded for 12-18 h. Afterwards, 
the membrane was neutralised in 2 x SSC and transferred RNA was fixed to the membrane by 
UV-crosslinking (350 nm) for 100 sec and subsequent incubation (2 h, 80°C). Membranes 
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were stored between Whatman™ filter papers at room temperature until further use 
(Sambrook, 1989). 
20 x SSC   3 M  NaCl 
    0.3 M  sodium citrate 
 
 
3.2.8.2 Preparation of α-
32
P-labelled DNA probes 
 
For probing northern blots radioactive labelled DNA samples were generated by using the 
MegaprimeTM DNA labelling system (Amersham Biotech) according to the supplied protocol. 
After denaturation of purified DNA the Klenow fragment of E. coli DNA polymerase 
synthesises a second DNA strand and incorporates 32P-labelled dCTP starting at the random 
primer present in the reaction mix. This primer mix contains nonanucleotides, which 
statistically bind every 80-100 nucleotides along the template. 
To 25 ng DNA and 5 µl random primer solution the appropriate volume of water was added 
to give a final volume of 50 µl in the final MegaprimeTM reaction. After 5 min denaturation at 
100°C, 10 µl labelling buffer, 5 µl dCTP32 (10 µCi/µl) and 2 µl enzyme were added and 
incubated for 15 min at 37°C. The reaction was stopped by applying 5 µl EDTA (0.2 M) to 
chelate the bivalent cations, needed for the reaction. The radioactive probes were then purified 
from non-incorporated 32P-labelled dCTP by size exclusion using MicroSpinTM G-50 
Columns (Amersham Biotech) before the activity was measured by a scintillation counter 
(Beckmann). 
 
 
3.2.8.3 Hybridisation 
 
To identify and visualise specific mRNA molecules the radiolabelled probes were hybridised 
to the nucleic acid bound onto the nylon membrane. Before hybridisation the membranes 
were equilibrated with 10 mg/ml denatured herring sperm DNA-containing hybridisation 
solution at 42°C overnight to minimise unspecific binding of the probe to the membrane 
afterwards. For hybridisation the radiolabelled probe was denatured at 100°C for 10 min, 
chilled on ice and finally added to the hybridisation solution. Hybridisation was performed 
overnight at 42°C in a rotation incubator. 
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Hybridisation solution 5 x  SSPE 
    50% (v/v) formamide 
    5 x Denhardt solution 
    1% (w/v) SDS 
    10% (w/v) dextrane sulphate sodium salt 
20 x SSPE   3 M   NaCl 
    0.2 M  NaH2PO4·H2O 
    0.02 M EDTA 
      pH 7.4 
 
100 x Denhardt solution 2% (w/v) Ficoll 
    2% (w/v) polyvinylpyrrolidone 
    2% (w/v)  bovine serum albumin 
 
 
3.2.8.4 Washing 
 
Unspecifically bound radiolabelled probes were removed by separate washing. Membranes 
were washed twice with low stringent buffer (2 x SSPE) for 15 min at room temperature, then 
twice with medium stringent buffer (2 x SSPE, 2% (w/v) SDS) for 15 min at 65°C. After 
monitoring the radioactivity of the membrane high stringent buffer (0.1 x SSPE) was applied 
at room temperature as long as no further background activity could be monitored. For 
visualisation by autoradiography the membranes were exposed to Hyperfilms (Amersham 
Biotech) at -70°C for some hours up to some days depending on signal intensity. 
 
20 x SSPE   3 M   NaCl 
    0.2 M  NaH2PO4·H2O 
    0.02 M EDTA 
      pH 7.4 
3.2.8.5 Stripping 
 
In order to normalise the RNA quantity transferred to the membrane, blots need to be stripped 
and probed with α-32P-labelled GAPDH afterwards. Therefore, initially applied radioactice 
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labelled probes were removed by heating the membrane in stripping solution for 10 min at 
100°C. 
 
Stripping solution  0.015 M NaCl 
0.1 x   SSC 
1% (w/v)  SDS 
 
20 x SSC   3 M   NaCl 
    0.3 M   Na3citrate· H2O 
      pH 7 
 
 
3.2.9 Cloning and ligation 
 
The construction of vectors was performed by two different ways. Either DNA was generated 
by PCR, purified by agarose gel electrophoresis and isolation from the gel, digested in the 
primer sites and cloned into a vector of choice which was linearised using the same restriction 
endonucleases. In case of single cut reaction the vector was dephosphorylated with shrimp 
alkaline phosphatase (0.1 U/µl) (Roche) before the ligation (30 min, 37°C). Or alternatively, 
DNA was generated by PCR and directly cloned into pT-Adv Vector (Clontech) by TA-
cloning. In both cases ligation mixes were transformed into E.coli competent cells to amplify 
plasmids. Subsequently, plasmids were isolated, analysed by restriction digested and 
sequence analysis. The vectors are listed in appendix E.  
 
 
3.2.9.1 Restriction 
 
1 to 5 µg of DNA (either plasmids or PCR-fragments) were cut by 1 µl restriction 
endonucleases (10 U/µl, New England Biolabs, NEB) in the presence of 2 µl of the 
appropriate 10-fold concentrated reaction buffer in a final volume of 20 µl. The restriction 
mix was incubated for 90 min at 37°C. In case of plasmids the restriction reaction was 
controlled by gel electrophoresis and the linearised DNA or the insert were directly purified 
by the QIAquick Gel Extraction Kit (Qiagen) similar to the protocol given in section 3.2.3.  
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3.2.9.2 Ligation 
 
Prior to ligation the concentration of purified and restricted DNA was estimated from agarose 
gel as described in section 3.2.1.2. The vector/insert-ratio was adjuste to 1:3 for best ligation 
efficiency. The ligation was carried out at 16°C overnight using 1 µl T4-DNA ligase (6 U/µl) 
(NEB), 2 µl 10 x ligation buffer (NEB), vector and insert DNA in the calculated ratio. ddH2O 
was applied to a final volume of 20 µl. The ligation mix was stored until transformation into 
E .coli cells. 
 
 
3.2.9.3 TA-cloning 
 
TA-cloning was performed as described by Clontech´s user manual. During PCR 
thermostable Taq polymerase adds a single desoxyadenosine (A) to the 3´ends and the pT-
Adv Vector, with it´s 3´T-overhangs, enables to directly clone these products. Fresh PCR 
products and 50 ng pT-Adv Vector were added to 1 µl ligation buffer and 1 µl T4 DNA ligase 
(4U/µl) in a final volume of 10 µl. The ligation reaction was incubated at 14°C either for 4 h or 
overnight and finally transformation into E.coli cells was performed.  
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3.3 Microbiology 
 
All microbiological procedures were done in a laminar flow hood (Flow BSB 4a) with sterile 
devices and solutions according to security level 1 conditions. Liquid cultures were carefully 
shaken and LB-plates were kept in an incubator. Both, liquid cultures and plates were 
incubated at 37°C. 
 
 
3.3.1 Preparation of competent E. coli cells 
 
To produce competent E. coli cells the bacteria were streaked out for a single colony on LB-
plates. One colony was inoculated into 10 ml LB-medium and incubated in a shaker overnight 
at 37°C. The next day 100 ml LB-medium were inoculated with approximately 5 ml overnight 
culture to give a final optical density of OD600 = 0.1 and the bacterial suspension was grown 
to OD600 = 0.7 – 1.0 at 37°C. 50 ml of the culture was centrifuged (5 min, 4500 x g, 4°C), 
resuspended in 20 ml ice-cold 0.1 M MgCl2-solution and incubated for 10 min on ice. After a 
second centrifugation (5 min, 4500 x g, 4°C), the pellet was resuspended in 20 ml ice-cold 
0.1 CaCl2-solution and kept on ice for further 25 min. Finally, the suspension was again 
centrifuged (5 min, 4500 x g, 4°C), the pellet resuspended in 2 ml ice-cold 0.1 M 
CaCl2-solution and 500 µl glycerol (100%) were added to immediately freeze cells in liquid 
nitrogen in 100 µl aliquots for storage. Competent cells were stored at -70°C. 
 
 
LB-medium   1% (w/v) peptone 
    0.5% (w/v) yeast extract 
    1% (w/v)  NaCl 
 
LB-plates   LB-medium 
1.5% (w/v) agar 
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3.3.2 Transformation of E.coli cells 
 
For transformation. one aliquot (100 µl) of competent E.coli cells was thawed on ice, either 
10 µl of ligation mix or 1 µl of isolated plasmid-DNA was added and the mixture was 
incubated on ice for 30 min. To allow the DNA to permeate the cell membrane, cells were 
heat shocked at 42°C for 2 min. After 5 min on ice, 300 µl LB-medium was added and the 
mixture was incubated at 37°C for 1 h. Cells were then plated onto LB plates containing the 
antibiotic ampicillin (50µg/ml) and incubated at 37°C until single colonies were grown. In 
case of blue/white screenings additionally 0.01% (w/v) X-Gal and 0.1 mM IPTG had been 
spread on the LB-plates before. 
 
3.3.3 Cultures of E. coli cells 
 
In order to isolate plasmid-DNA or to make glycerol stocks one single colony of choice was 
picked and inoculated in 3 ml LB-medium containing ampicillin (50µg/ml) overnight at 37°C 
until the culture was saturated. 
 
3.3.4 Storage of E. coli cells 
 
For long time conservation 700 µl of a saturated bacterial suspension was mixed with 300 µl 
of glycerol (100%) and stored at -70°C. 
 
 
3.4 Protein biochemistry 
 
For protein isolation the cells were cultured as described in 3.1.1 and 3.1.1.1. Cells were 
either passaged or protein isolation took part after reaching a confluent cell monolayer 
without subculturing the cells. The whole protein was isolated after two days in incubation 
medium. 
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3.4.1 Isolation of proteins from cultured cells 
 
Cells were washed (3x) with PBS, covered with SPBS-solution, scratched with a rubber 
policeman and collected in a clean tube. All steps after washing were performed on ice to 
avoid proteinase activity. After centrifugating (4°C, 400 x g, 10 min) the supernatant was 
discarded and the pellet was resuspended in 100 µl SPBS buffer containing protease inhibitor. 
The cells were homogenised by piptting up and down with a syringe, diluted in 100 µl 
SDS (2x) and denatured for 5 min at 95°C in order to destroy the nucleic acids present in the 
whole protein lysate. The protein-solutions were stored at –20°C. 
 
SPBS    50 mM NaPi (pH 7.4) 
150 mM NaCl 
0.32 M Sucrose 
1 mM  Na-EDTA, 
Protease Inhibitor Cocktail® (Boehringer Mannheim) 
 
3.4.2 Determination of protein concentration 
 
In order to determine the protein concentration of the isolated solubilised proteins the method 
developed by Bradford was used (citation). It involves addition of an acidic dye to protein 
solution and measured at 595 nm with a spectrophotometer. Comparison to a standard curve 
provides a relative measurement of protein concentration. Bio-Rad protein assay is a dye-
binding assay in which a differential colour change of a dye occurs in response to various 
concentrations of protein. The absorbance maximum for Commassie Brilliant Blue G-250 dye 
shifts from 465 nm to 595 nm when binding to protein occures. 
 
 
3.4.3 SDS-polyacrylamide gel electrophoresis 
 
Discontinuous polyacrylamid gel electrophoresis (SDS-PAGE) (Laemmli 1970) was 
performed in order to separate complex mixtures of proteins according to their size. Both the 
sample buffer, containing anionic detergent SDS, and heating to 100°C denatures the proteins 
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to give a so called random-coil conformation. SDS also masks the intrinsic protein charge and 
gives all proteins a net negative charge which is proportional to their molecular weight. When 
loaded onto a gel matrix and placed into an electric field, the negatively charged proteins 
migrate towards the anode and are separated by a molecular sieving effect. Discontinuous gels 
contain a short stacking gel with a low percentage of acrylamide to concentrate the sample 
followed by a resolving gel with a higher percentage of acrylamide. The degree of protein 
separation depends on the concentration of polyacrylamide, and so the concentration of the 
separating gel must be chosen according to the expected molecular weight of the sample 
proteins (table 3-5). Before gel electrophoresis protein samples were denatured for 10 min at 
100°C in Laemmli sample buffer. For a 10 cm x 10 cm gel, electrophoresis was performed 
with 1 x electrophoresis buffer at 20 mA per gel. Experimental conditions for SDS-PAGE are 
listed in table 3-6. 
 
Table 3-5: Acrylamide concentration for separation of proteins 
Resolving gel (% acrylamide) 6 8 10 12 15 
Molecular weight range (kDa) 30-200 20-175 15-150 10-100 6-50 
 
Table 3-6: Compounds of SDS-gels. 
 
Stacking gel 
4.0% 
Resolving gel 
8% 
ddH2O 1.85 ml 2.9 ml 
0.4% (w/v) SDS, 1.5 M Tris/HCl, pH 8.8 0.75 ml - 
0.4% (w/v) SDS, 0.5 M Tris/HCl, pH 8.8 - 1.5 ml 
Acrylamid / bisacrylamid (37.5 /1) 0.5 ml 1.6 ml 
TEMED 20 µl 20 µl 
APS (10% (w/v) 12 µl 12 µl 
 
Laemmli sample buffer (3 x)  30% (v/v)  glycerol 
     15% (v/v) β-mercaptoethanol 
     6% (w/v) SDS 
     37.5% (v/v) 0.4% (w/v) SDS, 0.5 M Tris/HCl, pH 6.8 
     small amounts of bromphenol blue 
 
Electrophoresis buffer  0.25 M Tris/HCl 
     2 M  glycerol 
     10% (w/v) SDS 
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3.4.4 Coomassie Blue staining 
 
The location of proteins in a gel was determined by Coomssie Blue staining. This detection 
method depends on non-specific binding of the dye Coomassie Brilliant Blue R to proteins. 
The detection limit is 0.3 to 1 µg per protein band. Proteins separated in a polyacrylamid gel 
precipitated using a fixing solution containing 25% (v/v) isopropanol, 10% (v/v) acetic acid 
and 0.05% (w/v) Coomassie Brilliant Blue for 30 min. For denstaining the gel was agitated in 
10% acedic acid until the blue protein bands appeared against the clear background. 
 
 
3.4.5 Protein blotting and immunodetection 
 
The expression of proteins was detected by seperating the whole isolated protein by SDS-
polyacrylamid-gel electrophoresis (section 3.4.3) and transferring it onto a positively charged 
nylon membrane (Hybond, Amersham Biotech) by semi-dry blotting. Thus, the proteins are 
immobilised and accessible for antibodies. The nylon membrane was pre wetted with transfer 
buffer and the gel was transferred onto the membrane. The gel and the membrane were 
positioned between the transfer-buffer pre-wetted Whatman™ paper and an electrical field 
(0.5 mA/cm2) was applied for 15 hours. Subsequently, the membrane was washed 3 times 
with H2O and rests of the gel were removed. Afterwards, the membrane was pre-blocked with 
PVP (2% w/v) 3 times for 5 min. The primary antibody was applied in a dilution of 1:1000 in 
0.1% PVP (w/v) for 1h (see table 3-7). The membrane was washed again in PVP (2%) and the 
secondary POD-labelled antibody was applied for 30 min in 0.1% PVP. The detection of the 
signal was performed by applying Amersham Biosciences Innovative ECL Kit™ (Amersham) 
and exposure to Hyperfilms (Amersham Biotech). The protein loading was determined by 
Protogold Detection Kit™. For this reason the membrane was washed in H2O and incubated 
overnight in Protogold solution. Subsequently, the membrane was washed again with H2O 
and the intensity of the staining was observed. 
 
Transfer buffer:  
20 mM  Tris 
150 mM  Glycin 
0.1%(w/v)  SDS 
20% (v/v)  Methanol 
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Table 3-7: Antibodies for western blotting 
Primary antibody dilution (in 0.1% PVP (w/v); 0.05%TWEEN (v/v) in PBS ) 
Rabbit anti-Occludin (Zymed Laboratories) 1: 1000  (0.25 mg/L) 
Rabbit anti-Claudin 5 (Calbiochem) 1: 1000  (0.25 mg/L) 
Rabbit anti-ZO1 (Zymed Laboratories) 1:1000  (0.25 mg/L) 
Mouse anti-lamin A/C (Santa Cuz) 1:1000  
 
Secondary antibody 
dilution (in 0.1% PVP (w/v); 0.05%TWEEN (v/v) in PBS ) 
Goat anti-mouse (POD) (Sigma) 1:3000 (0.35µg/L) 
Goat anti-rabbit (POD) (Chemicon) 1:3000 (0.53 µg/L) 
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4 Results 
 
Hydrocortisone is known to induce the barrier forming phenotype in cultured porcine brain 
capillary endothelial cells (Hoheisel et al., 1998). The aim of the present work was to 
establish new primary culture system of murine derived brain capillary endothelial cells 
(MBCEC) and to investigate the effect of hydrocortisone on this culture system. After 
establishment of the murine based blood-brain barrier model in vitro the cells were 
characterised regarding their morphology, expression of common endothelial cell proteins and 
unique proteins of cerebral capillary endothelial cells. Subsequently, the barrier-forming 
effect of hydrocortisone was studied. Finally the porcine and the murine system were 
compared with respect to their barrier-forming properties.  
 
 
4.1 Establishment of the primary culture of mouse brain capillary 
endothelial cells 
 
Two alternative ways have been worked out to obtain microvascular endothelial cells from the 
brain for culturing. The cloning of endothelial cell islands emerging from identified capillaries 
plated in vitro (Dehouck, et al., 1990; Meresse et al., 1989) and the use of enzymatic digestion 
followed by a gradient centrifugation (Abbott et al., 1992; Franke et al., 2000). In this thesis a 
two-step digest was used to isolate the capillaries from the surrounding brain parenchyma and 
to open the basement membrane. Using this method, the cells are able to proliferate after 
seeding from the digested capillaries to a confluent monolayer.  
The isolation was performed following a modified protocol from Maria Deli4 (section 3.1.1). 
After scarifying the mice, the brains were taken out and the meninges of the brains were 
removed. Subsequently, the brains were homogenised. In order to receive high yields several 
digestion times for the first digest with collagenase were observed. It was found that the best 
yields were reached after 1 h incubation with 750 µl collagenase CLS2 (10 mg/ml w/v). After 
centrifugation, the myelin could be removed and the second unspecific digest was performed. 
The optimal incubation time for the second digestion step was also 1 h applying 750 µl 
                                                 
4 Deli, M.A., Biological research centre Szeged, Hungary; personal communication 
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collagenase/dispase (10 mg/ml w/v). After the second digest, the cell-suspension was 
centrifuged, the pellet was resuspended in 2 ml DMEM and applied to a continuous percoll-
gradient. The white microvessel-containing interphase was aspirated and the microvessels 
were obtained by centrifugation. Microvessels were seeded in different densities. To reach a 
confluent monolayer after 3-4 days in vitro the isolated capillaries were seeded in a total of 
3 to 4 cm2/brain on collagen IV/fibronectin-coated petri dishes. For characterisation of the 
cells see section 4.2. 
 
 
4.2 Characterisation of murine brain capillary endothelial cells 
 
Cerebral capillary brain endothelial cells derived from 6-10 weeks old mice of either sex were 
isolated and cultured as described in section 3.1.1. Immunofluorescence-staining was 
performed to prove the localisation of endothelium specific markers like factor VIII-related 
antigen or blood-brain barrier-relevant proteins like tight junction-proteins. The expression 
level of tight junction proteins was investigated both, by western blot analysis and 
quantitative real-time PCR (QRT-PCR).  
 
 
4.2.1 Morphological characterisation of MBCEC 
 
Endothelial cells in vitro express a spindle-shaped morphology building up a confluent 
monolayer. Depending on the isolation procedure primary MBCEC cultures are more or less 
contaminated by glial cells. Thus, the first aim of this work was to establish a primary 
MBCEC culture system with low content of glial cells like astrocytes and pericytes. In order 
to receive reproducible data it was important to obtain monocultures of BCEC without 
contamination of astrocytes, pericytes or other cells from the brain parenchym. 
 
4.2.1.1 Morphology of the MBCEC monolayer  
Capillary endothelial cells can resist the damage caused by the isolation and enrichment 
procedures (Panula et al., 1978). Due to the fact that brain capillaries in vivo are tightly 
embedded in diverse glia cells like astrocytes and pericytes (figure 4-2), the isolation 
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procedure is not completely endothelial cell-specific but leads to co-cultivation with latter 
mentioned glial cells. 
To ensure that only MBCEC were present in the cell culture, the cells were cultured the first 
two days in vitro in puromycin supplemented medium. Puromycin is an antibiotic with 
apoptosis inducing properties and allows to select specifically the endothelial cells in culture, 
while other cells die (Sanwal et al., 2001; Fernandez et al., 2001; Linnell et al., 2001; 
Francoise Roux & Maria Deli, personal communication).  
One day after seeding freshly isolated MBCEC, groups of cells formed small islands 
expressing the so-called “fibroblast-like” morphology. After DIV 4 a confluent monolayer of 
cells was formed with a fusiform cell-shape with oval nucleus in the centre, neighbouring 
cells tightly apposed to each other. As shown in figure 4-1 A, this shape dominates the murine 
culture after reaching confluence. Cells cultured in absence of puromycin express also 
confluent monolayers with the same fusiform morphology but are visibly contaminated by 
other cell. In phase contrast images of these cultures cells with astrocytic and pericytic shape 
are visible within the cell-layer (figure 4-1 B).  
 
 
 
Figure 4-1 Endothelial cell morphology after 4 DIV determined by phase contrast microscopy. Panel A 
illustrates cells cultured in puromycin containing medium. The cells within the monolayer show the 
typical spindle-shaped morphology without gaps between cells. No contaminating cells are visible. 
Panel B images a cell layer of MBCEC cultured in absence of puromycin. In addition to the spindle-
shaped morphology different structures are visible (arrows 1+2). The presence of contact inhibition is 
seen in both panels as no visible multilayers of cells can be detected. 
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Indirect immunofluorescence staining was performed with anti-GFAP-antibody against the 
astrocyte-specific glial fibrillary acidic protein (Pegram et al., 1985) and anti-α-sm-actin-
antibody against smooth-muscle cell-actin for visualisation of pericytes (Skalli et al., 1989). 
Figure 4-2 indicates that no astrocytes were detectable in both, cultures supplemented with 
and without puromycin. In contrast, MBCEC cultured without puromycin are contaminated 
by pericytes (figure 4-2 C). No pericytes remain detectable in MBCEC cultured in 
puromycin-containing medium (figure 4-2 D). 
Only these monocultures of MBCEC were chosen for further experiments concerning blood-
brain barrier properties. 
 
Figure 4-2: Immunofluorescence stain of MBCEC in vitro. A+B: Immunostaining against glial fibrillaric 
acidic protein (GFAP). A: puromycin-free medium B: puromycin-supplemented medium. C+D: 
Immunofluorescence against α-smooth-muscle cell actin. C: puromycin-free medium D: puromycin-
supplemented medium. While no astrocytes are detectable (A+B), cells cultured without puromycin are 
contaminated by pericytes (C).  
 
4.2.1.2 Immunostaining of tight junction- and tight junction-associated proteins  
One characteristic feature of cerebral capillary endothelial cells is the presence of well 
developed tight junctions. These tight cell-cell contacts are basically influenced by membrane 
localised proteins and form a belt between adjacent cells (section 2.2.1). The presence of tight 
junctions and tight junction-related proteins, such as ZO-1, was determined by indirect 
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immuofluorescence staining (3.1.3). The staining was performed either on permeable filters or 
on cover slips. On both substrates, MBCEC expressed the same staining pattern of 
investigated proteins. Thus, it was examined that the substrate has no effect on the 
immunofluorescence staining of cells. Due to the fact that no difference could be detected 
between the two culture conditions, only the data from MBCEC cultured on filter–substrates 
are shown. For investigation of tight junction expression, the tight junction-proteins occludin, 
claudins-1 and -5 and the tight junction-associated protein ZO-1 were chosen (figure 4-3). 
 
Figure 4-3: Tight junction expression in MBCEC. Micrographs show immunofluorescence labelling of 
cells after 6 DIV in serum-containing medium using antibodies against the tight junction proteins 
occludin, ZO-1, claudin-1 and -5. Panel A shows staining of occludin, panel B indicates ZO-1-staining. 
Panel C: Claudin-5; panel D: Claudin-1. Panel E: Secondary antibody control to A, C+E; F: secondary 
antibody control for B. Partial areas in the cell layer show cobble-stone cells while others express the 
fusiform morphology. Except claudin-1, the tight junction proteins occludin, claudin-5 and ZO-1 could 
be detected by immunofluorescence staining.  
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Figure 4-3 A reveals a specifically membrane-localised staining of occludin. The cell borders 
appear frayed. The cells express a heterogeneous morphology: Some of the cell bodies show 
the fusiform shape while others appear more cobble-stone-shaped. In contrast to ZO-1 and 
occludin, claudin-5 staining appears not as a distinct border between adjacent cells but shows 
a dotted line. The staining indicates only membrane-localisation while no staining can be 
detected at the nucleus. The same applies to claudin-5 and occludin (figure 4-3 B, C). The 
heterogeneous morphology of MBCEC is detectable by staining with anti-occludin and anti-
claudin-5 antibody. Claudin-1 was not detectable in MBCEC by immunofluorescence staining 
(figure 4-4 D). 
Double immunofluorescence staining was performed to investigate co-localisation of 
occludin, claudin-5 and ZO-1. Double staining against ZO-1 and occludin was performed as 
well as against ZO-1 and claudin-5. Data indicates a co-localisation of these three proteins at 
the cell borders between adjacent cells (figure 4-4).  
 
Figure 4-4: Immunofluorescence labelling of tight junction proteins in MBCEC. Double-
immunofluorescence staining was performed at the 6. DIV. A+B: Immunostaining for ZO-1 (A) and 
occludin (B): C+D: co-localisation of ZO-1 (C) and claudin-5. The cells show both, a spindle-shaped 
morphology with distinct staining at the cell borders and a more cobble-stone shape with fuzzy 
staining. ZO-1 and the transmembrane proteins occludin and claudin-5 are co-localised. 
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4.2.1.3 Cellular localisation of brain multidrug resistance protein and factor VIII 
 
Endothelial cells show expression of different membrane localised transporters as for instant 
P-glycoprotein or multi-drug resistance proteins of the family of ABC-transporters (Cordon-
Cardo et al., 1989; Huai-Yun et al., 1998; McNamara and Lenox, 1998; Zhang et al., 2000). 
Brain Multidrug Resistance Protein (BMDP), a new multidrug resistance protein at the blood 
brain-brarrier, was detected in porcine capillary endothelial cells (Eisenblatter and Galla 
2002). In order to observe, if this transporter is present in the isolated MBCEC as well, 
immunofluorescence staining against BMDP was performed. The MBCEC in vitro show a 
membrane-localised staining for BMDP (figure 4-5 A). The cells stained with antibodies 
against BMDP show the typical spindle-shaped morphology and are attached to each other. 
The protein is mainly located at the membrane and shows a weak cytoplasmic signal (see also 
figure 4-13). The expression of BMDP and P-glycoprotein was quantified on RNA- and 
protein level (section 4.3)  
 
  
Figure 4-5: Localisation of brain multidrug resistance protein and factor VIII in MBCEC after 6 DIV. A: 
Anti-BXP 391 staining of BMDP. The protein is located at the membranes and shows weak 
cytoplasmic staining. B: MBCEC stained with secondary antibody to A. Panel C shows a micrograph of 
immunofluorescence staining against factor VIII. The protein is localised in the cytoplasm and 
indicates a granular pattern. Panel D shows the control stained with secondary antibody.  
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Another characterisitic marker for endothelial cells is the expression of factor VIII (Bowman 
et al., 1981, Phillips et al., 1979). Figure 4-5 C renders the typical immunostaining pattern of 
this cytoplasmatic localised protein in MBCEC that is mainly accumulated in Weibel-Pallade-
bodies (Wagner and Marder, 1984). 
 
 
4.3 Identification of blood-brain barrier related proteins on RNA-
level 
 
Several methods were developed to detect RNA and to determine the RNA expression levels 
of specific genes. Northern blot analysis is the main tool used to identify genes quantitatively 
on the RNA level, but this technique requires large amounts of total RNA (25 µg). With PCR 
and its application to analyse RNA by reverse transcription (RT) and its ability to amplify the 
target genes by polymerase chain reaction, a new approach was found to quantify expression 
with small amounts of RNA (0.4 µg). While existing methods are generally time-consuming, 
the new method developed by (Higuchi et al., 1992; Higuchi et al., 1993) allowed the real-
time detection of amplicons during the PCR (quantitative real-time polymerase chain reaction 
(QRT-PCR). This method facilitates the detection of different expressed genes in RNA-
species isolated from cultured cells or tissues. The expression pattern of proteins in a cell 
population is closely related to the function of the cells in vivo. Thus, it is possible to estimate 
the presence of proteins by determining their expression on the RNA-level. However, to 
quantify the expression of proteins, western blot analysis is necessary. 
The application of QRT-PCR is benefical to identify specific markers for microvascular brain 
endothelial cells on the RNA level. The reaction was performed and data was examined as 
described in section 3.2.7.2. Figure 4-6 presents the retrieved data of QRT-PCR. The typical 
marker enzymes for endothelial cells and blood-brain barrier phenotype are expressed on the 
RNA-level. The grade of expression of angiotensin converting enzyme and ferrintransferase is 
similar to the expression of GAPDH which was used as a house-keeping gene. γ-
Glutaryltraspeptidase (GGT) and alkaline phosphatase (ALP) is lower expressed on the RNA-
level but also detectable in MBCEC. Two other typical proteins could be detected: 
P-glycoprotein and BMDP. The RNA-expression level of these enzymes is comparable high 
in MBCEC. 
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Two well known marker enzymes for blood-brain barrier endothelial cells are alkaline 
phosphatase (ALP) and γ-glutaryltranspeptidase. Ferrin-transferase and angiotensin 
converting enzyme are known to be expressed in endothelial cells. As described above, the 
transporters P-glycoprotein and BMDP, were shown to be highly expressed at the blood 
brain-barrier. These enzymes were chosen to be investigated on expression pattern in the 
primary culture of MBCEC.  
 
 
 
Figure 4-6: Expression of mRNA of blood-brain barrier related proteins and house-keeping genes. 
QRT-PCR was performed with 0.4 µg total-RNA isolated from cells after DIV  5 in serum-containing 
medium. The reaction was executed with primers reported in appendix D. ∆CT-values: alkaline 
phosphatase: 4.59; angiotensin-converting. enzyme: 8.27; β-actin: 14; ferrintransferase: 8.21; 
γ-glutaryltranspeptidase (GGT): 5.61; brain multidrug-resistance protein: 11.33; P-glycoprotein: 11.26. 
(standart deviation for n=3) 
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4.4 Functional effects of hydrocortisone on MBCEC 
 
4.4.1 Electrical properties of MBCEC 
 
It is well known that hydrocortisone strengthens the barrier function with respect to the 
electrical resistance and the permeability for sucrose of porcine brain capillary endothelial 
cells (Hoheisel et al., 1998a). The question arises, if this strengthening is a common effect in 
mammalian primary cultures of endothelial cells derived from brain capillaries. 
 
4.4.1.1 Results of impedance spectroscopy and quartz microbalance on MBCEC 
 
Impedance spectroscopy is, as described in section 3.1.6, a sensitive method to determine the 
transendothelial electrical resistance (TEER) across cell monolayers. As previously described, 
Hoheisel et al., (1998) found that porcine microvascular endothelial cells cultured in 
hydrocortisone-containing medium form a barrier with high electrical resistances and low 
sucrose permeability. Both, permeability and TEER mirror a degree of barrier formation 
similar to in vivo conditions. Following the assumption that murine derived endothelial cells 
behave similarly, MBCEC were isolated and cultured under similar conditions as PBCEC 
(section 3.1.1). These cells were subcultured for 2 days on rat tail collagen coated transwell 
filters (Costar) until they reached confluence. The TEER and permeability experiments were 
performed either 24 h or 48 h after the addition of the incubation medium (either serum-
containing medium or SFM with hydrocortisone). Alternatively, long-term measurements 
were started directly after addition of hydrocortisone and serum, respectively.  
Experiments show that hydrocortisone, in physiological concentration of 550 nM (Karlson, 
1994), leads to a 5-fold higher electrical resistance than serum containing medium in 
MBCEC. The TEER rarely reached values higher than 500 Ω·cm2 after addition of 
hydrocortisone-supplemented medium. But usually the TEER amounted to 200 Ω·cm2 in 
hydrocortisone-containing medium while serum maintained the resistance at around 40 Ω·cm2 
(figure 4-7). The withdrawal of serum and incubation of the cells in serum-free medium leads 
to a further decrease of TEER (30 Ω·cm2). In comparison to the primary culture of porcine 
endothelial cells this is a contradictory result. The withdrawal of serum in PBCEC-culture 
leads to an increase in TEER (Hoheisel et al., 1998).  
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Figure 4-7: Influence of hydrocortisone on transendothelial resistance on MBCEC under different 
culture conditions. The cells were subcultured after DIV 3 and incubation medium was applied on the 
DIV 5. The measurement was performed after 2 more days. Cells cultured with hydrocortisone show a 
5-fold higher TEER (201 Ω·cm2 ± 3.6 Ω·cm2) than cells cultured in serum-containing medium 42 Ω·cm2 
(± 2.1 Ω·cm2 while TEER of cells cultured without both supplements reach values of about 28 Ω·cm2 
(± 1.7 Ω·cm2). (Standart deviation for n=5) 
 
In order to investigate the time course of HC induced barrier strengthening the TEER was 
observed for 72 hours after addition of the incubation medium. Following the measurement 
(figure 4-8) the resistance starts to increase not directly but 2 hours after addition of 
hydrocortisone-containing medium. The resistance increase (6 Ω·cm2/h) is almost linear until 
15 hours after exchange of medium. The maximum value is reached after 40 hours. These 
results match the data received from PBCEC although these cells reach the highest resistance 
after 16 hours in hydrocortisone-containing medium (Nitz, 2001). MBCEC cultured under 
hydrocortisone conditions stay at high resistances for 20 hours and the decrease is 
recognisable after 55 hours in culture. In serum-containing medium the resistance increases 
slowly for 15 hours. Finally the cells remain at resistances around 40 Ω·cm2 for 40 hours. A 
following decrease is detectable after 40 hours and the measurement was stopped after 72 
hours when the cells reached 80% of the maximum value. The cells cultured in serum-
containing medium stay at low resistances during the observed 70 hours. The TEER reaches 
30% of the maximum value of hydrocortisone-treated cells. 
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Figure 4-8: Time-dependent effect of hydrocortisone in MBCEC. The cells were subcultured after DIV 3 and 
the medium was exchanged after DIV 5. The measurement was started directly after application of incubation 
medium. The continuous line indicates the values for the hydrocortisone-supplemented cells, the broken line 
shows values for cells in serum-containing medium. The highest value for hydrocortisone was set as 100%. The 
measurement was performed on rat-tail collagen coated filters. All values were averaged (standard deviation for 
n=3). 
 
 
4.4.1.2 Electric cell-substrate impedance sensing and quartz crystal microbalance 
measurements on MBCEC 
 
As described in section 3.1.6.2 electrical cell-substrate sensing is a method to discriminate 
between three different morphological parameters. Whereas impedance spectroscopy on 
filters only gives the sum of resistances over the cell layer the application of ECIS allows 
distinguishing between more parameters. The parameter α describes the impedance 
contribution from the cell substrate adhesion zone and Rb indicates the resistance between the 
cells. Furthermore, it is possible to follow the capacitance of the system. The advantage in the 
separation of Rb and α is the opportunity to correlate changes in cell-substrate interaction and 
increase or decrease in paracellular resistance respectively. 
In section 3.1.7 the applicability of QCM was described. This feature as well as ECIS to 
distinguish between α and Rb. Additionally, it is possible to measure the electrical parameter 
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in correlation with mechanical properties of the cells since a modulation in attachment to the 
quartz crystal would result in a difference in resonance parameters. 
In quartz mode the cells were examined for their properties under different culture conditions 
(figure 4-9). MBCEC grown in serum-containing medium show no significant difference in 
motional resistance R but a trend to higher values is observed when cells are treated with 
hydrocortisone. The values for serum-treated cells reach 481 Ω (±16 Ω) while hydrocortisone-
treated cells are characterised by 512 Ω (± 20 Ω). The values for inductivity are also similar 
under both, serum- and hydrocortisone conditions. The difference between both culture 
conditions lay in range from 3.5 µH (± 4.6 µH) for serum-treated cells to 4.3 µH (± 0.3 µH) 
for hydrocortisone-treated cells.  
 
 
 
 
Figure 4-9: A the motional inductance ∆L and the B motional resistance ∆R of MBCEC cultured under 
two different conditions. The measurement was performed at room-temperature after an equilibration-
time of 10 min. A total of n=5 resonators were investigated. A weighted average is presented. 
 
 
The cell mode of the same measurements indicates a change in the electrical parameter. The 
parameters α and Rb show an increase from cells cultured in serum-containing medium 
compared to hydrocortisone-treated cells. The value of serum treated cells is around 
13.5 Ω1/2·cm (± 0.3 Ω1/2·cm) for α whereas Rb reaches 17.9 Ω·cm2 (± 2.8 Ω·cm2). There is a 
significant increase when the cells are cultured with 550 nM hydrocortisone (α = 23.5. Ω1/2cm 
± 0.9 Ω1/2cm and Rb = 72.3 Ω·cm2 ± 8.4 Ω·cm2). This fact is a hint that hydrocortisone 
influences both, the cell-cell contacts (tight junctions) and the cell-substrate interactions. 
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It was interesting to find that hydrocortisone influences the capacitance of the cell layer. In 
PBCEC the membrane capacitance was quantified to 1 µF/cm2 for both culture conditions. 
MBCEC, however, reach values of 0.66 µF/cm2 (serum treated-cells) and 0.82 µF/cm2 
(hydrocortisone-treated cells). Whereas the capacitance is governed by the structure of the 
membrane (microvilli, smooth surface) these findings implicate a change in membrane 
morphology. The ECIS-measurements performed on 8-well electrodes (data not shown) as 
described in section 3.1.6.2 correlated directly with the data shown in (figure 4-10). 
 
 
 
Figure 4-10: Results of ECIS. The same cells as in figure 4-9 were measured. α, Rb and CM are 
presented as weighted average values for n=5. The measurement was performed at room-
temperature after equilibrating the cells for 10 min. Hydrocortisone increases the parameter α 
indicating that the cell-substrate contact or the extracellular matrix is influenced by the glucocorticoid 
hormone. Rb indicates a strengthening of cell-cell contacts induced by hydrocortisone. The values for 
the membrane capacitance indicate a monolayer structure different from a layer of endothelial cells. 
Hydrocortisone influences this parameter as well as α and Rb. 
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4.4.2 Sucrose permeability of MBCEC  
 
The intact microvasculature is an impermeable barrier for sucrose in vivo. This molecule 
diffuses neither passively across the barrier nor is it transported actively across the cell 
monolayer. This is also well known from in vivo-studies (Bowman et al., 1983; Gruenau et 
al., 1982; Neuhaus et al., 1991; Rubin et al., 1991). The fact that sucrose is a small 
hydrophilic molecule makes it suitable to quantify barrier properties of endothelial and 
epithelial cell-layers. Small lacks in the cell layer drastically increase the permeability for this 
marker. In this work sucrose permeability was studied to discover the barrier forming 
properties of MBCEC in correlation to the electrical resistances found as described in section 
4.4.1.  
Independent from the culture conditions the permeability of MBCEC is very high. While the 
permeability of PBCEC is in the range of 6·10-7, MBCEC show a permeability in a range 
from 1.5·10-5 up to 1·10-4 cm/sec (figure 4-11). The latter value is already in the range of an 
empty filter without a cell layer. It is obvious that in presence of hydrocortisone the cells 
possess a lower permeability than cells cultured in serum free-medium. Hydrocortisone 
decreases the permeability down to 2.7·10-5 cm/sec in comparison to serum-free medium. On 
the other hand the presence of serum reduces the permeability to values comparable with 
hydrocortisone. These results have to be interpreted carefully due to the systematic errors. 
Figure 4-11: Permeability of MBCEC. Cells were cultured 3 DIV and subcultured for 2 DIV until 
exchange of medium. After the second day in incubation medium the permeability for 14 C-sucrose was 
determined for different incubation media (standart deviation n=5). 
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4.4.3 Influence of hydrocortisone and serum on morphology of MBCEC 
and localisation of tight junction proteins 
 
To ascertain the influence of hydrocortisone on MBCEC initially on the morphology and 
localisation, expression and structure of tight junction proteins of the cells, MBCEC treated 
with hydrocortisone were examined in comparison to cells cultured in serum containing 
medium. Especially the increase in the electrical resistance of the parameter Rb (cell-cell 
contacts) leads to the assumption that the expression of tight junction proteins is altered. After 
the monolayer reached confluence, the medium was exchanged from culture medium to 
incubation medium (either serum-free medium supplemented with or without hydrocortisone) 
or serum-containing medium (foetal calf serum). 
 
 
4.4.3.1 Cell morphology 
 
Figure 4-12 (A+B) show phase contrast images of cells cultured in two culture-conditions. 
The cells were cultured in either serum containing medium or in medium without serum 
supplemented, with hydrocortisone. The cells were not subcultured, but grew in petri dishes 
until reaching confluence. As figure 4-12 indicates, both culture conditions have no influence 
on the visible integrity of the monolayer. The layers are confluent and neither hydrocortisone 
nor serum-containing medium interrupts or cause larger gaps in the layer. While under serum-
content the cells confirm their spindle shaped morphology, cells under influence of 
hydrocortisone express both, a cobble-stone structure and spindle-shaped pads within the 
layer. In areas with spindle-shaped morphology lower contrast remain detectable. The change 
of morphology takes place after 8-10 hours following the exchange of the medium. Indirect 
immunostaining against the membrane localised tight junction protein occludin also illustrates 
this phenomenon (figure 4-12 C+D). The cells were cultured on permeable filters and 
analysed by impedance spectroscopy before fixing and providing the immunostaining 
procedures. The hydrocortisone treated MBCEC show a heterogenic morphology: Some cells 
are cobble-stone shaped while others, within the layer, form pads appearing in a spindle-
shaped morphology. The staining at cell borders in areas with spindle-shaped cells is more 
distinct while the areas with different shape are characterised by a more diffuse structure of 
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cell-cell contacts. The ratio of spindle shaped cells is in a range of 50%. The serum-treated 
cells form a more homogenic layer with more or less cobble stoned morphology. 
Interestingly, the cells react different after subcultivation (figure 4-12 C+D). Before 
subculturing, the cells express spindle-shaped structures after serum-treatment, while the 
subcultured cells grown on filters and cultured in serum show the homogenic cobble-stone 
structure. Evidently the serum-treated cells show less distinct staining at the cell borders but 
more a diffuse cytoplasmic fluorescence (see also figure 4-13).  
 
 
Figure 4-12: Morphology of cells treated either with serum- or with hydrocortisone-containing medium. 
A: Phase contrast of cells cultured until confluence without subculturing in serum-containing medium. 
Serum-treated cells show a fusiform cell-morphology. B: Phase contrast of cells treated with 
hydrocortisone containing medium. Hydrocortisone cells form a cobble-stone monolayer with pads of 
spindle-shaped cells. C+D: Cells after subculturing on rat-tail collagen coated filter-membranes. C: 
Anti-occludin staining of cells (serum). Serum-treated cells indicate a homogenic cobble-stone 
shapedcell-layer. D: anti-occludin staining of cells on filter membranes (hydrocortisone). These cells 
indicate a heterogenic morphology, either cobble stone- or fusiform shape. 
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4.4.3.2 Localisation of tight junction- and tight junction associated proteins 
 
The identification and localisation of tight junction proteins occludin, claudins or occludin 
associated proteins like ZO-1 mirror the state of the tight junctions. As shown in figure 4-3, 
the tight junction proteins occludin and claudin-5 are expressed in MBCEC in vitro. The same 
applies to ZO-1. As described in section 4.4.1, hydrocortisone strengthens the electrical 
resistance from MBCEC. To observe if this is an effect of tight junction formation MBCEC 
were examined by immuofluorescence staining concerning the structure of tight junction 
proteins. Due to the fact that BMDP staining is membrane localised and similar to tight 
junction staining, the detection of this protein gives the advantage when comparing a non-
tight junction specific change in the membrane morphology of the cells. 
Figure 4-13 shows the results for indirect immunofluorescence of latter mentioned proteins. 
As referred to in section 4.4.3.1, hydrocortisone influences the structure of antibody-mediated 
staining of target proteins. The cells shown in figure 4-13 were cultured under three different 
conditions: They were either treated with serum-free medium with or without hydrocortisone 
or with serum-containing medium. As figure 4-13 indicates, withdrawing the serum already 
cause a redistribution of ZO-1. Serum-treated cells show a more diffuse staining of the 
membrane with partially fuzzy staining between adjacent cells, the serum withdrawal results 
in more distinct staining. Furthermore, several gaps appear between the tight junction strands 
of adjacent cells cultured in serum (figure 4-13 A+B). The frayed staining pattern disappears 
in culture with hydrocortisone. Additionally, the background stain and stain around the 
nucleus vanishes. The cell borders are more distinct and the cell morphology changes from 
cobble stone shape with serum to spindle shape when treated with hydrocortisone. The same 
applies to occludin. The change in morphology can be observed in figure 4-13 (D-E). The 
cells are lanker and the staining appears more distinct. Also gaps appear between cells under 
serum conditions while the membranes indicate a frayed morphology. Supplementing the 
culture medium with hydrocortisone leads to an increase in membrane staining when using 
anti-occludin primary antibody. The indirect immunofluorescence of BMDP, as a membrane 
standing, but not tight junction-associated protein gives the same appearance. In the presence 
of hydrocortisone the protein seems to be translocated to the membrane. Again the staining is 
more distinct while the background vanishes. 
4 Results  73 
 
Figure 4-13: Effect of hydrocortisone on tight junctions. A, B, C: ZO-1; D, E, F: occludin; G, H, I: 
BMDP. Serum-containing medium: A, D and G; serum-free medium: B, E and H; hydrocortisone-
containing medium: C, F and I. The cell-cell contacts appear more distinct when the MBCEC are 
cultured in hydrocortisone-supplemented medium. The cell-morphology changes to fusiform shape 
after hydrocortisone-treatment.  
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4.4.3.3 Influence of serum and hydrocortisone on the cytoskeleton 
Actin is the most frequent protein in cells and occurs both, as soluble globular actin (G-actin) 
and as fibrous actin (F-actin). F-actin builds together with myosin the major compound of the 
cytoskeleton. Because of the contractile properties of f-actin and its linking to the tight 
junctions (figure 2-3), hydrocortisone may influence redistribution of actin filaments and 
therefore, may induce a morphological change of cells.  
Figure 4-14 displays a staining with rhodamine-labelled phalloidin against actin filaments. 
The cells were cultured on microporous filter membranes, like the cells shown in previous 
images. Cells cultured in serum-containing medium indicate a lateral staining localised 
predominantly at the membranes with a high contrast to the cytoplasm (perijunctional 
staining). With removal of serum, actin redistributes within the cell body and evinces a 
filamentous distribution in the longitudinal direction of the cells. The addition of 
hydrocortisone enhances this effect and the intensity of distinct filamentous staining is 
increased (figure 4-14 B) in comparison to serum-free cultured cells (figure 4-14 C). Due to 
the fact that the tight junctions are linked to the cytoskeleton a change in the distribution of 
stress fibres may result in a morphological change of the distribution pattern of the membrane 
standing tight junction proteins. 
 
 
 
 
 
 
 
 
 
 
Figure 4-14: Direct phalloidin-staining of actin in MBCEC. A: serum-containing medium; B: serum-free 
medium; C: serum-free medium supplemented with hydrocortisone. The cells were cultured 2 days in 
incubation medium. The withdrawal of serum leads to a redistribution of actin within the cells. After 
addition of hydrocortisone, distinct actin-filaments appear in the longitudinal direction of the cell.   
25 µm 
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4.4.4 Influence of hydrocortisone on cell-cell contacts and cell surface 
 
Phase contrast imaging and immunofluorescence staining give an idea of localisation and 
expression of individual proteins. To investigate the ultrastructure of the cells, other 
applications are necessary. Atomic force microscopy is a powerful tool for detection of 
ultrastructural characteristics of biological probes under physiological conditions.  
 
4.4.4.1 Investigations of MBCEC by Atomic force microscopy 
Phase contrast imaging and immunofluorescence staining of MBCEC indicates a 
morphological change after application of hydrocortisone. To investigate ultrastructural 
changes, atomic force microscopy was performed to explore changes in the surface 
morphology and the elasticity of cells cultured in different media. As mentioned in section 
3.1.4, AFM allows obtaining information about changes in surface structures and enables the 
imaging of cell-cell contacts and stress fibres. The tight junction region between the cells was 
of special interest. Furthermore, it is possible to measure the elasticity by calculation of the 
Young´s modulus. This information enables to draw conclusions about change in morphology 
as well as probable redistribution of actin filaments. 
 
 
4.4.4.1.1 Investigation of topography profiles of MBCEC by AFM 
Figure 4-15 presents topography profiles and deflection of cells cultured either with or 
without hydrocortisone5. The AFM images imply a hydrocortisone-induced structural 
reorganisation or formation of cytoskeleton elements and a change in the tight junction 
morphology. In correlation with immunofluorescence, cell-cell contact areas indicate frayed 
tight junction regions. The cells are cobble-stone shaped and the cytoskeleton elements are 
marginally seen. In hydrocortisone-treated cells the cell-cell contacts appear as distinct lines 
between adjacent cells and cytoskeletal elements are distributed in the longitudinal direction 
of the cells. The tight junctional region in hydrocortisone-treated cells indicates a cleft which 
can be seen in figure 4-15 B. In comparison, the structure of the cells cultured without 
                                                 
5 AFM investigations were performed in collaboration with Sebastian Schrot, Institut für Biochemie, WWU 
Münster, Germany. 
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hydrocortisone implies an increased altitude at the cell borders. This finding can be proven by 
analysing the profiles of the tight junction region (figure 4-16). After hydrocortisone-
treatment, the average of altitude of tight junction regions indicates an increase. The data of 
cells cultured in serum-containing medium correspond to the findings in serum-free medium 
(data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-15: Topography images of MBCEC in vitro. A: Left images show the surface and deflection 
of cells cultured in serum-free medium. Cells on the right were treated with hydrocortisone. The 
serum-free cultured cells indicate frayed tight junctions (arrows) while the hydrocortisone-treated cells 
have distinct lines between adjacent cells (arrow-head). The arrow shows cable-like structures in 
longitudinal direction of the cell indicating stress fibres. B: 3D-image of cells cultured in 
hydrocortisone-containing medium. The cleft represents the contact-zone between adjacent cells. 
Arrows indicate the same region in both pictures. 
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Figure 4-16: Height of tight junctions in different media. A: Average of the altitude within the tight 
junctional zone of cells culture with/without hydrocortisone. Cells cultured in HC show an increase of 
the altitude within the tight junctional zone. (standard deviation n=8) B: Cross section of the profile 
within a tight junction zone of cells cultured under different conditions. 
 
4.4.4.1.2 Investigations of force curves of MBCEC by AFM 
 
The force curves of AFM measurements give an idea about the elastic properties of the cell 
surface. These mechanical properties may play a major role in cellular processes as migration 
and cell division and can be brought in correlation with redistribution of cytoskeleton 
elements like stress fibres (Rademacher, 2002; Sackmann, 1994). The protein actin can form 
interconnected double-helical polymer fibres with a periodicity of 3.7 nm and is associated 
with a large number of proteins controlling the architecture of this network (Hartwig and 
Kwiatkowski, 1991). The investigation of mechanical properties was performed as described 
in section 3.1.4. As shown in figure 4-17 the cells treated with hydrocortisone posses a higher 
Young´s modulus indicating a formation or redistribution of actin filaments (Rademacher, 
2002). 
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Figure 4-17: Force mapping of MBCEC under different conditions. A: Serum-free treated cells; B: 
Hydrocortisone-treated cells. The data implicate a change of mechanical properties of MBCEC under 
different culture conditions. C: Young´s modulus of cells from different culture conditions. Cells treated 
with hydrocortisone possess higher elasticity. (+HC=8304 kPa ±2491 kPa; -HC= 5129 kPa 
± 1538 kPa; standard deviation n=6) 
 
 
4.4.5 Transmission electron microscopy 
 
As described in section 3.1.5, transmission electron microscopy gives the opportunity to 
investigate ultrathin sections of cells cultured on filter membranes. These specimen are 
contrasted with electron-dense heavy metal ions. At these electron-dense areas, the electron 
beam is refracted and thus, it is possible to image the probes and visualise subcellular details. 
To apply this technique, the cells were cultured on filter membranes as described in section 
3.1.1 and after 2 days in incubation medium the TEER was determined in order to choose the 
cells with the highest transendothelial resistance of each culture condition. 
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TEM images of MBCEC indicate a flat morphology whereas hydrocortisone-treated cells are 
recognisably more flat than serum treated cells. As demonstrated in figure 4-19, all cells show 
vesicle-like structures, which could be glycogen reservoirs, indicating that the energy state of 
the cells is saturated. The cells cultured in presence of serum (A+B) are not as tightly attached 
to the substrate as hydrocortisone treated cells (C+D) especially at the cell-cell contact 
regions. In other regions of the cell layer, wide overlapping areas are expressed (figure 4-
19 C) which correlates to the capacitance values of QCM-measurements (section 3.1.7). One 
of these areas is shown in figure 4-18. This image indicates a contact area of three adjacent 
cells cultured in serum. Two cells form blunt cell-cell contacts and overgrow a third cell. The 
differences between the culture conditions are mainly based on the cell-cell contact region. 
Most contact areas from serum-treated cells are blunt and marginal folds develop but do not 
attached to the adjacent cell (figure 4-19 B). The cells treated with hydrocortisone express 
electron dense tight junction regions with marginal folds attached to the adjacent cell (figure 
4-19 D, E).  
 
 
Figure 4-18: Micrograph of a TEM-image of MBCEC. Overlapping region of cells indicated by electron 
microscopy. The MBCEC were cultured in serum-containing medium. The image indicates a contact 
point between three adjacent cells. The tight junctions are indicated by arrows. As seen in all serum-
treated cells the tight junctions are weak expressed.  
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Figure 4-19: TEM images of MBCEC. A, B, C: MBCEC cultured under serum conditions DIV 2; D, E: 
hydrocortisone treated cells (DIV 2). A: Blunt cell-cell contacts without visuable tight junctions. B: Cell-
cell contact with marginal fold not attached to the adjacent cell (arrow-head). C: Overlapping area of 
adjacent cells. D: Cell-cell contact with attached marginal folf (left arrow) and electron dense tight 
junction area (right arrow). E: Cell-cell contact with electron dense tight junction area (arrow). 
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4.4.6 Influence of hydrocortisone on expression of blood brain-barrier 
related proteins on RNA-level 
 
As described in section 2.4, hydrocortisone is a glucocorticoid hormone which regulates the 
expression of proteins on the RNA level by binding to glucocorticoid receptors and 
association to glucocorticoid response elements at DNA targets. This implicates that the 
change of MBCEC properties and the tight junction morphology may be the result of 
hydrocortisone-induced expression of different targets. In PBCEC the subtractive suppression 
hybridisation was applied to identify differentially expressed genes on the RNA level 
(Eisenblätter, 2002; Weidenfeller, 2000). Tight junction proteins were not affected by 
hydrocortisone-treatment but a new multidrug resistance protein (BMDP) was detected in 
PBCEC and identified as upregulated in the presence of hydrocortisone (Eisenblatter and 
Galla, 2002; Eisenblätter, 2002). In this work the tight junction-protein expression of MBCEC 
on RNA-level were investigated with QRT-PCR (3.2.7.2). Additionally, the expression of 
BMDP was checked in order to prove, if hydrocortisone also induces upregulation of this 
protein in MBCEC. Furthermore, the influence of different culture conditions on the RNA 
expression level of various blood-brain barrier marker proteins (4.3). 
Figure 4-20: Results of QRT-PCR in MBCEC. Expression of RNA of different proteins and the 
house-keeping genes after one and two days in incubation medium. There are no significant 
differences on RNA-level of tight-junction protein expression on the same DIV. P-glycoprotein (PGP) 
and BMDP show higher expression in serum the first day whereas the expression at the second day 
indicates an increase with hydrocortisone. The values give the ∆Ct-values in relation to GAPDH. 
(standard deviation n=3) 
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Figure 4-20 shows the expression of tight junction proteins and transporters BMDP and 
P-glycoprotein after one and two days in incubation medium. When comparing the two 
culture conditions of MBCEC, the tight junction proteins occludin and claudin-5 show no 
significant change in their expression on the RNA-level. The same result was found for ZO-1 
(data not shown). However, after two days in incubation medium the expression state is 
higher under both conditions. The same applies to the transporters BMDP and P-glycoprotein. 
But the expression state shows differences relating to the culture conditions. Serum-treated 
cells show a significantly increased expression of BMDP after one day in culture while the 
second day no significant changes can be detected (data with similar results not shown.). P-
glycoprotein is not affected by hydrocortisone. The comparison of blood-brain barrier marker 
proteins shows also no significant change in the expression state of RNA-level of proteins in 
different culture conditions.  
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Figure 4-21: Expression pattern on RNA-level of blood-brain barrier markers in MBCEC after one and 
two days in incubation medium (either hydrocortisone containing medium or serum containing 
medium). The values give the ∆Ct-values in relation to GAPDH. 
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4.4.7 Influence of hydrocortisone on protein expression of tight junction 
proteins 
 
Since there was no significant influence in expression among investigated tight junction 
proteins on the RNA-level, western blot analysis was performed to prove gene expression on 
protein level. The proteins were isolated as described in section 3.4.1 and visualised by 
incubation with POD-labelled 2nd antibody.  
The expression of the tight junction protein occludin, claudin-5 and the tight junction-
associated protein ZO-1 was determined to find possible differences between different culture 
conditions. The blots were stripped afterwards and the gel loading was controlled by staining 
the whole protein content by Protogold Detection Kit™ (Amersham). 
Figure 4-22 shows the results of western blot analysis. There are no detectable differences in 
the expression level of the investigated proteins. The signal intensity is the same in both, 
hydrocortisone and serum treated cells. The phosphorylation state of occludin is rather low 
indicated by the distinct signal. In contrast to this finding, occludin isolated from PBCEC is 
highly phosphorylated.  
 
 
Figure 4-22: Western blot analysis of tight junction proteins. All cells were cultured until DIV 5. The 
incubation medium (either with hydrocortisone or serum) was added after a confluent monolayer was 
obtained. The protein isolation was performed after two further days in culture. A: occludin B: ZO-1, C: 
claudin-5. The first lane indicates the protein content of hydrocortisone-treated cells; the second lane 
shown the signal of cells cultured in serum-containing medium. For control of gel-loading staining with 
Protogold Detection Kit™ (Amersham) is shown. No significantly change on protein-level of the 
proteins cultured under different culture conditions was observed. 
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4.5 Gene silencing at primary cultures of brain capillary endothelial 
cells 
 
As described in section 3.1.2, RNA interference (RNAi) was investigated in this thesis on the 
application to primary blood-brain barrier culture systems. RNAi is a powerful method to 
investigate the effect of loss or down regulation of specific genes within a cell culture. Due to 
the fact that mammalian cells and especially brain endothelial cells are difficult to transfect 
with antisense plasmids, RNAi gives the opportunity to transfect small double-stranded RNA 
which can easily pass the membrane mediated by cationic lipids. Furthermore the targets of 
these RNA-species are the cytoplasmic localised mRNA. Thus, the transfection of nucleic 
acids into the nucleus is not necessary. It is known that RNA interference works in cultured 
mouse cells (Svoboda et al., 2001) and so the method was applied to the primary culture of 
MBCEC. After successful application RNAi was extended to PBCEC. These cells are 
available in higher quantity and thus, better suited for high throughput screening.  
 
 
4.5.1 Immunofluorescence staining of siRNA-transfected cells 
 
The cells were transfected with siRNA as described in section 3.1.2 and the result of silence 
inducing properties were investigated by indirect immunofluorescence. Afterwards, western 
blot analysis completed the investigation of the down regulation of the target proteins. The 
target protein was lamin A/C which is localised in the membrane of the nucleus. This protein 
was one of the first targets knocked down by RNAi in mammalian cell culture systems 
(Elbashir et al., 2001; Harborth et al., 2001; Tuschl et al., 2001). To get the same culture- and 
transfection conditions for cells cultured in petri dishes and on cover slips, the cover slips 
were placed into petri dishes and removed for immunofluorescence investigations before the 
isolation of proteins was performed. To estimate if the silencing-effect of transfected RNA 
depends on its concentration different amounts of siRNA were applied. 
The cells were fixed and the immunofluorescence staining was performed as described in 
section 3.1.3. Figure 4-23 shows the result of indirect immunostaining against lamin A/C of 
siRNA-transfected and non transfected cells. As the images indicate the transfection with 
lamin A/C was successful and a significantly weaker signal could be detected in transfected 
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cells. While the minority of the cells seem to be unaffected by siRNA, nearly 60% of the cells 
show a significantly weaker signal.  
 
 
Figure 4-23: Immunodetection of lamin A/C in cultured murine and porcine brain capillary endothelial 
cells. The cells were transfected with a final concentration of 25 nM siRNA. A-C: MBCEC; D-F: 
PBCEC, A+D control without siRNA, B+E: transfected cells, C+F: secondary antibody-control. 
 
 
4.5.2 Western blot with siRNA transfected cells 
 
Western blot analysis was performed to quantify the efficiency of down-regulation. Figure 4-
24 shows the result of the lamin detection of isolated proteins from porcine brain capillary 
endothelial cells. To find out if the efficiency is concentration dependent, cells were 
transfected with different amounts of siRNA. The immunoblot was performed with an anti-
lamin A/C antibody (mouse) which recognizes both gene products of splice variants A and C. 
As indicated by figure 4-24, a down-regulation is visible in all concentrations of siRNA. 
Applying 100 nM siRNA results in an extensive loss of the signal (lane 3a) whereas 400 nM 
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is not as effective (lane 4). Protein loading is indicated by vimentine which was used as a 
marker protein.  
 
 
 
Figure 4-24: Change in expression of lamin A/C on protein level after transfection of cells with siRNA 
against lamin A/C. Lane a represents the protein isolated from transfected cells, b: control from not-
transfected cells. Concentration of siRNA: 1: 25nM; 2: 50 nm, 3: 100 nM 4: 400 nM. 
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5 Discussion 
 
5.1 In vitro model of murine brain capillary endothelial cells 
 
Many in vitro models of the blood-brain barrier have been established to investigate the 
regulation of blood-brain barrier properties and the transport of compounds like pharmaka 
across the barrier. This thesis describes a new primary culture model based on murine-derived 
brain capillary endothelial cells. The model was characterised and compared to our well 
established serum-free porcine model of the blood brain barrier in vitro (Hoheisel et al., 
1998b). The cells were isolated from brains of 6-10 weeks old mice (C57BL6/J) following a 
modified protocol of (Imaizumi et al., 1996) and cultivated for up to 8 days (section 3.1.1). 
Characterisation studies of the model indicate a well defined culture of primary endothelial 
cells after puromycin-treatment without almost any contaminating cells like astrocytes and 
pericytes. The cells are contact inhibited and form a confluent monolayer. Due to the fact that 
the culture contains no glia cells it is possible to use the whole cell population without 
subcultivation after reaching confluence. Also a subcultivation of the whole cell-population is 
practicable. Cells in a confluent monolayer show the typical spindle-shape endothelial cell 
morphology and they express common as well as blood-brain barrier specific endothelial 
markers. Expression of von Willebrand-factor (factor VIII-related antigen (Phillips et al., 
1979a) as well as tight junction proteins claudin-5, occludin, and ZO-1 were demonstrated in 
indirect immunofluorescence staining. The latter proteins have also been identified in western 
blot analysis. On RNA-level all tested blood brain-barrier markers like γ-
glutamyltranspeptidase (Orlowski et al., 1974), alkaline phophatase (Karnushina et al., 1980b) 
and endothelial cell markers like angiotensin converting-enzyme (Gimbrone et al., 1979) and 
transferrin (Jefferies et al., 1984) have been detected. Furthermore the proteins ZO-1, 
claudin-5 and occludin were found to be highly expressed by QRT-PCR. A special property 
of the microvascular endothelial cells in the brain is the presence of numerous transporters 
which protect the brain against toxical compounds. The presence of P-glycoprotein and 
BMDP is a further hint that the cultured brain endothelial cells express blood-brain barrier 
related transport proteins. P-glycoprotein and BMDP were found to be expressed on RNA-
level and BMDP could be additionally observed on protein level by immunofluorescence 
staining. 
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The transendothelial electrical resistance is much lower in cultured MBCEC in vitro. The 
TEER of PBCEC in vitro under serum-free conditions increases in the presence of 
hydrocortisone up to 2000 Ω·cm2 which correlates with the in vivo-situation (brain capillaries 
of frog ~2000 Ω·cm2, (Crone and Olesen 1982); brain capillaries of rat ~1500 Ω·cm2 (Butt 
and Jones, 1992). MBCEC develop in serum-containing medium resistance values of up to 
50 Ω·cm2 were detected whereas cultures of MBCEC in hydrocortisone-containing serum-free 
medium reached rarely values of up to 600 Ω·cm2 but usually averaged to 200 Ω·cm2. This 
correlates with the high permeability for sucrose of 2.5·10-5 cm/s. These data indicate that the 
primary culture of MBCEC express all typical markers of cerebral microvessel endothelial 
cells except the barrier function that lags behind the in vivo situation or the properties of 
PBCEC in culture. However, the measured values of transendothelial resistance are in the 
range of other cell culture systems (Hurst and Clark, 1998; Ramsohoye and Fritz, 1998; 
Reardon and Audus, 1993a). The low resistances and high permeability may be the result of 
incomplete tight junction formation in culture caused by a dedifferentiation as response to the 
in vitro situation. The differentiation of MBCEC in vitro is apparently not identical with the in 
vivo situation (Joo 1992; Reardon and Audus 1993b). 
 
 
5.2 Influence of hydrocortisone on electrical properties of MBCEC 
 
The transendothelial resistance is a strong indicator for the integrity of blood brain-barrier 
culture systems in vitro. While in vivo the TEER reaches values of about 2000 Ω·cm2 (section 
5.1) a lot of groups work with primary culture systems or cell lines with much lower 
resistances. The porcine brain capillary endothelial cell system in our group expresses high 
resistances in vitro when the cells are cultured under serum-free conditions in hydrocortisone-
supplemented medium (Hoheisel et al., 1998a). The lipophilic glucocorticoid-hormone 
hydrocortisone diffuses across the plasma membrane into the cytoplasm of the cells. In the 
porcine system it was shown that the TEER increased when the cells were exposed to 
hydrocortisone. The applied concentration of this hormone was physiological (550 nM, 
(Karlson 1994)) and the increase was independent from apical or basolateral application of the 
glucocorticoid. The question arose, if this effect is pig-specific or wether hydrocortisone has 
an influence on other primary cultures of brain derived microvascular endothelial cells as 
well. The new established murine model of the blood-brain barrier was analysed with respect 
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to a response upon hydrocortisone exposure. To investigate the effect of hydrocortisone, the 
cells were cultured 2 days in vitro in hydrocortisone-containing medium and, for comparison, 
in medium supplemented with foetal calf serum. Hydrocortisone induces the blood-brain 
barrier phenotype and allows the investigation of the cultured cells in serum-free and 
therefore chemically defined medium. This influence of hydrocortisone on the murine in vitro 
model will be discussed in the course of the following passage. 
Using the mouse model, the glucocorticoid increases the resistance up to five-fold compared 
to serum containing and serum-free medium. In some cultures, cells reached electrical 
resistances in hydrocortisone-supplemented medium between 150 and 600 Ω·cm2. Mostly the 
values lay around 180 Ω·cm2. The effect was time-dependent and detectable after a lag period 
of 2 hours. During the following 20 hours the TEER increased linearly and the maximum 
value was reached after 40 hours while cells cultured in presence of serum and serum-free 
medium respectively reached maximum values of 40 Ω·cm2. 
From ECIS and QCM measurements it became clear that the parameter α and Rb depend on 
the culture conditions especially on the presence of hydrocortisone. The parameter α indicates 
the resistance underneath the cells between the cell monolayer and the substrate while Rb 
quantifies the resistance due to the cells-cell contacts. The change of these two parameters can 
be followed separately by ECIS and QCM. As mentioned earlier, a change of Rb indicates 
alterations in paracellular resistance while higher values for α point to a closer cell-substrate 
contact. For both, α and Rb higher values could be detected in hydrocortisone-containing 
medium. The value for the parameter α increases about 75% while Rb even reaches values of 
250% of the value of MBCEC treated with serum. This clearly shows that the paracellular 
electrical permeability of MBCEC is reduced mainly by Rb which gives evidence for an 
improved cell-cell contact. The increase of the parameter α after treatment of cells with 
hydrocortisone may be the result of several factors. First, a change of cell-substrate contact 
can result in altered values for α. Cells, which are attached close to the substrate inhibit the 
flow of inorganic ions.  An increase in production or secretion of extracellular matrix proteins 
can also reduce the flow of inorganic ions in the electrical field beneath the cells. Secondly, at 
high electrical resistances received in PBCEC-culture the total resistance is dominated by Rb. 
The impact of α becomes almost negligible. In cell cultures with lower electrical resistances 
like the MBCEC used here, an increase of α besomes more important and contributes more to 
the overall TEER. Normally, the TEER is measured without discrimination of cell-cell and 
cell-substrate contributions. This may lead to a false conclusion with respect to the 
mechanism since some mediators influence the TEER by acting on the cell-matrix interaction 
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indicated by a change of α.. For this it is necessary to investigate both, α and Rb which is 
technically impossible on permeable filters which are mainly used. 
The influence of hydrocortisone on the TEER may be the result of many subcellular changes. 
It is known for long that glucocorticoids increase the barrier properties of vascular cells 
(Ingraham et al., 1952; Jarden et al., 1989; Long et al., 1966a; Long et al., 1966b; Yamada et 
al., 1983). It was also shown that hydrocortisone increases barrier properties in term of TEER 
and permeability for 14C-mannitol in epithelial cells (Zettl et al., 1992). A similar influence 
was found in a breast cancer tumour cell line (con8) (Buse et al., 1995a). Using PBCEC, 
Engelbertz et al. (2000) could show by concentration dependent measurements and 
experiments including antagonists for glucocorticoid receptors that the influence of 
hydrocortisone directly correlated with the occupation of glucocorticoid receptors. This leads 
to the conclusion that hydrocortisone somehow influences the process of transcription of 
genes either by enhancing or repressing the transcription. The main role of hydrocortisone is 
the enhancer effect in transcription. Targets of glucocorticoids are several genes encoding for 
enzymes which are involved in glucose and energy metabolism of the cell as there are 
gluconeogenesis and lipolysis (Jungermann and Möhler, 1980). A repression mediated by 
glucocorticoids was observed by (Vrtovsnik et al., 1994) who found a protein kinases C 
(PKC) mediated hydrocortisone and dexamethasone-induced repression of the expression of 
Na-Pi-co-transporter in renal kidney epithelial cells. In an immortalised endothelial cell-line a 
PKC-mediated dexamethasone induced increase of P-glycoprotein activity was found while 
no influence on the expression of the corresponding gene was found (Regina et al., 1999). The 
effect of hydrocortisone may be based on two different mechanisms. Most target-genes 
possess cis-stimulating enhancer elements (glucocorticoid response elements, GRE). These 
elements are able to interact with a hormone-receptor complex by, for instance, interaction of 
zinc-finger motives. Most of these elements also include binding regions for transcription 
factors. Together with the glucocorticoid-receptor-complex these factors regulate the 
transcription of the target genes. Another example is the direct interaction between the 
glucocorticoid-receptor complexes with transcription factors. This interaction enhances or 
represses the expression of genes without GRE (Brostjan et al., 1997). Via this signal-
transduction pathway, glucocorticoids may influence the expression of matrix metallo-
proteinases (MMP). These enzymes play an important role in the remodelling of the 
extracellular matrix proteins (Nishino et al., 2002; Pirila et al., 2003; Sternlicht and Werb, 
2001). The expression of MMP can be down-regulated by supplementing medium with 
glucocorticoids. Jonat et al. (1990) found a hydrocortisone induced down-regulation of 
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transcription of collagenases gene. The repression was observed to be dependent on the 
interaction of the hormone receptor complex with the transcription factors AP-1 (fos/jun). 
Altogether the glucocorticoid-regulated genes are rather low in particular cell-types (Miesfeld 
1989). The variable inducibility of target-genes within different cell-types may be a cell-
specific difference in the concentration of transcription factors within the cell that are needed 
as cofactors. Recent studies noted that matrix-metallo-proteinases (MMP) expression in 
PBCEC in vitro is influenced by hydrocortisone (Lohmann 2003). The secretion of MMP-9 to 
the extracellular matrix is significantly decreased after incubation in hydrocortisone-
supplemented medium. In correlation with this result the parameter α could be increased since 
higher MMP expression would lead to a degradation of ECM-proteins followed by a lower 
value of α. Furthermore, Lohmann also observed that higher activity of MMP leads to a 
degradation of occludin. This could explain the lower value for the parameter Rb. 
The incubation of MBCEC in serum containing medium has no significantly effect on the 
TEER in experiments on permeable filter membranes. The electrical resistance is stable for 72 
hours after addition (figure 4.6). In contrast the withdrawal of serum induces a decrease of the 
TEER of about 10 Ω·cm2. This result is contradictory to the data received in the porcine 
system. The TEER in PBCEC is increased after withdrawal of serum. The difference in the 
response of MBCEC and PBCEC may be a species differences between porcine and murine 
microvascular endothelial cells. One of the main functions of serum is to supply the cells with 
growth factors and mitogens. Furthermore, serum acts as a buffer system and neutralises 
acidic metabolites. Nitz et al. (2003) observed that several compounds of serum influence the 
electrical resistances of PBCEC. A 66 kDa-fraction could be identified by MALDI which was 
shown to influence the TEER significantly after application to PBCEC. Heat-inactivated 
serum induces a decrease in TEER similar to not heat-inactivated serum although reduced in 
amplitude. Different compounds contained in serum were shown to influence the permeability 
and the TEER respectively. Lysophosphatidic acid (LPA) was shown by (Alexander et al., 
1998) to decrease the permeability for cyanocobalamine in bovine pulmonary aortic 
endothelial cells (BPAEC). In conflict to that (English et al., 1999) observed an increase of 
TEER in BPAEC caused by LPA. (Schulze et al., 1997) noticed that LPA in physiological 
conditions decreases the TEER and increases the permeability in PBCEC. Vascular 
endothelial growth factor (VEGF) is also known to influence permeability and electrical 
resistance of vascular endothelial cells (Esser et al., 1998; Keck et al., 1989; Senger et al., 
1983). VEGF was also shown to decrease TEER in the PBCEC in vitro model. Discussing the 
effect of serum on cultured brain microcapillary endothelial cells it should be taken into 
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account that different sera provide different results. Foetal calf serum and ox serum cause a 
strong influence on PBCEC while TEER from pig serum-treated cells is not as much affected. 
Horse and human serum have almost no effect on PBCEC6. These data indicate that species 
differences always have to be taken into account.  
 
 
5.3 Influence of hydrocortisone and serum on morphology and 
mechanical properties of MBCEC 
 
Mouse brain capillary endothelial cells were investigated for their morphological and 
mechanical properties when cultured under different conditions. All cells were treated the first 
two days with puromycin-containing medium. Puromycin is known to be an inducer of 
apoptosis and thus an additive to select different cell-lines with introduced resistant against 
puromycin (de la Luna and Ortin, 1992; Suzuki et al., 2001). For further experiments the cells 
were either treated with serum-containing medium, serum-free medium or serum-free medium 
supplemented with hydrocortisone (550 nM). The cells cultured in petri dishes showed the 
typical spindle-shaped morphology. They reached confluence after 3-4 days in culture in 
serum-containing medium. The cells cultured in serum-containing medium had less contrast 
than serum-treated cells in phase contrast imaging and expressed a spindle-shaped 
morphology. After withdrawal of serum the cells changed their morphology to cobble-stone 
shape with pads of spindle-shaped cells. These findings correlate with the results from 
immunostaining analysis of MBCEC. The cells cultured with hydrocortisone show a 
homogenous morphology while cells in hydrocortisone form cobble-stone areas and in 
between extended parts of spindle-shaped cells. The staining of tight junction proteins like 
occludin and claudin-5 indicate that the cell-cell-contact points of spindle-shaped cells are 
more distinct while the cell-cell contact in areas with cobble-stone morphology especially at 
contact points of three cells express a frayed pattern. This result was supported by the finding 
that indirect immunofluorescence staining against the membrane-localised brain multidrug 
resistance protein shows a similar pattern. This fact leads to the conclusion that not only the 
tight junction strands are involved in the morphological change but with re-orientation of the 
cells the membrane morphology changes. 
                                                 
6 Hüwel, Sabine; Institut für Biochemie, WWU Münster; personal communication 
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The different shape of the cells can also be observed in atomic force microscopy. The cell-cell 
contacts in cells cultured with hydrocortisone-containing medium are seen as distinct lines 
between the cells (figure 4-15). The region of contact points between two endothelial cells 
indicates cambered structures and the contact-region is elevated in comparison to serum-
treated cells. These structures are also known from in vivo as marginal folds, small areas in 
which the edge of one of the cells protrudes and associates with the adjacent cells. These 
structures could also be observed in transmission electron microscopy of MBCEC as 
described later. AFM-imaging also shows a flat morphology of the cell-body with the 
exception of the nucleus whereas serum-treated cell are not as flat. Furthermore, in deflection 
and height profile imaging, cells cultured in presence of hydrocortisone show the expression 
of cable-like structures in the longitudinal direction which can be assigned to f-actin stress 
fibres. In correlation with this, force curves of AFM indicate that the cells cultured in 
presence of hydrocortisone possess 60% higher Young´s modules than cells cultured without 
hydrocortisone. Recent studies on elasticity of cells under physiological conditions indicate 
that actin stress fibres and intermediary filaments influence the elastic properties of cells 
while microtubulus structures have no influence on the force mapping of cells (Haga et al., 
2000; Hassan et al., 1998). These structures can be detected in both, the nucleus-area and the 
cytoplasmic area of the cells indicating well developed stress fibres with hydrocortisone. 
Theoretically, stress fibres increase the elasticity modulus of endothelial cells by a factor 2-10 
(Satcher and Dewey, 1996). In correlation with this, actin filaments could be observed in 
longitudinal direction of the cells by direct staining with rhodamine-labelled phalloidin. 
Phalloidin staining in cells cultured in serum-containing medium show a membrane located 
belt of actin filaments known as perijunctional actomyosin ring (PAMR) (Fanning et al., 
1998; Madara et al., 1992). The withdrawal of serum and cultivation in serum-free medium 
leads to a redistribution or formation of actin filaments to the longitudinal direction of the 
cells. In the presence of hydrocortisone, this effect is intensified; however, the PAMR is still 
visible at the borders of the cells. 
Several factors are responsible for the formation and redistribution of actin. LPA is known to 
induce formation of actin stress fibres (English et al., 1999; Schulze et al., 1997) and is, as 
described recently, one component of serum. The influence of serum and especially of LPA 
on the transendothelial resistance was already described (Miki et al., 2000). The influence on 
the redistribution and formation of stress fibres may result in a change of permeability and 
electrical resistance, respectively, especially since it has been found that dexamethasone and 
hydrocortisone induce an increased contractility in human lung fibroblasts caused by a de-
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novo synthesis of filamentous actin in three-dimensional gel-matrix culture. The fibroblasts 
were cultured under serum-free conditions with dexamethasone (10-5 M). In contrast 
(Coulomb et al., 1984) reported a decrease of fibroblast contractility cultured in a gel-lattice 
in presence of serum and hydrocortisone in a concentration range of 2·10 4 to 1.5 · 10 3 M. 
The glucocorticoid dexamethasone was also applied to phenotypically stable cultures of 
untransformed mouse mammary epithelial cells (31EG4) (Zettl et al., 1992). This group could 
find no indication that glucocorticoids influence the de-novo synthesisis or redistribution of 
actin stress fibres. Rubenstein et al., (2003) recently showed that RhoA small GTpase is 
regulated by glucocorticoids. They demonstrated that the glucocorticoid down-regulation of 
RhoA is a required step in the steroid signalling pathway which controls the organization of 
the apical junctional complex and the actin cytoskeleton in mammary epithelial cells. The 
tight junction, the adherens junction, and the cytoskeleton form an integrated functional unit 
based on multiprotein complexes. For example, the cadherin proteins of the adherens junction 
are structurally connected to F-actin polymers through β-catenin and α-catenin (Tsukita et al., 
1992). Also, the actin cytoskeleton interacts with the tight junction-related protein ZO-1  
(Fanning et al., 1999) or potentially indirectly through ZO-1-binding proteins such as spectrin 
(Mattagajasingh et al., 2000) and cortactin (Katsube et al., 1998). Furthermore, the actin 
cytoskeleton interacts with additional proteins localized to the tight junction, such as ZO-2, 
ZO-3, occludin (Wittchen et al., 1999) and cingulin (D'Atri and Citi, 2001). Therefore, one 
mechanism by which cellular RhoA activity could potentially disrupt the junctional complex 
is by selectively altering the cytoskeleton (Rubenstein et al., 2003). Rubenstein proposed that 
the steroid-induced down-regulation of RhoA leads to an apical F-actin organization that 
permits β-catenin accumulation at the lateral plasma membranes by generating a cytoskeletal 
scaffold to which β-catenin, and possibly ZO-1, can bind at points of cell-cell contacts. 
Alternatively, a dominant negative RhoA may cause the adherens and tight junction proteins 
to organize at the lateral plasma membrane and thus provide anchorage for actin filaments. 
Interestingly, in the quartz-mode of QCM (section 3.1.7) no difference was detectable in the 
mechanical properties of cells from both culture conditions. Changes in the resonance 
frequency of the quartz are results from the attachment and changes of structures close to the 
basolateral membrane of the cells. Thus, by QCM-experiments, changes to the basolateral 
membrane can be observed while by AFM changes at the apical membrane are detectable. 
Taking the results of ECIS into account, the changes of the electrical parameter α result from 
a closer cell-substrate interaction, but no significant changes of the mechanical properties of 
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the cells are detectable. These differences mainly base on the redistribution of the 
cytoskeleton to the apical membrane of the cells. 
Transmission electron microscopy indicated also a morphological change in MBCEC. In 
cross-sections of MBCEC-monolayers the hydrocortisone-treated cells appear more flat than 
serum-treated cells. Tight junctions are expressed under both culture conditions but appear 
more intensely expressed with hydrocortisone. The cell-cell contact region expresses marginal 
folds in hydrocortisone-containing medium whereas serum leads to a loss of these structures 
from adjacent cells. The images indicate a higher contrast of structures beneath the cells. This 
is a possible hint on a higher content of extracellular matrix proteins. In parallel the cells 
cultured with hydrocortisone are closely attached to the substrate especially at the cell-cell 
contact regions while serum treated cells are detached in these areas. The cell-cell contact 
regions show also the main differences between these two culture conditions. Cells under 
serum-containing conditions either form blunt end contact points with gaps between adjacent 
cells or an extensive overlapping region with adjacent cells. Hydrocortisone treated cells 
show, as already described contact points with marginal folds and tight connections with 
neighbouring cells. The double layer is also detectable but not as extended as under serum 
conditions. This finding correlates with the capacitance CM found in ECIS experiments. The 
capacitance of a cell-monolayer with a smooth cell surface amounts to 1 µF/cm2. The 
determined capacitance for cells cultured with hydrocortisone reaches values of 
approximately 0.82 µF/cm2. This value can be explained by the formation of double layer 
regions at the cell-cell contacts. The more expanded these regions are, the lower are the values 
for the membrane capacitance CM. The values detected in MBCEC in both culture conditions 
confirm these findings. The serum treated cells show partial double layer formation at contact 
regions but not as extended as serum-treated cells. Taking into account that cells cultured onto 
permeable filters show in immunofluorescence staining of tight junction proteins a 
heterogenic morphology (either spindle- shaped with distinct cell borders or cobble stone-
shaped with frayed staining pattern at cell-cell contacts) the influence of the reduce of 
capacitance may be caused by cobble-stone regions with overgrowth. A possible explanation 
of the frayed pattern in immunofluorescence staining caused by the overlapping of cells is 
given in figure 5-1. The TEM picture shows the contact region of three adjacent cells. The 
lower cell expresses tight junctions to both overlaying cells (see also figure 4-18). As recently 
described the tight junctions are directly linked to the actin filaments of the cytoskeleton. A 
redistribution of stress fibres may lead to a redistribution of tight junctions. The withdrawal of 
serum leads to a redistribution of F-actin in cultured MBCEC. The homogenous frayed 
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staining pattern in serum-treated cells vanishes and a more heterogeneous morphology of the 
cells appears. The addition of hydrocortisone leads as already described to cytoplasmic 
localised actin filaments in longitudinal direction within the cells in correlation with spindle-
shaped morphology of the cells. Some areas still appear as cobble-stone shaped. 
Hydrocortisone may influence the cytoskeletal elements of MBCEC in a way that 
redistribution leads to the morphological change of some but not all cells. The cells forming 
pads in spindle-like manner can induce a change in cells between these pads.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-1: Model for tight junction localisation and resulting staining pattern in immunofluorescence 
detection of tight junction proteins. A: TEM image of cells cultured in serum. Tight junctions are 
indicated by black bars. B: model of overgrowth of adjacent cells and possible cross section of the 
TEM image indicated by the dotted line (view from the top). Arrows indicate the localisation of the 
corresponding tight junctions in the TEM-image and the model. C: Possible result of 
immunofluorescence staining against tight junction proteins in overlapping-region of adjacent cells. D: 
Immunofluorescence staining of ZO-1. The arrow indicates a region with possible overgrowth of the 
contact point between three adjacent cells.  
 
 
A 
B 
 
C 
 
 
D 
5 Discussion  97 
5.4  Influence of hydrocortisone on RNA- and protein expression 
 
The expression of tight junction-relevant proteins was quantified to determine if the increase 
of TEER after hydrocortisone-application is caused by altered expression. Occludin, ZO-1 
and claudins are known to be involved in tight junction formation in endothelial and epithelial 
cells. For this reason, occludin, claudin-1 and -5 as well as ZO-1 were investigated for their 
expression in MBCEC. To quantify the influence of hydrocortisone on expression on RNA-
level quantitative real-time PCR (QRT-PCR) was applied as described in section 3.2.7.2. The 
received data indicate that hydrocortisone has no influence on the mRNA expression of the 
investigated tight junction proteins. Claudin-1 was nearly not detectable by QRT-PCR. Also 
in western blot analysis and immunofluorescence staining no signal was detectable for 
claudin-1 indicating that this protein is not involved in tight junction formation in MBCEC in 
vitro. This finding goes confirm with the observations of Perrière et al.7 who could detect 
claudin-1 neither in freshly isolated capillaries nor in cultured rat microvessel endothelial 
cells. In the porcine BBB-in vitro model, claudin-1 was not detectable by western blot 
analysis. However, it could be detected in PBCEC by immunofluorescence staining after long 
incubation with the primary antibody and on RNA level by northern blot analysis after long-
term exposure of the probes.. The mRNA content of the tight junction proteins occludin and 
claudin-5 is uneffected in all tested mRNA species. These proteins are expressed on the same 
level after one and two days in culture and after treatment with hydrocortisone or serum. 
ZO-1 mRNA content is not influenced by addition of the hydrocortisone as well. These 
findings correlate with the observations in PBCEC. Thus, the altered transendothelial 
resistance and the differences in immunofluorescence staining are no effects of the expression 
level of the investigated tight junction proteins. Detection of mRNA of specific proteins 
allows estimating the presence of the gene product but it is necessary to detect the protein by 
western blot analysis to observe the transcription rate. To examine the expression of occludin, 
claudin-5 and ZO-1 on protein level, western blot analysis of these proteins were performed. 
Occludin, claudin-5 and ZO-1 are expressed similar in both, hydrocortisone and serum-treated 
MBCEC. In contrast, (Antonetti et al., 2002) reported, that occludin expression on both, 
RNA- and protein-level is increased after glucocorticoid treatment of endothelial cells of the 
blood-retina barrier. Stelwagen et al., (1999) observed an increase in occludin expression after 
                                                 
7 Pierrère, N., Chaverot, N., Couraud, P.O., Deli, M.A., Cazaubon, S. Roux, F. Characterization of an in vitro rat 
blood-brain barrier model; poster on the “Sixth Symposium on Signal Transduction in the Blood-Brain Barrier” 
2003, Szeged, Hungary 
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treatment of mouse HC11 epithelial cells in combination with prolactin. Also an increase of 
occludin and ZO-1 expression was detected in cultured rat brain endothelial cells after 
dexamethasone-treatment (Romero et al., 2003). Since no altered expression of the 
investigated tight junction proteins is detectable in MBCEC, the blood-brain barrier properties 
in this system are regulated somehow different. As already described, the withdrawal of 
serum and the addition of hydrocortisone induce a redistribution of f-actin. The formation of 
stress fibres together with the redistribution of actin-linked tight junctions may cause higher 
electrical resistance and enhanced barrier functioning in MBCEC. 
Another main function of brain capillary endothelial cells is the protection of the brain from 
toxic substances by special transport systems. Transporters like multi-drug resistance proteins 
are known to be involved in this process. For this reason, expression level of the transporters 
BMDP and P-glycoprotein were examined. QRT-PCR showed that hydrocortisone has no 
influence on the expression of P-glycoprotein and BMDP on RNA-level. Both are highly 
expressed independent from the culture conditions. Eisenblatter and Galla (2002) observed an 
induction of expression after treatment of PBCEC with hydrocortisone. Furthermore, BMDP 
is higher expressed on RNA level in cultured brain microvascular endothelial cells than P-
glycoprotein. The expression pattern of BMDP in whole brain tissue in comparison with P-
glycoprotein was also investigated by (Eisenblätter 2002). Porcine brain tissue indicates a 
higher content of BMDP-RNA than a lysate of mouse brain tissue. In MBCEC P-glycoprotein 
and BMDP were shown to be highly expressed on the same level in vitro. Regina et al., 
(1999) could show that the synthetic glucocorticoid dexamethasone increases the expression 
of P-glycoprotein on protein level. Also a higher activity was observed in the investigated 
immortalised rat brain endothelial cell line GPNT.  
The application of hydrocortisone had no influence on markers of blood-brain barrier 
endothelial cells as proven on mRNA-level by northern blot and QRT-PCR.. Therefore, 
hydrocortisone seems not to change the differentiation of the cells. But expression of the 
markers has still to be examined on protein level by western blot analysis or 
immunofluorescence staining.  
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5.5 Application of RNA interference method on primary cultures of 
microvascular endothelial cells 
 
After the establishment and characterisation of the primary culture of mouse-derived brain 
capillary endothelial cells, RNA interference-technique (RNAi) was tested for its application 
on the blood-brain barrier systems based on both, MBCEC and on PBCEC. The application of 
RNAi gives the opportunity to investigate the down-regulation of target-proteins in vitro and 
in vivo. While less genomic data is available for pig, the blood-brain barrier in vitro model of 
MBCEC completes the PBCEC-culture by the knowledge of complete genome data.  
RNAi was shown to work in both culture systems. The chosen target protein was lamin A/C, a 
nuclear membrane located protein. Successful knock down of this protein by RNAi was 
previously shown by Elbashir et al., (2002) and Harborth et al., (2001). Both, PBCEC and 
MBCEC were cultured until reaching 70% confluence as described in section 3.1.1 and 
transfected with siRNA against lamin A/C. Immunofluorescence staining indicates that the 
nuclear membrane localised lamin A/C is down-regulated in transfected cells. The staining 
indicates that lamin disappears in 70% of the cultured MBCEC and PBCEC (figure 4-23). 
Western blot analysis goes confirm with this finding. A significant down regulation of the 
investigated proteins is detectable but there is still a signal of lamin A/C. Some cells express 
lamin A/C as non-transfected cells, while other cells show only weak expression. The down-
regulation is dose-dependent and the best effect is detectable after application a concentration 
of 100 nM of silence inducing double stranded RNA. The fact, that some cells still express 
lamin A/C can be the result of incomplete transfection with siRNA. The target of the 
transfected oligo-siRNA is the cytoplasmic localised mRNA. Due to the fact, that primary 
cultures are difficult to transfect with vectors, which express their antisense sequences within 
the nucleus, the advantage of RNAi is that it works in the cytoplasm. Furthermore, the RNA 
consists of only 21 nucleotides which are easier to transfect than plasmids. Cells, once 
transfected with siRNA, keep the silencing effect when dividing. However, some cells are not 
affected by siRNA indicating incomplete transfection efficiency. To observe effects after 
down-regulation of proteins in a cell culture model and to get facile assays for loss of function 
in a well-defined cellular system it is necessary to reach a significant down-regulation of the 
target proteins in all cells. Interestingly, the down-regulation of lamin A/C was not detectable 
by northern blot analysis (data not shown). So far, the down-regulation of occludin, ve-
cadherin and BMDP was unsuccessful as well (data not shown). As described by (Tuschl et 
al., 2001) the parameters for selecting targets of siRNA are well defined and the siRNAs need 
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to be highly specific (base composition, target position, beginning and ending of the sequence 
and G/C-content). But considering all these parameters there is no guarantee for effective 
silencing of the target protein. The silence-inducing effect was observed in several groups 
after application of several different siRNA with sequence homology to the target-mRNA. For 
the silencing of occludin and ve-cadherin effective target sequences were not found so far. 
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6 Conclusion 
 
With the isolation and cultivation of murine brain capillary endothelial cells (MBCEC) a new 
primary culture system as an in vitro model for blood-brain barrier is available. The cultured 
cells express a highly differentiated phenotype with specific endothelial and microvascular 
markers. They show the typical morphology of brain capillary endothelial cells and express 
transporters as P-glycoprotein and BMDP which were shown to be involved in multidrug 
resistance phenomena in cerebral microvessels. Thus, observations of drug transport are 
practicable in this culture system. Furthermore, MBCEC express well developed tight 
junction complexes. Proteins as occludin, claudin-5 and ZO-1 could be shown to be involved 
in these tight cell-cell contacts by immunofluorescence staining, northern blot- and western 
blot analysis. Together with the well established porcine culture of microvascular endothelial 
cells derived from brain, two models are available to investigate the regulation of barrier 
function and the transport properties of endothelial cells.  
The MBCEC were shown to be influenced by the glucocorticoid hormone hydrocortisone. In 
serum-free medium, supplemented with 550 nM hydrocortisone, the cells express a 5-fold 
higher electrical resistance than cells cultured in serum containing medium. Hydrocortisone 
has no influence on the expression of the investigated tight junction proteins but influences 
the mechanical properties of the cells. In immunofluorescence staining could be shown that 
actin forms bundle-like structures in the longitudinal direction of the cells after 
hydrocortisone treatment, while cells, cultured in serum-containing medium indicate 
perijcuntional-localised staining of f-actin. This finding correlates with observations made by 
atomic force microscopy. The Young´s modulus of cells after hydrocortisone treatment is 
significantly increased and actin filaments can be detected in AFM imaging of 
hydrocortisone-treated MBCEC. The higher elasticity modulus indicates a distribution of 
f-actin within the whole cell. However, this finding is different from phenomena reported in 
the literature. The perijunctional actin-myosin ring (PAMR) was observed in cells with high 
electrical resistance in the literature, while MBCEC express lower TEER in this case. 
However, the PAMR is still detectable but a formation of stress fibres in the longitudinal 
direction of the cells takes part. Taking into consideration that the cytoskeleton is directly 
linked to the tight junction region by interaction with ZO-1, the redistribution of the 
cytoskeleton may have a more important influence than expression of tight junction proteins. 
In transmission electron micrographs differences in the cell-cell contact regions were obvious. 
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MBCEC cultured in presence of serum show wide overlapping regions at the contact of 
adjacent cells while this effect was not detectable in this extent after hydrocortisone treatment. 
This may also be an effect of changes in the structure of the cytoskeleton.  
The down-regulation of specific proteins involved in tight junction formation in the cell 
culture would give important information about the regulation of the barrier properties. If it is 
possible to inhibit specific signal transduction pathways in developing cultures of 
microvascular endothelial cells, investigations of protein targeting and distribution would give 
important hints, which proteins and enzymes are involved in the formation of the tight 
junctions or which effects are responsible for the distribution of the cytoskeleton. RNA-
interference gives the opportunity to inhibit the expression of specific target proteins within 
the cell culture. First observations showed that this method is practicable in primary cultures 
of isolated brain microvascular endothelial cells. PBCEC and MBCEC transfected with 
siRNA against lamin A/C showed a significant down-regulation of this nuclear-localised 
protein. The effect could be observed by western blot analysis and immunofluorescence 
staining. The protein was significantly down-regulated but still expressed in some cells. For 
this reason, the transfection efficiency has to be elevated and RNAi has to be optimised in 
future. 
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7.1 Materials 
acetic acid       Merck (Darmstadt, Germany) 
acetone       Merck (Darmstadt, Germany) 
acrylamid/bisacrylamid (37.5/1)    AppliChem (Darmstadt, Germany) 
acrylamid/bisacrylamid (50/0.8)    USB (Cleveland, Ohio/USA) 
Advantage cDNA Polymerase Mix    Clontech (Palo Alto, California/USA) 
AdvanTAge PCR Cloning Kit     Clontech (Palo Alto, California/USA) 
agar        Sigma-Aldrich (Deisenhofen, Germany) 
agarose NEEO      ROTH (Karlsruhe, Germany) 
Albumine, bovine     Sigma-Aldrich (Deisenhofen, Germany) 
ammonium acetate      Riedel-de Haën (Seelze, Germany) 
ammonium sulfate      Merck (Darmstadt, Germany) 
ampicillin       Sigma-Aldrich (Deisenhofen, Germany) 
APS        Sigma-Aldrich (Deisenhofen, Germany) 
 
Basic fibroblast growth factor    Boehringer Mannheim (Germany) 
bromophenol blue      ICN Biochemicals (Eschwege, Germany) 
BSA        Sigma-Aldrich (Deisenhofen, Germany) 
CaCl2        Merck (Darmstadt, Germany) 
chloroform       Merck (Darmstadt, Germany) 
collagen G       Seromed (Berlin, Germany) 
Collagen type IV     Sigma-Aldrich (Deisenhofen, Germany) 
Collagenase CLS2     Worthington (Lakewood, USA) 
collagenase/dispase (for PBCEC)   Roche (Basel, Swiss) 
collagenase/dispase  (for MBCEC)   Boehringer Mannheim    
Coomassie Brilliant Blue G250     Sigma-Aldrich (Deisenhofen, Germany) 
32P-dCTP       Amersham Biotech (Uppsala, Sweden) 
 
dextran (~ 1632 kDa/mol)     Sigma-Aldrich (Deisenhofen, Germany) 
dextran sulfate sodium salt     Sigma-Aldrich (Deisenhofen, Germany) 
DMEM        Biochrom KG (Berlin, Germany) 
DMEM/Ham’s F12      Sigma-Aldrich (Deisenhofen, Germany) 
DMF        Sigma-Aldrich (Deisenhofen, Germany) 
DMPC        Sigma-Aldrich (Deisenhofen, Germany) 
DNA ladders (100 bp and 1 kb)    Life Technologies (Eggenstein, Germany) 
DNase I      Sigma-Aldrich (Deisenhofen, Germany) 
dNTPs, 10mM       Sigma-Aldrich (Deisenhofen, Germany) 
DTT        Sigma-Aldrich (Deisenhofen, Germany) 
 
EDTA        Merck (Darmstadt, Germany) 
Emerald Enhancer      Perkin Elmer (Weiterstadt, Germany) 
ethanol       Merck (Darmstadt, Germany) 
ethidiumbromide      ROTH (Karlsruhe, Germany) 
 
FCS        Life Technologies (Eggenstein, Germany) 
Fibronectin      Sigma-Aldrich (Deisenhofen, Germany) 
Ficoll 400       Sigma-Aldrich (Deisenhofen, Germany) 
formaldehyde (37%)      Merck (Darmstadt, Germany) 
formamide       Janssen (Neuss, Germany) 
 
Galacton       Perkin Elmer (Weiterstadt, Germany) 
gentamicin       Biochrom KG (Berlin, Germany) 
glucose       Sigma-Aldrich (Deisenhofen, Germany) 
L-glutamine       Seromed (Berlin, Germany) 
glutaraldehyde       Sigma-Aldrich (Deisenhofen, Germany) 
glycerol       Merck (Darmstadt, Germany) 
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glycine        Sigma-Aldrich (Deisenhofen, Germany) 
 
HCl        Sigma-Aldrich (Deisenhofen, Germany) 
HEPES       Merck (Darmstadt, Germany) 
hering sperm DNA      Sigma-Aldrich (Deisenhofen, Germany) 
High Pure RNA Isolation Kit     Roche (Basel, Swiss) 
hydrocortisone       Sigma-Aldrich (Deisenhofen, Germany) 
Hyperfilm MP       Amersham Biotech (Uppsala, Sweden) 
 
IPTG        Biomol (Hamburg, Germany) 
isopropyl alcohol      Merck (Darmstadt, Germany) 
 
kanamycin       Sigma-Aldrich (Deisenhofen, Germany) 
KCl        Merck (Darmstadt, Germany) 
KH2PO4       Merck (Darmstadt, Germany) 
 
lysozyme       Sigma-Aldrich (Deisenhofen, Germany) 
 
M 199 Earle       Seromed (Berlin, Germany) 
MegaPrime DNA Labelling System    Sigma-Aldrich (Deisenhofen, Germany) 
methanol       Merck (Darmstadt, Germany) 
MgCl2        Merck (Darmstadt, Germany) 
MicroSpin G-50 Columns     Amersham Biotech (Uppsala, Sweden) 
molecular weight marker (HMW and LMW)   Amersham Biotech (Uppsala, Sweden) 
MOPS        Sigma-Aldrich (Deisenhofen, Germany) 
 
Na2HPO4       Merck (Darmstadt, Germany) 
NaCl        Merck (Darmstadt, Germany) 
NaHCO3       Sigma-Aldrich (Deisenhofen, Germany) 
NaOH        Sigma-Aldrich (Deisenhofen, Germany) 
NCS        Seromed (Berlin, Germany) 
NGS        Sigma-Aldrich (Deisenhofen, Germany) 
nylon membrane (GeneScreen Plus)    NEN Life Science Products (Boston, MA/USA) 
 
Oligo(dT)12-18 Primer      Life Technologies (Eggenstein, Germany) 
Oligofectamin      Invitrogen Karlsruhe (Germany) 
oligonucleotides MWG      Biotech (Ebersberg, Germany) 
Oligotex mRNA Mini Kit     Qiagen (Hilden, Germany) 
OptiMem      Invitrogen (Karlsruhe, Germany) 
ox serum       PAA (Linz, Austria) 
 
paraformaldehyde      Merck (Darmstadt, Germany) 
Paramount       Polysciences Inc. (Warrington, PA/USA) 
penicillin/streptomycin      Seromed (Berlin, Germany) 
peptone       Life Technologies (Eggenstein, Germany) 
percoll        Sigma-Aldrich (Deisenhofen, Germany) 
PDS       First Link (Brierley Hill, UK) 
phenol/chloroform/isoamyl alcohol (25/24/1)   Sigma-Aldrich (Deisenhofen, Germany) 
polyvinylpyrrolidone      Sigma-Aldrich (Deisenhofen, Germany) 
protease inhibitor coctail     Roche (Basel, Swiss) 
protease/dispase      Sigma-Aldrich (Deisenhofen, Germany) 
proteinase K       Sigma-Aldrich (Deisenhofen, Germany) 
pT-Adv       Clontech (Palo Alto, California/USA) 
 
QIAprep Spin Mini and Maxi Kit    Qiagen  (Hilden, Germany) 
QIAquick Gel Extraction Kit     Qiagen (Hilden, Germany) 
 
restriction endonucleases     New England Biolabs (Beverly, MA/USA) 
RNeasy Maxi-Kit      Qiagen (Hilden, Germany) 
 
SDS        Sigma-Aldrich (Deisenhofen, Germany) 
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shrimp alkaline phosphatase     Roche (Basel, Swiss) 
SMART DNA ladders (100bp and 1 kb)    Eurogentec (Seraing, Belgium) 
sodium acetate      Sigma-Aldrich (Deisenhofen, Germany) 
sodium citrate       Sigma-Aldrich (Deisenhofen, Germany) 
14C-sucrose       Amersham Biotech (Uppsala, Sweden) 
Superscript II Reverse Transcriptase    Life Technologies (Eggenstein, Germany) 
 
T4 DNA ligase       New England Biolabs (Beverly, MA/USA) 
Taq DNA polymerase      Life Technologies (Eggenstein, Germany) 
TEMED       AppliChem (Darmstadt, Germany) 
Tris        ICN Biochemicals (Eschwege, Germany) 
Triton X-100       Sigma-Aldrich (Deisenhofen, Germany) 
trypsine       Seromed (Berlin, Germany) 
trypsine/EDTA       Biochrom KG (Berlin, Germany) 
Tween-20       ICN Biochemicals (Eschwege, Germany) 
 
urea        Merck (Darmstadt, Germany) 
 
X-GAL        ROTH (Karlsruhe, Germany) 
xylene cyanole       ICN Biochemicals (Eschwege, Germany) 
 
yeast extract       Life Technologies (Eggenstein, Germany) 
 
7.2 Devices 
Incubator 
Vortex        IKA Labortechnik (Staufen, Germany) 
Hybridisation incubator      Merck (Darmstadt, Germany) 
Thermomixer comfort      Eppendorf (Hamburg, Germany) 
 
PCR 
Mastercycler gradient      Eppendorf (Hamburg, Germany) 
Mastercycler personal      Eppendorf (Hamburg, Germany) 
Gen Read IR4200 (for sequencing)    LI-COR (Lincoln, Nebraska/USA) 
GeneAmp 5700      PE Biosystems (Weiterstadt, Germany) 
 
Centrifuge 
Avanti 300       Beckman (München, Germany) 
Centrifuge 5415 C      Eppendorf (Hamburg, Germany) 
Centrifuge 5804 R      Eppendorf (Hamburg, Germany) 
Centrifuge J2-21 with rotors JA-14 and JA-20   Beckman (München, Germany) 
Type universal 16 R      Hettich (Tuttlingen, Germany) 
Ultra centrifuge Optima-L70     Beckman (München, Germany) 
Sepatech Megafuge 1.0     Heraeus (Hanau, Germany) 
Mikro Rapid/K 1306      Hettich (Tuttlingen, Germany) 
 
pH-meter 
pH 213       Merck (Darmstadt, Germany) 
 
Photometer 
Perkin-Elmer 320      Perkin-Elmer (Überlingen, Germany) 
Shimadzu UV-2100      Shimadzu (Düsseldorf, Germany) 
Shimadzu UV-1601 PC     Shimadzu (Düsseldorf, Germany) 
Microplate reader MR700     Dynatech (Denkendorf, Germany) 
UV spectrometer GeneQuant II    Pharmacia (Freiburg, Germany) 
 
Electrophoresis 
Muppid 2       Eurogentec (Seraing, Belgium) 
Electrophoresis Power Supply EPS 1000   Amersham Biotech (Uppsala, Sweden) 
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Power Pac 200      BioRAD (Hercules, Californien/USA) 
MultiSmall       Amersham Biotech (Uppsala, Sweden) 
 
Sonification 
Branson Sonifier 250      Heinemann (Schwäbisch Gmünd, Germany) 
 
Cell culture 
Laminar flow hood Flow BSB 6A and BSB 4A   Gelaire (Meckenheim, Germany) 
Water bath GFL 1004      GFL (Burgwedel, Germany) 
Incubator BB 6220 CU      Heraeus (Hanau, Germany) 
Incubator IG 150      Astel (Chateau Gontier, France) 
Autoclave –steam sterilizer 3870EL    Jürgens (Münster, Germany) 
Sterilisator UT 6120      Heraeus (Hanau, Germany) 
Hemocytometer (Bürker)     Fischer (Frankfurt, Germany) 
 
Microscope 
Inverse phase-contrast microscope    Leika (Wetzlar, Germany) 
Fluorescence microscope Diaphot TMD   Nikon (Düsseldorf, Germany) 
Fluorescence microscope DM IRB   Leika (Wetzlar, Germany) 
Confocal laser-scanning microscope TCS   Leika (Wetzlar, Germany) 
 
Radioactive work 
Scintillation counter      Beckman (München, Germany) 
Autoradiography cassettes Oncor   Appligene (Geithersburg, MD/USA) 
Agfa Curix60       Agfa AG (Leverkusen, Germany) 
XOMAT AR Scientific Imaging Films    Eastman Kodal Comp. (Rochester, NY/USA) 
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Appendix A: Abbreviations 
ABC     ATP-binding cassette 
APS     ammonium peroxodisulfate 
ATP     adenosine triphosphate 
 
BBB     blood-brain barrier 
BCEC     brain capillary endothelial cells 
BCSFB    blood-cerebrospinal fluid barrier 
BMDP     brain multidrug resistance protein 
bp base    pair(s) 
BSA     bovine serum albumin 
 
cDNA     complementary deoxyribonucleic acid 
CNS     central nervous system 
CSF     cerebrospinal fluid 
 
Da     Dalton 
dATP     deoxyadenosine triphosphate 
dCTP    deoxycytosine triphosphate 
dd     double distilled 
ddNTP     didesoxynucleoside triphosphate 
dGTP     deoxyguanosine triphosphate 
DIV     day(s) in vitro 
DMEM     Dulbecco’s Modified Eagle Medium 
DMF     dimethylformamide 
DMPC     dimethylpyrocarbonate 
DMSO     dimethylsulfoxide 
DNA     deoxyribonucleic acid 
dNTP     deoxynucleoside triphosphate 
ds     double-stranded 
DTT     dithiothreitol 
dTTP     desoxytyrosinetriphosphate 
 
E. coli    Escherichia coli 
ECIS    electric cell substrate sensing 
EDTA     ethylendiamine tetraacetic acid 
 
f.c.     final concentration 
FCS     fetal calf serum 
for    forward 
 
g     acceleration due to gravity (9.81 m/s2) 
GAPDH    glyceraldehyde-3-phosphate dehydrogenase 
GGT    γ-glutaryltranspeptidase 
 
h    hour(s) 
HC     hydrocortisone 
Hepes     2-[4-(2-hydroxyethyl)-1-piperazinyl]-ethanesulfonic acid 
HUVEC    human umbilical vein endothelial cells 
 
kb     kilo base 
kDa     kilo Dalton 
 
L     liter 
LB     Luria and Bertami 
LMW     low molecular weight marker 
 
M     molar (mol/l) 
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MBCEC    murine brain capillary endothelial cells 
min     minute(s) 
MOPS    [N-morpholino]-propylsulfonic acid 
mRNA     messenger ribonucleic acid 
MRP     multidrug resistance associated protein 
MW     molecular weight 
 
NCBI     National Centre for Biotechnology Information 
NCS     newborn calf serum 
 
OD     optical density 
 
p.a.     pro analysis 
PAEC     porcine aortic endothelial cells 
PAGE     polyacrylamide gel electrophoresis 
PAMR    perijunctional actomyosin ring 
PBCEC    porcine brain capillary endothelial cells 
PBS     phosphate buffered saline 
PCR     polymerase chain reaction 
PDS    Plasma derived bovine serum 
 
Pgp     P-glycoprotein 
 
QCM    Quartz crystal microbalance 
QRT-PCR   quantitative real-time polymerase chain reaction 
 
ρ     density 
RNA     ribonucleic acid 
RNAi    RNA-interference method 
Rev    revers 
rpm     rounds per minute 
rRNA     ribosomal ribonucleic acid 
RT     reverse transcription 
 
SDS     sodium dodecyl sulfate 
sec     seconds 
siRNA    silence-inducing ribonuceic acid 
SSC     standard saline citrate 
SSH     subtractive suppression hybridisation 
 
TEMED   N,N,N’,N’-tetramethylethyldiamine 
TEER    transendothelial/epithelial electrical resistance 
Tris    tris-(hydroxymethyl)-aminomethane 
 
TA    Annealing  temperature 
U     unit 
UV     ultra violet 
 
V     voltage 
VE    vascular endothelial 
VIS     visible 
v/v     volume per volume 
vol     volume 
 
W     watt 
w/v    weight per volume 
WWU    Westfälische Wilhelms-Universität 
 
ZO     zonula occludens 
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Appendix B: WWW links 
 
 
www.ub.uni-bielefeld.de/netahtml/jaso1.html  Jason: ordering of literature 
www.uni-muenster.de/ULB/Welcome.html   Uni-Muenster: download of papers 
Medline: literature search 
www.embl-heidelberg.de/srs5/    Genbank, EMBL: sequence data bases 
www.ncbi.nlm.nih.gov/   NCBI: sequence alignment, basic blast 
search, PubMed 
www.pubmed.de/index.plip3     Literature data bases 
www.expasy.ch/   Expert Protein Analysis System Molecular 
Biology Server 
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Appendix C: Genotypes of Escherichia coli K12 strains 
 
 
TOP10F This strain can be used for general cloning and blue/white screening without IPTG. 
F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacX74recA1 deoR araD139 
∆(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG 
 
TOP10F’ This strain exresses the Lac repressor (lacIq gene). For blue/white screening 
IPTG has to be added to obtain expressing from the lac promoter. This strain 
contains the F episome and can be used for single-strand rescue of plasmid 
DNA containing an f1 origin. 
F’ {lacIq Tn10(TetR)} mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 
∆lacX74recA1 deoR araD139 ∆(ara-leu)7697 galU galK rpsL (StrR) endA1 
nupG 
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Appendix D: Sequences 
Primer sequences: PCR 
 
Primers for PCR were purchased from MWG Biotech. 
 
 
porcine GAPDH    for  ACCACAGTCCATGCCATCAC 
    rev  TGAGCTTGACAAAGTGGTCG 
 
porcine lamin A/C    for  GAGCACTGCTCTCAGTGAGAAGCGC 
    rev  CTCTCAGCAGACTGCCTGGCATTGT 
 
porcine ve-cadherin   for  CGTGGTGGACAAGAACACTGAGAAG 
    rev  GAGTGATGAACACAGTGGCTGTGCC 
 
porcine occludin  for  CTACACAACTGGCGGCGAGTCCTGC 
    rev  CTCCAACCATCTTCTTGATGTGTGAC 
 
 
 
 
Primer sequences: QRT-PCR 
 
Primers for QRT-PCR were purchased from Proligo  
 
Alkaline phosphatase  for CCAAAAACCTCAAAGGCTTCTTC 
    rev CTGCTTGGCCTTACCCTCATG 
 
Angiotensin-converting enzyme for GACAAACCCAACCTCGATGTCA 
rev CCTCTGATACCCGGAACATGTG 
 
β-Actin    for CCTGACGGACTACCTCATGAA 
 rev TCACGCACGATTACCCTCTCA 
 
BMDP    rev GTGGTAACCTGCTGATGCAAA 
 for CCTTACTGGCTTCCGGGAAA 
 
Claudin-1   for TCCCCGGAAAACAACCTCTT 
    rev TGTCACACATAGTCTTTCCCA 
 
Claudin-5   for GGTGGAACGCTCAGATTTCAT 
    rev AGTGCCCCCAGGATCTCAGT 
 
Ferrintransferase  for AGCCCAGAGAGACGCTTTGG 
  rev GCAAGTTTCAACAGAAGACCTGTTC 
 
γ-Glutaryltranspeptidase for CGGTTTGCCTATGCCAAGAG 
    rev CATGTTGCGGATCACCTGAGA 
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GAPDH   for CAAGGCCGAGAATGGGAAG 
GAPDH   rev GGCCTCACCCCATTTGATGT 
 
 
Occludin   for TGACAGACGGAAACCTTAGAG 
 rev AGACATCGTGCAGGCAGATG 
   
P-glycoprotein   for TTACCCGTGGCTGGAAGCTA 
    rev CAAATACCAGCTGACAGTCCA 
 
ZO-1    for TGGACAACCAGATGTGGATTT 
rev TCCCGTCTTCATGAGCTGAAT 
   
 
siRNA sequences 
 
Lamin A/C1 sense siRNA CUG GAC UUC CAG AAG AAC  AdTdT 
 antisense siRNA UGU UCU UCU GGA AGU CCA GdTdT 
 
Occludin2 sense siRNA GAC UAC  ACA ACU  GGC GGC GdTdT 
 antisense siRNA CGC CGC CAG UUG  UGU AGU CdTdT 
 
VE-Cadherin2 sense siRNA GGU GCU CGU GAU GCU GCU CdTdT 
 antisense siRNA GAG CAG CAU  CAC GAG CAC CdTdT 
 
BMDP2 
target 3:     sense siRNA       AUC UUC GUU GUU AGA UGU CdTdT 
      antisense siRNA      GAC AUC UAA  CAA CGA AGA UdTdT 
 
target 5:     sense siRNA       ACA AGG ACG GAC CAT  CAT  CdTdT 
      antisense siRNA      CAU GAU CCU CCG UCC UUG UdTdT 
 
 
 
1 purchased from Xeragon 
2 purchased from Eurogentec 
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Appendix E: Clone charts 
Vectors designed for probing and sequencing 
 
porcine GAPDH in pT-Adv (provided by Tanja Eisenblätter) 
RT-PCR (total RNA from PBCEC, GAPDH-F and GAPDH-R, TA 55°C); TA-cloning. 
 
 
porcine ve-cadherin in pT-Adv 
RT-PCR (total RNA from PBCEC, ve-cadherin for and ve-cadherin rev, TA 58°C); TA-cloning 
 
porcine lamin A/C in PCR2.3 
RT-PCR (total RNA from PBCEC, lamin A/C for and lamin A/C rev, TA 58°C); TA-cloning 
 
porcine occludin in pT-Adv (provided by Tanja Eisenblätter) 
RT-PCR (total RNA from PBCEC, occludin for and occludin rev, TA 54°C); TA-cloning. 
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pT-Adv-Vector (Clontech) 
pTAdv-Clontech
3906 bps
500
1000
1500
2000
2500
3000
3500
HindIII
Acc65I
KpnI
Ecl136II
SacI
BamHI
SpeI
AflII
EcoRV
NotI
AvaI
XhoI
NsiI
Ppu10I
XbaI
EcoO109I
ApaI
Bsp120I
DraIII
BstAPI
XcmI
BglII
BclI
MscI
Tth111I
BssHII
DsaI
NcoI
RsrII
XmnI
ScaI
TatI
BpmI
BsaI
AhdI
BspHI
BspLU11I
 
PCR 2.1-Vector (Invitrogen) 
PCR2.1
4047 bps
1000
2000
3000
4000
FseI
HindIII
Acc65I
KpnI
Ecl136II
SacI
BamHI
SpeI
AflII
EcoRV
NotI
AvaI
XhoI
XbaI
BglII
BclI
MscI
Tth111I
SacII
BssHII
NcoI
RsrII
EcoNI
ScaI
TatI
ApaI
Bsp120I
BpmI
BsaI
AhdI
BspHI
Eco47III
BspLU11I
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Table captions 
 
Table 2 1: Common Features of Endothelial Cells (Deli and Joo, 1996) ............................................ 12 
Table 2 2: Effects of compounds on different blood-brain barrier models in vitro ............................... 15 
Table 3 1: Overview of amounts and concentrations of used solutions during transfection with siRNA
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Table 3 2: Primary antibodies used in immunofluorescence staining ................................................. 28 
Table 3 3: Secondary antibodies used in immunofluorescence staining ............................................ 28 
Table 3 4: Concentrations of agarose gels.......................................................................................... 39 
Table 3 5: Acrylamide concentration for separation of proteins .......................................................... 53 
Table 3 6: Compounds of SDS-gels. ................................................................................................... 53 
Table 3 7: Antibodies for western blotting             55 
 
 
Figure captions 
 
Figure 2-1: Schematic view of the mammalian brain. Overview about the ventricles of the choroid 
plexus. (Spector and Johanson, 1989)........................................................................................... 5 
Figure 2-2: Micrograph of a Cross-section of a brain capillary (Krstic, 1988). ....................................... 7 
Figure 2-3: Molecular structure of the tight junctions.. ........................................................................... 8 
Figure 2-4: Regulation of glucocorticoid secretion. .............................................................................  17 
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Figure 4-4: Immunofluorescence labelling of tight junction proteins in MBCEC.. ....................................  
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Figure 4-11: Permeability of MBCEC.. ................................................................................................. 69 
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Figure 4-15: Topography images of MBCEC in vitro. .......................................................................... 76 
Figure 4-16: Height of tight junctions in different media. .....................................................................  77 
Figure 4-17: Force mapping of MBCEC under different conditions...................................................... 78 
Figure 4-18: Micrograph of a TEM-image of MBCEC. ........................................................................  79 
Figure 4-19: TEM images of MBCEC. .................................................................................................. 80 
Figure 4-20: Results of QRT-PCR in MBCEC...................................................................................... 81 
Figure 4-21: Expression pattern on RNA-level of blood-brain barrier markers in MBCEC. ................  82 
Figure 4-22: Western blot analysis of tight junction proteins................................................................ 83 
Figure 4-23: Immunodetection of lamin A/C in cultured murine and porcine brain capillary endothelial 
cells. .............................................................................................................................................. 85 
Figure 4-24: Change in expression of lamin A/C on protein level after transfection of cells with siRNA 
against lamin A/C.......................................................................................................................... 86 
Figure 5-1: Model for tight junction localisation and resulting staining pattern in immunofluorescence 
detection of tight junction proteins. ............................................................................................... 96 
 
 
134   
   
Lebenslauf 
 
Name:   Christian Weidenfeller 
Geburtsdatum: 10.10.1973 
Gebutsort:  Oberhausen 
Familienstand: ledig 
 
Namen der Eltern: Ulrich Weidenfeller 
   Elisabeth Weidenfeller, geb. Hübner 
 
Schulbildung: 
1980-1984:  Besuch der St. Vincentius Grundschule in Rees-Mehr 
1984-1993:  Besuch des Gymnasiums Aspel der Stadt Rees 
17.06.1993  Abschluss mit Erhalt der Allgemeinen Hochschulreife, Rees 
 
Zivildienst 
08/93-09/94  St. Willibrord-Spital Emmerich-Rees 
 
Studium: 
10/1994: Grundstudium der Biologie, Chemie Lehramt (Sek. II/I) und Philosophie 
Lehramt (Sek. II/I) an der Westfälischen Wilhelms-Universität Münster. 
17.04.1996 Zwischenprüfung im Fach Chemie (Lehramt Sek. II) 
05/1996 Hauptstudium Chemie Lehramt (Sek. II/I) an der Westfälischen 
Wilhelms-Universität, Münster 
25.09.1996 Vordiplom im Fach Biologie 
10/1996 Hauptstudium der Biologie an der Westfälischen Wilhelms-Universität, 
Münster 
30.05.2000 Abschluss des Studiums mit dem Diplom im Fach Biologie 
 
Promotionsstudiengang: 
06.2000 Beginn der Dissertation unter der Betreuung von Prof. Dr. H.-J. Galla, 
Institut für Biochemie  
 
Tätigkeiten: 
06/2000-08/2003: Wissenschaftlicher Mitarbeiter am Institut für Biochemie der 
Wesfälischen Wilhelms-Universität, Münster 
